<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03529773</url>
  </required_header>
  <id_info>
    <org_study_id>C3671001</org_study_id>
    <secondary_id>RSV FIH</secondary_id>
    <nct_id>NCT03529773</nct_id>
  </id_info>
  <brief_title>A Study to Describe the Safety and Immunogenicity of a RSV Vaccine in Healthy Adults</brief_title>
  <official_title>A PHASE 1/2, PLACEBO-CONTROLLED, RANDOMIZED, OBSERVER-BLIND, DOSE-FINDING, FIRST-IN-HUMAN STUDY TO DESCRIBE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF A RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINE IN HEALTHY ADULTS</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pfizer</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Pfizer</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study will describe the safety, tolerability, and immunogenicity of up to 6 RSV vaccine&#xD;
      formulations when administered alone or concomitantly with seasonal inactivated influenza&#xD;
      vaccine (SIIV).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study will describe the safety, tolerability, and immunogenicity of up to 6 RSV vaccine&#xD;
      formulations when administered alone or concomitantly with SIIV. Healthy male and female&#xD;
      subjects divided into 2 age groups (18-49 years of age and 50-85 years of age in the sentinel&#xD;
      cohort and 18-49 years of age and 65-85 years of age in the expanded cohort) will be&#xD;
      enrolled. Age groups will run in parallel. Subjects in the sentinel cohort in each age group&#xD;
      will receive one of two RSV vaccine formulations at one of 3 antigen dose levels or placebo.&#xD;
      Subjects in the expanded cohort in each age group will receive one of two RSV vaccine&#xD;
      formulations at one of 3 antigen dose levels with and without SIIV.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 18, 2018</start_date>
  <completion_date type="Actual">December 28, 2020</completion_date>
  <primary_completion_date type="Actual">November 20, 2019</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Parallel</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
    <masking_description>Observer blind</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Sentinel Cohort: Percentage of Participants (Aged 18 to 49 Years) With Local Reactions Within 14 Days After Vaccination</measure>
    <time_frame>Within 14 days after vaccination</time_frame>
    <description>Local reactions included pain at injection site, redness and swelling recorded by participants in an electronic diary (e-diary). Redness and swelling were measured and recorded in measuring device units. 1 measuring device unit =0.5 centimeter (cm) and graded as mild: 2.5 to 5.0 cm, moderate: greater than (&gt;) 5.0 to 10.0 cm and severe: &gt;10 cm. Pain at injection site was graded as mild: did not interfere with daily activity, moderate: interfere with daily activity and severe: prevented daily activity.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sentinel Cohort: Percentage of Participants (Aged 50 to 85 Years) With Local Reactions Within 14 Days After Vaccination</measure>
    <time_frame>Within 14 days after vaccination</time_frame>
    <description>Local reactions included pain at injection site, redness and swelling recorded by participants in an e-diary. Redness and swelling were measured and recorded in measuring device units. 1 measuring device unit =0.5 cm and graded as mild: 2.5 to 5.0 cm, moderate: &gt; 5.0 to 10.0 cm and severe: &gt;10 cm. Pain at injection site was graded as mild: did not interfere with daily activity, moderate: interfered with daily activity and severe: prevented daily activity.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Expanded Cohort: Percentage of Participants (Aged 18 to 49 Years) With Local Reactions Within 14 Days After Vaccination 1</measure>
    <time_frame>Within 14 days after vaccination 1 on Day 1</time_frame>
    <description>Local reactions included pain at injection site, redness and swelling recorded by participants in an e-diary. Redness and swelling were measured and recorded in measuring device units. 1 measuring device unit =0.5 cm and graded as mild: 2.5 to 5.0 cm, moderate: &gt; 5.0 to 10.0 cm and severe: &gt;10 cm. Pain at injection site was graded as mild: did not interfere with daily activity, moderate: interfere with daily activity and severe: prevented daily activity.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Expanded Cohort: Percentage of Participants (Aged 65 to 85 Years) With Local Reactions Within 14 Days After Vaccination 1</measure>
    <time_frame>Within 14 days after vaccination 1 on Day 1</time_frame>
    <description>Local reactions included pain at injection site, redness and swelling recorded by participants in an e-diary. Redness and swelling were measured and recorded in measuring device units. 1 measuring device unit =0.5 cm and graded as mild: 2.5 to 5.0 cm, moderate: &gt; 5.0 to 10.0 cm and severe: &gt;10 cm. Pain at injection site was graded as mild: did not interfere with daily activity, moderate: interfered with daily activity and severe: prevented daily activity.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sentinel Cohort: Percentage of Participants (Aged 18 to 49 Years) With Systemic Reactions Within 14 Days After Vaccination</measure>
    <time_frame>Within 14 days after vaccination</time_frame>
    <description>Systemic reactions:fever, fatigue/tiredness, headache, nausea, muscle pain, joint pain, vomiting, diarrhea and any systemic event recorded by participants in an e-diary. Fever: greater than equal to (&gt;=)38.0 degrees (deg) Celsius (C), mild (&gt;=38.0 to 38.4 deg C, &gt;38.4 to 38.9 deg C), moderate (&gt;38.9 to 40.0 deg C and &gt;40.0 deg C), severe (&gt;38.9 deg C to 40.0 deg C) and grade 4 (&gt;40.0 deg C). Fatigue, headache, nausea, muscle pain and joint pain were graded as mild: did not interfere with activity, moderate: some interference with activity and severe: prevented daily routine activity. Vomiting was graded as mild: 1 to 2 times in 24 hours(h), moderate: &gt;2 times in 24h and severe: requires intravenous hydration. Diarrhea was graded as mild: 2 to 3 loose stools in 24h, moderate: 4 to 5 loose stools in 24h and severe: 6 or more loose stools in 24h.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sentinel Cohort: Percentage of Participants (Aged 50 to 85 Years) With Systemic Reactions Within 14 Days After Vaccination</measure>
    <time_frame>Within 14 days after vaccination</time_frame>
    <description>Systemic reactions: fever, fatigue/tiredness, headache, nausea, muscle pain, joint pain, vomiting, diarrhea and any systemic event recorded by participants in an e-diary. Fever: &gt;= 38.0 deg C, mild (&gt;=38.0 to 38.4 deg C, &gt;38.4 to 38.9 deg C), moderate (&gt;38.9 to 40.0 deg C and &gt;40.0 deg C), severe (&gt;38.9 deg C to 40.0 deg C) and grade 4 (&gt;40.0 deg C). Fatigue, headache, nausea, muscle pain and joint pain were graded as mild: did not interfere with activity, moderate: some interference with activity and severe: prevented daily routine activity. Vomiting was graded as mild: 1 to 2 times in 24 h, moderate: &gt;2 times in 24h and severe: requires intravenous hydration. Diarrhea was graded as mild: 2 to 3 loose stools in 24h, moderate: 4 to 5 loose stools in 24h and severe: 6 or more loose stools in 24h.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Expanded Cohort: Percentage of Participants (Aged 18 to 49 Years) With Systemic Reactions Within 14 Days After Vaccination 1</measure>
    <time_frame>Within 14 days after vaccination 1 on Day 1</time_frame>
    <description>Systemic reactions: fever, fatigue/tiredness, headache, nausea, muscle pain, joint pain, vomiting, diarrhea and any systemic event recorded by participants in an e-diary. Fever: &gt;= 38.0 deg C, mild (&gt;=38.0 to 38.4 deg C, &gt;38.4 to 38.9 deg C), moderate (&gt;38.9 to 40.0 deg C and &gt;40.0 deg C), severe (&gt;38.9 deg C to 40.0 deg C) and grade 4 (&gt;40.0 deg C). Fatigue, headache, nausea, muscle pain and joint pain were graded as mild: did not interfere with activity, moderate: some interference with activity and severe: prevented daily routine activity. Vomiting was graded as mild: 1 to 2 times in 24 h, moderate: &gt;2 times in 24h and severe: requires intravenous hydration. Diarrhea was graded as mild: 2 to 3 loose stools in 24h, moderate: 4 to 5 loose stools in 24h and severe: 6 or more loose stools in 24h.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Expanded Cohort: Percentage of Participants (Aged 65 to 85 Years) With Systemic Reactions Within 14 Days After Vaccination 1</measure>
    <time_frame>Within 14 days after vaccination 1 on Day 1</time_frame>
    <description>Systemic reactions: fever, fatigue/tiredness, headache, nausea, muscle pain, joint pain, vomiting, diarrhea and any systemic event recorded by participants in an e-diary. Fever: &gt;= 38.0 deg C, mild (&gt;=38.0 to 38.4 deg C, &gt;38.4 to 38.9 deg C), moderate (&gt;38.9 to 40.0 deg C and &gt;40.0 deg C), severe (&gt;38.9 deg C to 40.0 deg C) and grade 4 (&gt;40.0 deg C). Fatigue, headache, nausea, muscle pain and joint pain were graded as mild: did not interfere with activity, moderate: some interference with activity and severe: prevented daily routine activity. Vomiting was graded as mild: 1 to 2 times in 24 h, moderate: &gt;2 times in 24h and severe: requires intravenous hydration. Diarrhea was graded as mild: 2 to 3 loose stools in 24h, moderate: 4 to 5 loose stools in 24h and severe: 6 or more loose stools in 24h.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sentinel Cohort: Percentage of Participants (Aged 18 to 49 Years) With Adverse Events (AEs) Within 1 Month After Vaccination</measure>
    <time_frame>Within 1 month after vaccination (up to 35 days)</time_frame>
    <description>An AE was any untoward medical occurrence in a participant who received investigational product without regard to possibility of causal relationship. AEs included both serious and non-serious adverse events. Serious adverse event (SAE) was an AE resulting in any of the following outcomes or deemed significant for any other reason: death; initial or prolonged inpatient hospitalization; life-threatening experience (immediate risk of dying); persistent or significant disability/incapacity; congenital anomaly.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sentinel Cohort: Percentage of Participants (Aged 50 to 85 Years) With AEs Within 1 Month After Vaccination</measure>
    <time_frame>Within 1 month after vaccination (up to 35 days)</time_frame>
    <description>An AE was any untoward medical occurrence in a participant who received investigational product without regard to possibility of causal relationship. AEs included both serious and non-serious adverse events. SAE was an AE resulting in any of the following outcomes or deemed significant for any other reason: death; initial or prolonged inpatient hospitalization; life-threatening experience (immediate risk of dying); persistent or significant disability/incapacity; congenital anomaly.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Expanded Cohort: Percentage of Participants (Aged 18 to 49 Years) With AE Within 1 Month After Vaccination 1</measure>
    <time_frame>Within 1 month after vaccination 1 (up to 35 days)</time_frame>
    <description>An AE was any untoward medical occurrence in a participant who received investigational product without regard to possibility of causal relationship. AEs included both serious and non-serious adverse events. SAE was an AE resulting in any of the following outcomes or deemed significant for any other reason: death; initial or prolonged inpatient hospitalization; life-threatening experience (immediate risk of dying); persistent or significant disability/incapacity; congenital anomaly.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Expanded Cohort: Percentage of Participants (Aged 65 to 85 Years) With AE Within 1 Month After Vaccination</measure>
    <time_frame>Within 1 month after vaccination 1 (up to 35 days)</time_frame>
    <description>An AE was any untoward medical occurrence in a participant who received investigational product without regard to possibility of causal relationship. AEs included both serious and non-serious adverse events. SAE was an AE resulting in any of the following outcomes or deemed significant for any other reason: death; initial or prolonged inpatient hospitalization; life-threatening experience (immediate risk of dying); persistent or significant disability/incapacity; congenital anomaly.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sentinel Cohort: Percentage of Participants (Aged 18 to 49 Years) With Medically Attended Adverse Events (MAEs) and Serious Adverse Events (SAEs) Upto 12 Months After Vaccination</measure>
    <time_frame>Upto 12 months after vaccination (up to 378 days)</time_frame>
    <description>MAE was defined as a non-serious AE that resulted in an evaluation at a medical facility. SAE was an AE resulting in any of the following outcomes or deemed significant for any other reason: death; initial or prolonged inpatient hospitalization; life-threatening experience (immediate risk of dying); persistent or significant disability/incapacity; congenital anomaly.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sentinel Cohort: Percentage of Participants (Aged 50 to 85 Years) With MAEs and SAEs Upto 12 Months After Vaccination</measure>
    <time_frame>Upto 12 months after vaccination (upto 378 days)</time_frame>
    <description>MAE was defined as a non-serious AE that resulted in an evaluation at a medical facility. SAE was an AE resulting in any of the following outcomes or deemed significant for any other reason: death; initial or prolonged inpatient hospitalization; life-threatening experience (immediate risk of dying); persistent or significant disability/incapacity; congenital anomaly.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Expanded Cohort: Percentage of Participants (Aged 18 to 49 Years) With MAEs and SAEs Upto 12 Months After Vaccination 1</measure>
    <time_frame>Upto 12 months after vaccination 1 (upto 378 days)</time_frame>
    <description>MAE was defined as a non-serious AE that resulted in an evaluation at a medical facility. SAE was an AE resulting in any of the following outcomes or deemed significant for any other reason: death; initial or prolonged inpatient hospitalization; life-threatening experience (immediate risk of dying); persistent or significant disability/incapacity; congenital anomaly.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Expanded Cohort: Percentage of Participants (Aged 65 to 85 Years) With MAEs and SAEs 12 Months After Vaccination 1</measure>
    <time_frame>Upto 12 months after vaccination 1 (upto 378 days)</time_frame>
    <description>MAE was defined as a non-serious AE that resulted in an evaluation at a medical facility. SAE was an AE resulting in any of the following outcomes or deemed significant for any other reason: death; initial or prolonged inpatient hospitalization; life-threatening experience (immediate risk of dying); persistent or significant disability/incapacity; congenital anomaly.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Expanded Cohort: Percentage of Participants (Aged 18 to 49 Years) With AEs Within 1 Month After Vaccination 2</measure>
    <time_frame>Within 1 month after vaccination 2 (upto Day 70)</time_frame>
    <description>An AE was any untoward medical occurrence in a participant who received investigational product without regard to possibility of causal relationship. AEs included both serious and non-serious adverse events.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Expanded Cohort: Percentage of Participants (Aged 65 to 85 Years) With AEs Within 1 Month After Vaccination 2</measure>
    <time_frame>Within 1 month after vaccination 2 (upto Day 70)</time_frame>
    <description>An AE was any untoward medical occurrence in a participant who received investigational product without regard to possibility of causal relationship. AEs included both serious and non-serious adverse events.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Sentinel Cohort: Geometric Mean Titers (GMTs) of Respiratory Syncytial Virus Subgroup A (RSV A) and RSV B Antigens Following Vaccination in Participants (Aged 18 to 49 Years)</measure>
    <time_frame>Before vaccination, and 2 weeks and 1, 2, 3, and 6 months after vaccination</time_frame>
    <description>GMTs of RSV A and RSV B antigens were measured using neutralizing assay. The neutralizing titer lower limit of quantitation (LLOQ) values were: A = 50 and B = 70. Assay results below the LLOQ were set to 0.5*LLOQ. Titers were expressed in terms of 1/dilution.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sentinel Cohort: GMTs of RSV A and RSV B Antigens Following Vaccination in Participants (Aged 50 to 85 Years)</measure>
    <time_frame>Before vaccination, and 2 weeks and 1, 2, 3, and 6 months after vaccination</time_frame>
    <description>GMTs of RSV A and RSV B antigens were measured using neutralizing assay. The neutralizing titer LLOQ values were: A = 50 and B = 70. Assay results below the LLOQ were set to 0.5*LLOQ. Titers were expressed in terms of 1/dilution.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Expanded Cohort: GMTs of RSV A and RSV B Antigens Following Vaccination in Participants (Aged 18 to 49 Years)</measure>
    <time_frame>Before vaccination,1, 2, 3, and 6 months after vaccination</time_frame>
    <description>GMTs of RSV A and RSV B antigens were measured using neutralizing assay. The neutralizing titer LLOQ values were: A = 50 and B = 70. Assay results below the LLOQ were set to 0.5*LLOQ. Titers were expressed in terms of 1/dilution.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Expanded Cohort: GMTs of RSV A and RSV B Antigens Following Vaccination in Participants (Aged 65 to 85 Years)</measure>
    <time_frame>Before vaccination,1, 2, 3, and 6 months after vaccination</time_frame>
    <description>GMTs of RSV A and RSV B antigens were measured using neutralizing assay. The neutralizing titer LLOQ values were: A = 50 and B = 70. Assay results below the LLOQ were set to 0.5*LLOQ. Titers were expressed in terms of 1/dilution.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Expanded Cohort: Hemagglutination Inhibition Assay (HAI) Titers for All Strains Following Vaccination With Seasonal Inactivated Influenza (SIIV) Vaccine in Participants (Aged 18 to 49 Years)</measure>
    <time_frame>Before vaccination and 1 Month after SIIV vaccination</time_frame>
    <description>The HAI titer LLOQ value for each strain was 10. Assay values below LLOQ were set to 0.5* LLOQ for analysis. Titers were expressed in terms of 1/dilution.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Expanded Cohort: Hemagglutination Inhibition Assay (HAI) Titers for All Strains Following Vaccination With Seasonal Inactivated Influenza (SIIV) Vaccine in Participants (Aged 65 to 85 Years)</measure>
    <time_frame>Before vaccination and 1 Month after SIIV vaccination</time_frame>
    <description>The HAI titer LLOQ value for each strain was 10. Assay values below LLOQ were set to 0.5* LLOQ for analysis. Titers were expressed in terms of 1/dilution.</description>
  </secondary_outcome>
  <number_of_arms>20</number_of_arms>
  <enrollment type="Actual">1253</enrollment>
  <condition>Respiratory Tract Infections</condition>
  <arm_group>
    <arm_group_label>Sentinel Arm 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Low dose formulation A</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sentinel Arm 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Mid dose formulation A</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sentinel Arm 3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>High dose formulation A</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sentinel Arm 4</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Low dose formulation B</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sentinel Arm 5</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Mid dose formulation B</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sentinel Arm 6</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>High dose formulation B</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sentinel Arm 7</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Expanded Arm 8</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Low dose formulation A and SIIV</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Expanded Arm 9</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Mid dose formulation A and SIIV</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Expanded Arm 10</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>High dose formulation A and SIIV</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Expanded Arm 11</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Low dose formulation B and SIIV</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Expanded Arm 12</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Mid dose formulation B and SIIV</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Expanded Arm 13</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>High dose formulation B and SIIV</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Expanded Arm 14</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Low dose formulation A and placebo</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Expanded Arm 15</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Mid dose formulation A and placebo</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Expanded Arm 16</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>High dose formulation A and placebo</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Expanded Arm 17</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Low dose formulation B and placebo</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Expanded Arm 18</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Mid dose formulation B and placebo</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Expanded Arm 19</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>High dose formulation B and placebo</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Expanded Arm 20</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>placebo and placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Formulation A</intervention_name>
    <description>RSV vaccine</description>
    <arm_group_label>Expanded Arm 10</arm_group_label>
    <arm_group_label>Expanded Arm 14</arm_group_label>
    <arm_group_label>Expanded Arm 15</arm_group_label>
    <arm_group_label>Expanded Arm 16</arm_group_label>
    <arm_group_label>Expanded Arm 8</arm_group_label>
    <arm_group_label>Expanded Arm 9</arm_group_label>
    <arm_group_label>Sentinel Arm 1</arm_group_label>
    <arm_group_label>Sentinel Arm 2</arm_group_label>
    <arm_group_label>Sentinel Arm 3</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Formulation B</intervention_name>
    <description>RSV vaccine</description>
    <arm_group_label>Expanded Arm 11</arm_group_label>
    <arm_group_label>Expanded Arm 12</arm_group_label>
    <arm_group_label>Expanded Arm 13</arm_group_label>
    <arm_group_label>Expanded Arm 17</arm_group_label>
    <arm_group_label>Expanded Arm 18</arm_group_label>
    <arm_group_label>Expanded Arm 19</arm_group_label>
    <arm_group_label>Sentinel Arm 4</arm_group_label>
    <arm_group_label>Sentinel Arm 5</arm_group_label>
    <arm_group_label>Sentinel Arm 6</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo</description>
    <arm_group_label>Expanded Arm 20</arm_group_label>
    <arm_group_label>Sentinel Arm 7</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Evidence of a personally signed and dated informed consent document (ICD) indicating&#xD;
             that the subject has been informed of all pertinent aspects of the study.&#xD;
&#xD;
          2. Healthy adults who are determined by medical history, physical examination, and&#xD;
             clinical judgment of the investigator to be eligible for inclusion in the study.&#xD;
&#xD;
          3. Willing and able to comply with scheduled visits, vaccination plan, laboratory tests,&#xD;
             and other study procedures.&#xD;
&#xD;
          4. Male subject who is able to father children and willing to use a highly effective&#xD;
             method of contraception as outlined in this protocol until at least 28 days after the&#xD;
             last dose of investigational product; female subject who is of childbearing potential&#xD;
             and at risk for pregnancy and who is willing to use a highly effective method of&#xD;
             contraception as outlined in this protocol until at least 28 days after the last dose&#xD;
             of investigational product; male subject not able to father children; female subject&#xD;
             not of childbearing potential.&#xD;
&#xD;
          5. Sentinel-cohort subjects only: Male and female adults aged 18 to 85 years at the time&#xD;
             of enrollment (signing of the ICD).&#xD;
&#xD;
          6. Expanded-cohort subjects only: Male and female adults aged 18 to 49 years of age or 65&#xD;
             to 85 years at the time of enrollment (signing of the ICD).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Sentinel-cohort subjects only: Any screening hematology and/or blood chemistry&#xD;
             laboratory value that meets the definition of a ≥ Grade 1 abnormality.&#xD;
&#xD;
          2. Sentinel-cohort subjects only: Positive test for human immunodeficiency virus (HIV),&#xD;
             hepatitis B surface antigen (HBsAg), hepatitis B core antibodies (HBc Abs), or&#xD;
             hepatitis C virus antibodies (HCV Abs) at the screening visit.&#xD;
&#xD;
          3. Investigator site staff members directly involved in the conduct of the study and&#xD;
             their family members, site staff members otherwise supervised by the investigator, or&#xD;
             subjects who are Pfizer employees, including their family members, directly involved&#xD;
             in the conduct of the study.&#xD;
&#xD;
          4. Participation in other studies involving investigational product within 28 days prior&#xD;
             to study entry and/or during study participation.&#xD;
&#xD;
          5. Known infection with HIV, hepatitis C virus (HCV), or hepatitis B virus (HBV).&#xD;
&#xD;
          6. Previous vaccination with any licensed or investigational RSV vaccine, or planned&#xD;
             receipt throughout the study of nonstudy RSV vaccine.&#xD;
&#xD;
          7. History of severe adverse reaction associated with a vaccine and/or severe allergic&#xD;
             reaction (eg, anaphylaxis) to any component of the investigational product(s).&#xD;
&#xD;
          8. Immunocompromised subjects with known or suspected immunodeficiency, as determined by&#xD;
             history and/or laboratory/physical examination.&#xD;
&#xD;
          9. Subjects who receive treatment with immunosuppressive therapy, including cytotoxic&#xD;
             agents or systemic corticosteroids, eg, for cancer or an autoimmune disease, or&#xD;
             planned receipt throughout the study. If systemic corticosteroids have been&#xD;
             administered short term (&lt;14 days) for treatment of an acute illness, subjects should&#xD;
             not be enrolled into the study until corticosteroid therapy has been discontinued for&#xD;
             at least 28 days before investigational product administration. Intra-articular,&#xD;
             intrabursal, or topical (skin or eyes) corticosteroids are permitted.&#xD;
&#xD;
         10. Subject with a history of autoimmune disease or an active autoimmune disease requiring&#xD;
             therapeutic intervention including but not limited to: systemic or cutaneous lupus&#xD;
             erythematosus, autoimmune arthritis/rheumatoid arthritis, Guillain-Barré syndrome,&#xD;
             multiple sclerosis, Sjögren's syndrome, idiopathic thrombocytopenia purpura,&#xD;
             glomerulonephritis, autoimmune thyroiditis, giant cell arteritis (temporal arteritis),&#xD;
             psoriasis, and insulin-dependent diabetes mellitus (type 1).&#xD;
&#xD;
         11. Receipt of blood/plasma products or immunoglobulin, from 60 days before&#xD;
             investigational product administration or planned receipt throughout the study.&#xD;
&#xD;
         12. Other acute or chronic medical or psychiatric condition including recent (within the&#xD;
             past year) or active suicidal ideation or behavior or laboratory abnormality that may&#xD;
             increase the risk associated with study participation or investigational product&#xD;
             administration or may interfere with the interpretation of study results and, in the&#xD;
             judgment of the investigator, would make the subject inappropriate for entry into this&#xD;
             study.&#xD;
&#xD;
         13. Bleeding diathesis or condition associated with prolonged bleeding that would, in the&#xD;
             opinion of the investigator, contraindicate intramuscular injection.&#xD;
&#xD;
         14. Women who are pregnant or breastfeeding.&#xD;
&#xD;
         15. Expanded-cohort subjects only: Vaccination with any influenza vaccine within 6 months&#xD;
             (182 days) before investigational product administration.&#xD;
&#xD;
         16. Expanded-cohort subjects only: Allergy to egg proteins (egg or egg products) or&#xD;
             chicken proteins.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pfizer CT.gov Call Center</last_name>
    <role>Study Director</role>
    <affiliation>Pfizer</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Coastal Clinical Research, Inc.</name>
      <address>
        <city>Mobile</city>
        <state>Alabama</state>
        <zip>36608</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Anaheim Clinical Trials LLC-Clinical Research</name>
      <address>
        <city>Anaheim</city>
        <state>California</state>
        <zip>92801</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Paradigm Clinical Research Centers, Inc.</name>
      <address>
        <city>La Mesa</city>
        <state>California</state>
        <zip>91942</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Paradigm Clinical Research Center</name>
      <address>
        <city>Redding</city>
        <state>California</state>
        <zip>96001</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinical Research of South Florida</name>
      <address>
        <city>Coral Gables</city>
        <state>Florida</state>
        <zip>33134</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinical Neuroscience Solutions, Inc.</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32801</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Meridian Clinical Research, LLC</name>
      <address>
        <city>Savannah</city>
        <state>Georgia</state>
        <zip>31406</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinical Research Atlanta</name>
      <address>
        <city>Stockbridge</city>
        <state>Georgia</state>
        <zip>30281</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>East-West Medical Research Institute</name>
      <address>
        <city>Honolulu</city>
        <state>Hawaii</state>
        <zip>96814</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Meridian Clinical Research</name>
      <address>
        <city>Sioux City</city>
        <state>Iowa</state>
        <zip>51106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Augusta Family Practice</name>
      <address>
        <city>Augusta</city>
        <state>Kansas</state>
        <zip>67010</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Heartland Research Associates, LLC</name>
      <address>
        <city>Augusta</city>
        <state>Kansas</state>
        <zip>67010</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Axtell Clinic, P.A.</name>
      <address>
        <city>Newton</city>
        <state>Kansas</state>
        <zip>67114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Heartland Research Assocites, LLC</name>
      <address>
        <city>Newton</city>
        <state>Kansas</state>
        <zip>67114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Heartland Research Associates, LLC</name>
      <address>
        <city>Wichita</city>
        <state>Kansas</state>
        <zip>67207</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sundance Clinical Research, LLC</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63141</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Meridian Clinical Research, LLC</name>
      <address>
        <city>Norfolk</city>
        <state>Nebraska</state>
        <zip>68701</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Quality Clinical Research, Inc.</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>United Medical Associates</name>
      <address>
        <city>Binghamton</city>
        <state>New York</state>
        <zip>13901</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Regional Clinical Research, Inc.</name>
      <address>
        <city>Endwell</city>
        <state>New York</state>
        <zip>13760</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rochester Regional Health/Rochester General Hospital</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14621</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Rochester Medical Center</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14642</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>PMG Research of Charlotte, LLC</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28209</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>PMG Research of Raleigh, LLC</name>
      <address>
        <city>Raleigh</city>
        <state>North Carolina</state>
        <zip>27609</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>PMG Research of Wilmington, LLC</name>
      <address>
        <city>Wilmington</city>
        <state>North Carolina</state>
        <zip>28401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>PMG Research of Winston-Salem, LLC</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sterling Research Group, Ltd.</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45219</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Aventiv Research Inc.</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43213</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>PriMed Clinical Research</name>
      <address>
        <city>Dayton</city>
        <state>Ohio</state>
        <zip>45419</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lynn Health Science Institute</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73112</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Benchmark Research</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78705</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Texas Health Care, PLLC</name>
      <address>
        <city>Fort Worth</city>
        <state>Texas</state>
        <zip>76104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ventavia Research Group, LLC</name>
      <address>
        <city>Fort Worth</city>
        <state>Texas</state>
        <zip>76104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Benchmark Research</name>
      <address>
        <city>Fort Worth</city>
        <state>Texas</state>
        <zip>76135</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>HealthFirst Medical Group</name>
      <address>
        <city>Fort Worth</city>
        <state>Texas</state>
        <zip>76135</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinical Trials of Texas, Inc.</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>J. Lewis Research, Inc. / Foothill Family Clinic</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84109</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>J. Lewis Research, Inc. /Foothill Family Clinic South</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84121</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>J.Lewis Research, Inc. / Jordan River Family Medicine</name>
      <address>
        <city>South Jordan</city>
        <state>Utah</state>
        <zip>84095</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Advanced Clinical Research</name>
      <address>
        <city>West Jordan</city>
        <state>Utah</state>
        <zip>84088</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://pmiform.com/clinical-trial-info-request?StudyID=C3671001</url>
    <description>To obtain contact information for a study center near you, click here.</description>
  </link>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>April 17, 2018</study_first_submitted>
  <study_first_submitted_qc>May 7, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 18, 2018</study_first_posted>
  <results_first_submitted>November 18, 2020</results_first_submitted>
  <results_first_submitted_qc>February 11, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">March 4, 2021</results_first_posted>
  <last_update_submitted>May 12, 2021</last_update_submitted>
  <last_update_submitted_qc>May 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Respiratory tract infections, RSV, vaccine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Tract Infections</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Pfizer will provide access to individual de-identified participant data and related study documents (e.g. protocol, Statistical Analysis Plan (SAP), Clinical Study Report (CSR)) upon request from qualified researchers, and subject to certain criteria, conditions, and exceptions. Further details on Pfizer's data sharing criteria and process for requesting access can be found at: https://www.pfizer.com/science/clinical_trials/trial_data_and_results/data_requests.</ipd_description>
    <ipd_time_frame>Starting 24 months after study completion.</ipd_time_frame>
    <ipd_url>https://www.pfizer.com/science/clinical_trials/trial_data_and_results/data_requests</ipd_url>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>June 11, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/73/NCT03529773/Prot_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>June 15, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/73/NCT03529773/SAP_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Sentinel Cohort: Respiratory Syncytial Virus (RSV) Vaccine 60 Microgram (mcg) Age 18-49 Years</title>
          <description>Participants aged 18-49 years received single 60-mcg dose of RSV vaccine, intramuscularly. Participants were followed up to 12 months after vaccination.</description>
        </group>
        <group group_id="P2">
          <title>Sentinel Cohort: RSV 60 mcg With Aluminum Hydroxide Age 18-49 Years</title>
          <description>Participants aged 18-49 years received single 60-mcg dose with aluminum hydroxide intramuscularly. Participants were followed up to 12 months after vaccination.</description>
        </group>
        <group group_id="P3">
          <title>Sentinel Cohort: RSV 120 mcg Age 18-49 Years</title>
          <description>Participants aged 18-49 years received single 120-mcg dose intramuscularly. Participants were followed up to 12 months after vaccination.</description>
        </group>
        <group group_id="P4">
          <title>Sentinel Cohort: RSV 120 mcg With Aluminum Hydroxide Age 18-49 Years</title>
          <description>Participants aged 18-49 years received single 120-mcg dose with aluminum hydroxide intramuscularly. Participants were followed up to 12 months after vaccination.</description>
        </group>
        <group group_id="P5">
          <title>Sentinel Cohort: RSV 240 mcg Age 18-49 Years</title>
          <description>Participants aged 18-49 years received single 240-mcg dose intramuscularly. Participants were followed up to 12 months after vaccination.</description>
        </group>
        <group group_id="P6">
          <title>Sentinel Cohort: RSV 240 mcg With Aluminum Hydroxide Age 18-49 Years</title>
          <description>Participants aged 18-49 years received single 240-mcg dose with aluminum hydroxide intramuscularly. Participants were followed up to 12 months after vaccination.</description>
        </group>
        <group group_id="P7">
          <title>Sentinel Cohort: Placebo Age 18-49 Years</title>
          <description>Participants aged 18-49 years received placebo matched to RSV vaccine intramuscularly. Participants were followed up to 12 months after vaccination.</description>
        </group>
        <group group_id="P8">
          <title>Sentinel Cohort: RSV Vaccine 60 mcg Age 50-85 Years</title>
          <description>Participants aged 50-85 years received single 60-mcg dose of RSV vaccine, intramuscularly. Participants were followed up to 12 months after vaccination.</description>
        </group>
        <group group_id="P9">
          <title>Sentinel Cohort: RSV 60 mcg With Aluminum Hydroxide Age 50-85 Years</title>
          <description>Participants aged 50-85 years received single 60-mcg dose with aluminum hydroxide intramuscularly. Participants were followed up to 12 months after vaccination.</description>
        </group>
        <group group_id="P10">
          <title>Sentinel Cohort: RSV 120 mcg Age 50-85 Years</title>
          <description>Participants aged 50-85 years received single 120-mcg dose intramuscularly. Participants were followed up to 12 months after vaccination.</description>
        </group>
        <group group_id="P11">
          <title>Sentinel Cohort: RSV 120 mcg With Aluminum Hydroxide Age 50-85 Years</title>
          <description>Participants aged 50-85 years received single 120-mcg dose with aluminum hydroxide intramuscularly. Participants were followed up to 12 months after vaccination.</description>
        </group>
        <group group_id="P12">
          <title>Sentinel Cohort: RSV 240 mcg Age 50-85 Years</title>
          <description>Participants aged 50-85 years received single 240-mcg dose intramuscularly. Participants were followed up to 12 months after vaccination.</description>
        </group>
        <group group_id="P13">
          <title>Sentinel Cohort: RSV 240 mcg With Aluminum Hydroxide Age 50-85 Years</title>
          <description>Participants aged 50-85 years received single 240-mcg dose with aluminum hydroxide intramuscularly. Participants were followed up to 12 months after vaccination.</description>
        </group>
        <group group_id="P14">
          <title>Sentinel Cohort: Placebo Age 50-85 Years</title>
          <description>Participants aged 50-85 years received placebo matched to RSV vaccine intramuscularly. Participants were followed up to 12 months after vaccination.</description>
        </group>
        <group group_id="P15">
          <title>Expanded Cohort: RSV 60 mcg With Seasonal Inactivated Influenza Vaccine (SIIV)-Age 18-49 Years</title>
          <description>Participants aged 18-49 years received 2 doses of RSV vaccine 60 mcg along with 0.5 milliliter (mL) SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
        </group>
        <group group_id="P16">
          <title>Expanded Cohort: RSV 60 mcg With Placebo Age 18-49 Years</title>
          <description>Participants aged 18-49 years received 2 doses of RSV vaccine 60 mcg along with placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
        </group>
        <group group_id="P17">
          <title>Expanded Cohort: RSV 60 mcg With Aluminum Hydroxide and SIIV Age 18-49 Years</title>
          <description>Participants aged 18-49 years received 2 doses of RSV vaccine 60 mcg along with aluminum hydroxide and 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
        </group>
        <group group_id="P18">
          <title>Expanded Cohort: RSV 60 mcg With Aluminum Hydroxide and Placebo Age 18-49 Years</title>
          <description>Participants aged 18-49 years received 2 doses of RSV vaccine 60 mcg along with aluminum hydroxide and placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
        </group>
        <group group_id="P19">
          <title>Expanded Cohort: RSV 120 mcg With SIIV Age 18-49 Years</title>
          <description>Participants aged 18-49 years received 2 doses of RSV vaccine 120 mcg along with 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
        </group>
        <group group_id="P20">
          <title>Expanded Cohort: RSV 120 mcg With Placebo Age 18-49 Years</title>
          <description>Participants aged 18-49 years received 2 doses of RSV vaccine 120 mcg along with placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
        </group>
        <group group_id="P21">
          <title>Expanded Cohort: RSV 120 mcg With Aluminum Hydroxide and SIIV Age 18-49 Years</title>
          <description>Participants aged 18-49 years received 2 doses of RSV vaccine 120 mcg along with aluminum hydroxide and 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
        </group>
        <group group_id="P22">
          <title>Expanded Cohort: RSV 120 mcg With Aluminum Hydroxide and Placebo Age 18-49 Years</title>
          <description>Participants aged 18-49 years received 2 doses of RSV vaccine 120 mcg along with aluminum hydroxide and placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
        </group>
        <group group_id="P23">
          <title>Expanded Cohort: RSV 240 mcg With SIIV Age 18-49 Years</title>
          <description>Participants aged 18-49 years received 2 doses of RSV vaccine 240 mcg along with 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
        </group>
        <group group_id="P24">
          <title>Expanded Cohort: RSV 240 mcg With Placebo Age 18-49 Years</title>
          <description>Participants aged 18-49 years received 2 doses of RSV vaccine 240 mcg along with placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
        </group>
        <group group_id="P25">
          <title>Expanded Cohort: RSV 240 mcg With Aluminum Hydroxide and SIIV Age 18-49 Years</title>
          <description>Participants aged 18-49 years received 2 doses of RSV vaccine 240 mcg along with aluminum hydroxide and 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
        </group>
        <group group_id="P26">
          <title>Expanded Cohort: RSV 240 mcg With Aluminum Hydroxide and Placebo Age 18-49 Years</title>
          <description>Participants aged 18-49 years received 2 doses of RSV vaccine 240 mcg along with aluminum hydroxide and placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
        </group>
        <group group_id="P27">
          <title>Expanded Cohort: Placebo Age 18-49 Years</title>
          <description>Participants aged 18-49 years received placebo matched to RSV vaccine intramuscularly. Participants were followed up to 12 months after vaccination.</description>
        </group>
        <group group_id="P28">
          <title>Expanded Cohort: RSV 60 mcg With SIIV Age 65-85 Years</title>
          <description>Participants aged 65-85 years received 2 doses of RSV vaccine 60 mcg along with 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
        </group>
        <group group_id="P29">
          <title>Expanded Cohort: RSV 60 mcg With Placebo Age 65-85 Years</title>
          <description>Participants aged 65-85 years received 2 doses of RSV vaccine 60 mcg along with placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
        </group>
        <group group_id="P30">
          <title>Expanded Cohort: RSV 60 mcg With Aluminum Hydroxide and SIIV Age 65-85 Years</title>
          <description>Participants aged 65-85 years received 2 doses of RSV vaccine 60 mcg along with aluminum hydroxide and 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
        </group>
        <group group_id="P31">
          <title>Expanded Cohort: RSV 60 mcg With Aluminum Hydroxide and Placebo Age 65-85 Years</title>
          <description>Participants aged 65-85 years received 2 doses of RSV vaccine 60 mcg along with aluminum hydroxide and placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
        </group>
        <group group_id="P32">
          <title>Expanded Cohort: RSV 120 mcg With SIIV Age 65-85 Years</title>
          <description>Participants aged 65-85 years received 2 doses of RSV vaccine 120 mcg along with 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
        </group>
        <group group_id="P33">
          <title>Expanded Cohort: RSV 120 mcg With Placebo Age 65-85 Years</title>
          <description>Participants aged 65-85 years received 2 doses of RSV vaccine 120 mcg along with placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
        </group>
        <group group_id="P34">
          <title>Expanded Cohort: RSV 120 mcg With Aluminum Hydroxide and SIIV Age 65-85 Years</title>
          <description>Participants aged 65-85 years received 2 doses of RSV vaccine 120 mcg along with aluminum hydroxide and 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
        </group>
        <group group_id="P35">
          <title>Expanded Cohort: RSV 120 mcg With Aluminum Hydroxide and Placebo Age 65-85 Years</title>
          <description>Participants aged 65-85 years received 2 doses of RSV vaccine 120 mcg along with aluminum hydroxide and placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
        </group>
        <group group_id="P36">
          <title>Expanded Cohort: RSV 240 mcg With SIIV Age 65-85 Years</title>
          <description>Participants aged 65-85 years received 2 doses of RSV vaccine 240 mcg along with 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
        </group>
        <group group_id="P37">
          <title>Expanded Cohort: RSV 240 mcg With Placebo Age 65-85 Years</title>
          <description>Participants aged 65-85 years received 2 doses of RSV vaccine 240 mcg along with placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
        </group>
        <group group_id="P38">
          <title>Expanded Cohort: RSV 240 mcg With Aluminum Hydroxide and SIIV Age 65-85 Years</title>
          <description>Participants aged 65-85 years received 2 doses of RSV vaccine 240 mcg along with aluminum hydroxide and 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
        </group>
        <group group_id="P39">
          <title>Expanded Cohort: RSV 240 mcg With Aluminum Hydroxide and Placebo Age 65-85 Years</title>
          <description>Participants aged 65-85 years received 2 doses of RSV vaccine 240 mcg along with aluminum hydroxide and placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
        </group>
        <group group_id="P40">
          <title>Expanded Cohort: Placebo Age 65-85 Years</title>
          <description>Participants aged 65-85 years received placebo matched to RSV vaccine intramuscularly. Participants were followed up to 12 months after vaccination.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="12"/>
                <participants group_id="P3" count="12"/>
                <participants group_id="P4" count="12"/>
                <participants group_id="P5" count="12"/>
                <participants group_id="P6" count="12"/>
                <participants group_id="P7" count="12"/>
                <participants group_id="P8" count="12"/>
                <participants group_id="P9" count="12"/>
                <participants group_id="P10" count="12"/>
                <participants group_id="P11" count="12"/>
                <participants group_id="P12" count="12"/>
                <participants group_id="P13" count="12"/>
                <participants group_id="P14" count="12"/>
                <participants group_id="P15" count="41"/>
                <participants group_id="P16" count="42"/>
                <participants group_id="P17" count="41"/>
                <participants group_id="P18" count="40"/>
                <participants group_id="P19" count="41"/>
                <participants group_id="P20" count="41"/>
                <participants group_id="P21" count="41"/>
                <participants group_id="P22" count="41"/>
                <participants group_id="P23" count="41"/>
                <participants group_id="P24" count="41"/>
                <participants group_id="P25" count="41"/>
                <participants group_id="P26" count="41"/>
                <participants group_id="P27" count="41"/>
                <participants group_id="P28" count="40"/>
                <participants group_id="P29" count="41"/>
                <participants group_id="P30" count="40"/>
                <participants group_id="P31" count="42"/>
                <participants group_id="P32" count="40"/>
                <participants group_id="P33" count="40"/>
                <participants group_id="P34" count="41"/>
                <participants group_id="P35" count="41"/>
                <participants group_id="P36" count="40"/>
                <participants group_id="P37" count="41"/>
                <participants group_id="P38" count="42"/>
                <participants group_id="P39" count="43"/>
                <participants group_id="P40" count="41"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="12"/>
                <participants group_id="P3" count="11"/>
                <participants group_id="P4" count="12"/>
                <participants group_id="P5" count="11"/>
                <participants group_id="P6" count="11"/>
                <participants group_id="P7" count="12"/>
                <participants group_id="P8" count="11"/>
                <participants group_id="P9" count="12"/>
                <participants group_id="P10" count="11"/>
                <participants group_id="P11" count="11"/>
                <participants group_id="P12" count="12"/>
                <participants group_id="P13" count="10"/>
                <participants group_id="P14" count="11"/>
                <participants group_id="P15" count="35"/>
                <participants group_id="P16" count="38"/>
                <participants group_id="P17" count="40"/>
                <participants group_id="P18" count="35"/>
                <participants group_id="P19" count="37"/>
                <participants group_id="P20" count="37"/>
                <participants group_id="P21" count="34"/>
                <participants group_id="P22" count="36"/>
                <participants group_id="P23" count="36"/>
                <participants group_id="P24" count="36"/>
                <participants group_id="P25" count="34"/>
                <participants group_id="P26" count="31"/>
                <participants group_id="P27" count="33"/>
                <participants group_id="P28" count="39"/>
                <participants group_id="P29" count="40"/>
                <participants group_id="P30" count="40"/>
                <participants group_id="P31" count="39"/>
                <participants group_id="P32" count="40"/>
                <participants group_id="P33" count="40"/>
                <participants group_id="P34" count="39"/>
                <participants group_id="P35" count="37"/>
                <participants group_id="P36" count="37"/>
                <participants group_id="P37" count="40"/>
                <participants group_id="P38" count="41"/>
                <participants group_id="P39" count="43"/>
                <participants group_id="P40" count="39"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="1"/>
                <participants group_id="P6" count="1"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="1"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="1"/>
                <participants group_id="P11" count="1"/>
                <participants group_id="P12" count="0"/>
                <participants group_id="P13" count="2"/>
                <participants group_id="P14" count="1"/>
                <participants group_id="P15" count="6"/>
                <participants group_id="P16" count="4"/>
                <participants group_id="P17" count="1"/>
                <participants group_id="P18" count="5"/>
                <participants group_id="P19" count="4"/>
                <participants group_id="P20" count="4"/>
                <participants group_id="P21" count="7"/>
                <participants group_id="P22" count="5"/>
                <participants group_id="P23" count="5"/>
                <participants group_id="P24" count="5"/>
                <participants group_id="P25" count="7"/>
                <participants group_id="P26" count="10"/>
                <participants group_id="P27" count="8"/>
                <participants group_id="P28" count="1"/>
                <participants group_id="P29" count="1"/>
                <participants group_id="P30" count="0"/>
                <participants group_id="P31" count="3"/>
                <participants group_id="P32" count="0"/>
                <participants group_id="P33" count="0"/>
                <participants group_id="P34" count="2"/>
                <participants group_id="P35" count="4"/>
                <participants group_id="P36" count="3"/>
                <participants group_id="P37" count="1"/>
                <participants group_id="P38" count="1"/>
                <participants group_id="P39" count="0"/>
                <participants group_id="P40" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
                <participants group_id="P11" count="0"/>
                <participants group_id="P12" count="0"/>
                <participants group_id="P13" count="0"/>
                <participants group_id="P14" count="0"/>
                <participants group_id="P15" count="0"/>
                <participants group_id="P16" count="0"/>
                <participants group_id="P17" count="0"/>
                <participants group_id="P18" count="0"/>
                <participants group_id="P19" count="0"/>
                <participants group_id="P20" count="0"/>
                <participants group_id="P21" count="0"/>
                <participants group_id="P22" count="0"/>
                <participants group_id="P23" count="0"/>
                <participants group_id="P24" count="0"/>
                <participants group_id="P25" count="0"/>
                <participants group_id="P26" count="0"/>
                <participants group_id="P27" count="0"/>
                <participants group_id="P28" count="0"/>
                <participants group_id="P29" count="0"/>
                <participants group_id="P30" count="0"/>
                <participants group_id="P31" count="1"/>
                <participants group_id="P32" count="0"/>
                <participants group_id="P33" count="0"/>
                <participants group_id="P34" count="0"/>
                <participants group_id="P35" count="0"/>
                <participants group_id="P36" count="1"/>
                <participants group_id="P37" count="0"/>
                <participants group_id="P38" count="0"/>
                <participants group_id="P39" count="0"/>
                <participants group_id="P40" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
                <participants group_id="P11" count="0"/>
                <participants group_id="P12" count="0"/>
                <participants group_id="P13" count="1"/>
                <participants group_id="P14" count="0"/>
                <participants group_id="P15" count="0"/>
                <participants group_id="P16" count="0"/>
                <participants group_id="P17" count="0"/>
                <participants group_id="P18" count="0"/>
                <participants group_id="P19" count="0"/>
                <participants group_id="P20" count="1"/>
                <participants group_id="P21" count="0"/>
                <participants group_id="P22" count="0"/>
                <participants group_id="P23" count="1"/>
                <participants group_id="P24" count="0"/>
                <participants group_id="P25" count="0"/>
                <participants group_id="P26" count="0"/>
                <participants group_id="P27" count="0"/>
                <participants group_id="P28" count="0"/>
                <participants group_id="P29" count="0"/>
                <participants group_id="P30" count="0"/>
                <participants group_id="P31" count="0"/>
                <participants group_id="P32" count="0"/>
                <participants group_id="P33" count="0"/>
                <participants group_id="P34" count="1"/>
                <participants group_id="P35" count="1"/>
                <participants group_id="P36" count="0"/>
                <participants group_id="P37" count="1"/>
                <participants group_id="P38" count="0"/>
                <participants group_id="P39" count="0"/>
                <participants group_id="P40" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="1"/>
                <participants group_id="P6" count="1"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
                <participants group_id="P11" count="0"/>
                <participants group_id="P12" count="0"/>
                <participants group_id="P13" count="0"/>
                <participants group_id="P14" count="1"/>
                <participants group_id="P15" count="4"/>
                <participants group_id="P16" count="1"/>
                <participants group_id="P17" count="1"/>
                <participants group_id="P18" count="0"/>
                <participants group_id="P19" count="1"/>
                <participants group_id="P20" count="1"/>
                <participants group_id="P21" count="2"/>
                <participants group_id="P22" count="4"/>
                <participants group_id="P23" count="1"/>
                <participants group_id="P24" count="4"/>
                <participants group_id="P25" count="3"/>
                <participants group_id="P26" count="4"/>
                <participants group_id="P27" count="5"/>
                <participants group_id="P28" count="0"/>
                <participants group_id="P29" count="0"/>
                <participants group_id="P30" count="0"/>
                <participants group_id="P31" count="1"/>
                <participants group_id="P32" count="0"/>
                <participants group_id="P33" count="0"/>
                <participants group_id="P34" count="1"/>
                <participants group_id="P35" count="1"/>
                <participants group_id="P36" count="0"/>
                <participants group_id="P37" count="0"/>
                <participants group_id="P38" count="0"/>
                <participants group_id="P39" count="0"/>
                <participants group_id="P40" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>No longer meets eligibility criteria</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
                <participants group_id="P11" count="0"/>
                <participants group_id="P12" count="0"/>
                <participants group_id="P13" count="0"/>
                <participants group_id="P14" count="0"/>
                <participants group_id="P15" count="0"/>
                <participants group_id="P16" count="0"/>
                <participants group_id="P17" count="0"/>
                <participants group_id="P18" count="0"/>
                <participants group_id="P19" count="0"/>
                <participants group_id="P20" count="0"/>
                <participants group_id="P21" count="0"/>
                <participants group_id="P22" count="0"/>
                <participants group_id="P23" count="1"/>
                <participants group_id="P24" count="0"/>
                <participants group_id="P25" count="0"/>
                <participants group_id="P26" count="0"/>
                <participants group_id="P27" count="0"/>
                <participants group_id="P28" count="0"/>
                <participants group_id="P29" count="0"/>
                <participants group_id="P30" count="0"/>
                <participants group_id="P31" count="0"/>
                <participants group_id="P32" count="0"/>
                <participants group_id="P33" count="0"/>
                <participants group_id="P34" count="0"/>
                <participants group_id="P35" count="0"/>
                <participants group_id="P36" count="0"/>
                <participants group_id="P37" count="0"/>
                <participants group_id="P38" count="0"/>
                <participants group_id="P39" count="0"/>
                <participants group_id="P40" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Other</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
                <participants group_id="P11" count="0"/>
                <participants group_id="P12" count="0"/>
                <participants group_id="P13" count="1"/>
                <participants group_id="P14" count="0"/>
                <participants group_id="P15" count="2"/>
                <participants group_id="P16" count="0"/>
                <participants group_id="P17" count="0"/>
                <participants group_id="P18" count="2"/>
                <participants group_id="P19" count="0"/>
                <participants group_id="P20" count="0"/>
                <participants group_id="P21" count="1"/>
                <participants group_id="P22" count="0"/>
                <participants group_id="P23" count="1"/>
                <participants group_id="P24" count="0"/>
                <participants group_id="P25" count="2"/>
                <participants group_id="P26" count="2"/>
                <participants group_id="P27" count="1"/>
                <participants group_id="P28" count="0"/>
                <participants group_id="P29" count="0"/>
                <participants group_id="P30" count="0"/>
                <participants group_id="P31" count="0"/>
                <participants group_id="P32" count="0"/>
                <participants group_id="P33" count="0"/>
                <participants group_id="P34" count="0"/>
                <participants group_id="P35" count="1"/>
                <participants group_id="P36" count="1"/>
                <participants group_id="P37" count="0"/>
                <participants group_id="P38" count="0"/>
                <participants group_id="P39" count="0"/>
                <participants group_id="P40" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
                <participants group_id="P11" count="0"/>
                <participants group_id="P12" count="0"/>
                <participants group_id="P13" count="0"/>
                <participants group_id="P14" count="0"/>
                <participants group_id="P15" count="0"/>
                <participants group_id="P16" count="0"/>
                <participants group_id="P17" count="0"/>
                <participants group_id="P18" count="0"/>
                <participants group_id="P19" count="0"/>
                <participants group_id="P20" count="1"/>
                <participants group_id="P21" count="1"/>
                <participants group_id="P22" count="0"/>
                <participants group_id="P23" count="0"/>
                <participants group_id="P24" count="0"/>
                <participants group_id="P25" count="0"/>
                <participants group_id="P26" count="0"/>
                <participants group_id="P27" count="0"/>
                <participants group_id="P28" count="0"/>
                <participants group_id="P29" count="0"/>
                <participants group_id="P30" count="0"/>
                <participants group_id="P31" count="0"/>
                <participants group_id="P32" count="0"/>
                <participants group_id="P33" count="0"/>
                <participants group_id="P34" count="0"/>
                <participants group_id="P35" count="0"/>
                <participants group_id="P36" count="0"/>
                <participants group_id="P37" count="0"/>
                <participants group_id="P38" count="0"/>
                <participants group_id="P39" count="0"/>
                <participants group_id="P40" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
                <participants group_id="P11" count="0"/>
                <participants group_id="P12" count="0"/>
                <participants group_id="P13" count="0"/>
                <participants group_id="P14" count="0"/>
                <participants group_id="P15" count="0"/>
                <participants group_id="P16" count="0"/>
                <participants group_id="P17" count="0"/>
                <participants group_id="P18" count="0"/>
                <participants group_id="P19" count="0"/>
                <participants group_id="P20" count="0"/>
                <participants group_id="P21" count="0"/>
                <participants group_id="P22" count="0"/>
                <participants group_id="P23" count="0"/>
                <participants group_id="P24" count="0"/>
                <participants group_id="P25" count="0"/>
                <participants group_id="P26" count="0"/>
                <participants group_id="P27" count="0"/>
                <participants group_id="P28" count="0"/>
                <participants group_id="P29" count="0"/>
                <participants group_id="P30" count="0"/>
                <participants group_id="P31" count="1"/>
                <participants group_id="P32" count="0"/>
                <participants group_id="P33" count="0"/>
                <participants group_id="P34" count="0"/>
                <participants group_id="P35" count="0"/>
                <participants group_id="P36" count="0"/>
                <participants group_id="P37" count="0"/>
                <participants group_id="P38" count="0"/>
                <participants group_id="P39" count="0"/>
                <participants group_id="P40" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="1"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="1"/>
                <participants group_id="P11" count="1"/>
                <participants group_id="P12" count="0"/>
                <participants group_id="P13" count="0"/>
                <participants group_id="P14" count="0"/>
                <participants group_id="P15" count="0"/>
                <participants group_id="P16" count="3"/>
                <participants group_id="P17" count="0"/>
                <participants group_id="P18" count="3"/>
                <participants group_id="P19" count="3"/>
                <participants group_id="P20" count="1"/>
                <participants group_id="P21" count="3"/>
                <participants group_id="P22" count="1"/>
                <participants group_id="P23" count="1"/>
                <participants group_id="P24" count="1"/>
                <participants group_id="P25" count="2"/>
                <participants group_id="P26" count="4"/>
                <participants group_id="P27" count="2"/>
                <participants group_id="P28" count="1"/>
                <participants group_id="P29" count="1"/>
                <participants group_id="P30" count="0"/>
                <participants group_id="P31" count="0"/>
                <participants group_id="P32" count="0"/>
                <participants group_id="P33" count="0"/>
                <participants group_id="P34" count="0"/>
                <participants group_id="P35" count="1"/>
                <participants group_id="P36" count="1"/>
                <participants group_id="P37" count="0"/>
                <participants group_id="P38" count="1"/>
                <participants group_id="P39" count="0"/>
                <participants group_id="P40" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Safety analysis set included all participants in the sentinel and expanded cohorts who received at least 1 dose of the investigational products.</population>
      <group_list>
        <group group_id="B1">
          <title>Sentinel Cohort: RSV Vaccine 60 mcg Age 18-49 Years</title>
          <description>Participants aged 18-49 years received single 60-mcg dose of RSV vaccine, intramuscularly. Participants were followed up to 12 months after vaccination.</description>
        </group>
        <group group_id="B2">
          <title>Sentinel Cohort: RSV 60 mcg With Aluminum Hydroxide Age 18-49 Years</title>
          <description>Participants aged 18-49 years received single 60-mcg dose with aluminum hydroxide intramuscularly. Participants were followed up to 12 months after vaccination.</description>
        </group>
        <group group_id="B3">
          <title>Sentinel Cohort: RSV 120 mcg Age 18-49 Years</title>
          <description>Participants aged 18-49 years received single 120-mcg dose intramuscularly. Participants were followed up to 12 months after vaccination.</description>
        </group>
        <group group_id="B4">
          <title>Sentinel Cohort: RSV 120 mcg With Aluminum Hydroxide Age 18-49 Years</title>
          <description>Participants aged 18-49 years received single 120-mcg dose with aluminum hydroxide intramuscularly. Participants were followed up to 12 months after vaccination.</description>
        </group>
        <group group_id="B5">
          <title>Sentinel Cohort: RSV 240 mcg Age 18-49 Years</title>
          <description>Participants aged 18-49 years received single 240-mcg dose intramuscularly. Participants were followed up to 12 months after vaccination.</description>
        </group>
        <group group_id="B6">
          <title>Sentinel Cohort: RSV 240 mcg With Aluminum Hydroxide Age 18-49 Years</title>
          <description>Participants aged 18-49 years received single 240-mcg dose with aluminum hydroxide intramuscularly. Participants were followed up to 12 months after vaccination.</description>
        </group>
        <group group_id="B7">
          <title>Sentinel Cohort: Placebo Age 18-49 Years</title>
          <description>Participants aged 18-49 years received placebo matched to RSV vaccine intramuscularly. Participants were followed up to 12 months after vaccination.</description>
        </group>
        <group group_id="B8">
          <title>Sentinel Cohort: RSV Vaccine 60 mcg Age 50-85 Years</title>
          <description>Participants aged 50-85 years received single 60-mcg dose with aluminum hydroxide intramuscularly. Participants were followed up to 12 months after vaccination.</description>
        </group>
        <group group_id="B9">
          <title>Sentinel Cohort: RSV 60 mcg With Aluminum Hydroxide Age 50-85 Years</title>
          <description>Participants aged 50-85 years received single 60-mcg dose with aluminum hydroxide intramuscularly. Participants were followed up to 12 months after vaccination.</description>
        </group>
        <group group_id="B10">
          <title>Sentinel Cohort: RSV 120 mcg Age 50-85 Years</title>
          <description>Participants aged 50-85 years received single 120-mcg dose intramuscularly. Participants were followed up to 12 months after vaccination.</description>
        </group>
        <group group_id="B11">
          <title>Sentinel Cohort: RSV 120 mcg With Aluminum Hydroxide Age 50-85 Years</title>
          <description>Participants aged 50-85 years received single 120-mcg dose with aluminum hydroxide intramuscularly. Participants were followed up to 12 months after vaccination.</description>
        </group>
        <group group_id="B12">
          <title>Sentinel Cohort: RSV 240 mcg Age 50-85 Years</title>
          <description>Participants aged 50-85 years received single 240-mcg dose intramuscularly. Participants were followed up to 12 months after vaccination.</description>
        </group>
        <group group_id="B13">
          <title>Sentinel Cohort: RSV 240 mcg With Aluminum Hydroxide Age 50-85 Years</title>
          <description>Participants aged 50-85 years received single 240-mcg dose with aluminum hydroxide intramuscularly. Participants were followed up to 12 months after vaccination.</description>
        </group>
        <group group_id="B14">
          <title>Sentinel Cohort: Placebo Age 50-85 Years</title>
          <description>Participants aged 50-85 years received placebo matched to RSV vaccine intramuscularly. Participants were followed up to 12 months after vaccination.</description>
        </group>
        <group group_id="B15">
          <title>Expanded Cohort: RSV 60 mcg With SIIV Age 18-49 Years</title>
          <description>Participants aged 18-49 years received 2 doses of RSV vaccine 60 mcg along with 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
        </group>
        <group group_id="B16">
          <title>Expanded Cohort: RSV 60 mcg With Placebo Age 18-49 Years</title>
          <description>Participants aged 18-49 years received 2 doses of RSV vaccine 60 mcg along with placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
        </group>
        <group group_id="B17">
          <title>Expanded Cohort: RSV 60 mcg With Aluminum Hydroxide and SIIV Age 18-49 Years</title>
          <description>Participants aged 18-49 years received 2 doses of RSV vaccine 60 mcg along with aluminum hydroxide and 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
        </group>
        <group group_id="B18">
          <title>Expanded Cohort: RSV 60 mcg With Aluminum Hydroxide and Placebo Age 18-49 Years</title>
          <description>Participants aged 18-49 years received 2 doses of RSV vaccine 60 mcg along with aluminum hydroxide and placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
        </group>
        <group group_id="B19">
          <title>Expanded Cohort: RSV 120 mcg With SIIV Age 18-49 Years</title>
          <description>Participants aged 18-49 years received 2 doses of RSV vaccine 120 mcg along with 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
        </group>
        <group group_id="B20">
          <title>Expanded Cohort: RSV 120 mcg With Placebo Age 18-49 Years</title>
          <description>Participants aged 18-49 years received 2 doses of RSV vaccine 120 mcg along with placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
        </group>
        <group group_id="B21">
          <title>Expanded Cohort: RSV 120 mcg With Aluminum Hydroxide and SIIV Age 18-49 Years</title>
          <description>Participants aged 18-49 years received 2 doses of RSV vaccine 120 mcg along with aluminum hydroxide and 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
        </group>
        <group group_id="B22">
          <title>Expanded Cohort: RSV 120 mcg With Aluminum Hydroxide and Placebo Age 18-49 Years</title>
          <description>Participants aged 18-49 years received 2 doses of RSV vaccine 120 mcg along with aluminum hydroxide and placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
        </group>
        <group group_id="B23">
          <title>Expanded Cohort: RSV 240 mcg With SIIV Age 18-49 Years</title>
          <description>Participants aged 18-49 years received 2 doses of RSV vaccine 240 mcg along with 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
        </group>
        <group group_id="B24">
          <title>Expanded Cohort: RSV 240 mcg With Placebo Age 18-49 Years</title>
          <description>Participants aged 18-49 years received 2 doses of RSV vaccine 240 mcg along with placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
        </group>
        <group group_id="B25">
          <title>Expanded Cohort: RSV 240 mcg With Aluminum Hydroxide and SIIV Age 18-49 Years</title>
          <description>Participants aged 18-49 years received 2 doses of RSV vaccine 240 mcg along with aluminum hydroxide and 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
        </group>
        <group group_id="B26">
          <title>Expanded Cohort: RSV 240 mcg With Aluminum Hydroxide and Placebo Age 18-49 Years</title>
          <description>Participants aged 18-49 years received 2 doses of RSV vaccine 240 mcg along with aluminum hydroxide and placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
        </group>
        <group group_id="B27">
          <title>Expanded Cohort: Placebo Age 18-49 Years</title>
          <description>Participants aged 18-49 years received placebo matched to RSV vaccine intramuscularly. Participants were followed up to 12 months after vaccination.</description>
        </group>
        <group group_id="B28">
          <title>Expanded Cohort: RSV 60 mcg With SIIV Age 65-85 Years</title>
          <description>Participants aged 65-85 years received 2 doses of RSV vaccine 60 mcg along with 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
        </group>
        <group group_id="B29">
          <title>Expanded Cohort: RSV 60 mcg With Placebo Age 65-85 Years</title>
          <description>Participants aged 65-85 years received 2 doses of RSV vaccine 60 mcg along with placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
        </group>
        <group group_id="B30">
          <title>Expanded Cohort: RSV 60 mcg With Aluminum Hydroxide and SIIV Age 65-85 Years</title>
          <description>Participants aged 65-85 years received 2 doses of RSV vaccine 60 mcg along with aluminum hydroxide and 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
        </group>
        <group group_id="B31">
          <title>Expanded Cohort: RSV 60 mcg With Aluminum Hydroxide and Placebo Age 65-85 Years</title>
          <description>Participants aged 65-85 years received 2 doses of RSV vaccine 60 mcg along with aluminum hydroxide and placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
        </group>
        <group group_id="B32">
          <title>Expanded Cohort: RSV 120 mcg With SIIV Age 65-85 Years</title>
          <description>Participants aged 65-85 years received 2 doses of RSV vaccine 120 mcg along with 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
        </group>
        <group group_id="B33">
          <title>Expanded Cohort: RSV 120 mcg With Placebo Age 65-85 Years</title>
          <description>Participants aged 65-85 years received 2 doses of RSV vaccine 120 mcg along with placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
        </group>
        <group group_id="B34">
          <title>Expanded Cohort: RSV 120 mcg With Aluminum Hydroxide and SIIV Age 65-85 Years</title>
          <description>Participants aged 65-85 years received 2 doses of RSV vaccine 120 mcg along with aluminum hydroxide and 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
        </group>
        <group group_id="B35">
          <title>Expanded Cohort: RSV 120 mcg With Aluminum Hydroxide and Placebo Age 65-85 Years</title>
          <description>Participants aged 65-85 years received 2 doses of RSV vaccine 120 mcg along with aluminum hydroxide and placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
        </group>
        <group group_id="B36">
          <title>Expanded Cohort: RSV 240 mcg With SIIV Age 65-85 Years</title>
          <description>Participants aged 65-85 years received 2 doses of RSV vaccine 240 mcg along with 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
        </group>
        <group group_id="B37">
          <title>Expanded Cohort: RSV 240 mcg With Placebo Age 65-85 Years</title>
          <description>Participants aged 65-85 years received 2 doses of RSV vaccine 240 mcg along with placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
        </group>
        <group group_id="B38">
          <title>Expanded Cohort: RSV 240 mcg With Aluminum Hydroxide and SIIV Age 65-85 Years</title>
          <description>Participants aged 65-85 years received 2 doses of RSV vaccine 240 mcg along with aluminum hydroxide and 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
        </group>
        <group group_id="B39">
          <title>Expanded Cohort: RSV 240 mcg With Aluminum Hydroxide and Placebo Age 65-85 Years</title>
          <description>Participants aged 65-85 years received 2 doses of RSV vaccine 240 mcg along with aluminum hydroxide and placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
        </group>
        <group group_id="B40">
          <title>Expanded Cohort: Placebo Age 65-85 Years</title>
          <description>Participants aged 65-85 years received placebo matched to RSV vaccine intramuscularly. Participants were followed up to 12 months after vaccination.</description>
        </group>
        <group group_id="B41">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="12"/>
            <count group_id="B2" value="12"/>
            <count group_id="B3" value="12"/>
            <count group_id="B4" value="12"/>
            <count group_id="B5" value="12"/>
            <count group_id="B6" value="12"/>
            <count group_id="B7" value="12"/>
            <count group_id="B8" value="12"/>
            <count group_id="B9" value="12"/>
            <count group_id="B10" value="12"/>
            <count group_id="B11" value="12"/>
            <count group_id="B12" value="12"/>
            <count group_id="B13" value="12"/>
            <count group_id="B14" value="12"/>
            <count group_id="B15" value="41"/>
            <count group_id="B16" value="42"/>
            <count group_id="B17" value="41"/>
            <count group_id="B18" value="40"/>
            <count group_id="B19" value="41"/>
            <count group_id="B20" value="41"/>
            <count group_id="B21" value="41"/>
            <count group_id="B22" value="41"/>
            <count group_id="B23" value="41"/>
            <count group_id="B24" value="41"/>
            <count group_id="B25" value="41"/>
            <count group_id="B26" value="41"/>
            <count group_id="B27" value="41"/>
            <count group_id="B28" value="40"/>
            <count group_id="B29" value="41"/>
            <count group_id="B30" value="40"/>
            <count group_id="B31" value="42"/>
            <count group_id="B32" value="40"/>
            <count group_id="B33" value="40"/>
            <count group_id="B34" value="41"/>
            <count group_id="B35" value="41"/>
            <count group_id="B36" value="40"/>
            <count group_id="B37" value="41"/>
            <count group_id="B38" value="42"/>
            <count group_id="B39" value="43"/>
            <count group_id="B40" value="41"/>
            <count group_id="B41" value="1233"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="32.2" spread="9.5"/>
                    <measurement group_id="B2" value="34.0" spread="9.0"/>
                    <measurement group_id="B3" value="34.8" spread="8.0"/>
                    <measurement group_id="B4" value="34.2" spread="8.7"/>
                    <measurement group_id="B5" value="43.3" spread="4.8"/>
                    <measurement group_id="B6" value="36.3" spread="8.4"/>
                    <measurement group_id="B7" value="35.2" spread="9.4"/>
                    <measurement group_id="B8" value="65.4" spread="9.9"/>
                    <measurement group_id="B9" value="66.3" spread="9.7"/>
                    <measurement group_id="B10" value="63.7" spread="7.4"/>
                    <measurement group_id="B11" value="62.6" spread="8.6"/>
                    <measurement group_id="B12" value="62.1" spread="9.8"/>
                    <measurement group_id="B13" value="61.3" spread="7.7"/>
                    <measurement group_id="B14" value="61.3" spread="9.8"/>
                    <measurement group_id="B15" value="33.4" spread="8.2"/>
                    <measurement group_id="B16" value="32.6" spread="9.1"/>
                    <measurement group_id="B17" value="33.0" spread="8.6"/>
                    <measurement group_id="B18" value="34.1" spread="9.3"/>
                    <measurement group_id="B19" value="34.1" spread="8.5"/>
                    <measurement group_id="B20" value="36.8" spread="8.8"/>
                    <measurement group_id="B21" value="34.1" spread="8.7"/>
                    <measurement group_id="B22" value="33.1" spread="9.4"/>
                    <measurement group_id="B23" value="36.2" spread="8.9"/>
                    <measurement group_id="B24" value="34.7" spread="8.9"/>
                    <measurement group_id="B25" value="33.9" spread="8.5"/>
                    <measurement group_id="B26" value="34.6" spread="7.7"/>
                    <measurement group_id="B27" value="33.6" spread="8.5"/>
                    <measurement group_id="B28" value="72.6" spread="5.9"/>
                    <measurement group_id="B29" value="71.9" spread="4.8"/>
                    <measurement group_id="B30" value="72.4" spread="5.6"/>
                    <measurement group_id="B31" value="72.8" spread="5.1"/>
                    <measurement group_id="B32" value="70.9" spread="5.5"/>
                    <measurement group_id="B33" value="71.7" spread="5.4"/>
                    <measurement group_id="B34" value="72.2" spread="4.7"/>
                    <measurement group_id="B35" value="71.3" spread="4.8"/>
                    <measurement group_id="B36" value="72.3" spread="5.0"/>
                    <measurement group_id="B37" value="71.6" spread="5.2"/>
                    <measurement group_id="B38" value="71.4" spread="5.1"/>
                    <measurement group_id="B39" value="70.7" spread="4.9"/>
                    <measurement group_id="B40" value="70.9" spread="4.7"/>
                    <measurement group_id="B41" value="52.47" spread="19.68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="6"/>
                    <measurement group_id="B4" value="10"/>
                    <measurement group_id="B5" value="9"/>
                    <measurement group_id="B6" value="9"/>
                    <measurement group_id="B7" value="5"/>
                    <measurement group_id="B8" value="7"/>
                    <measurement group_id="B9" value="8"/>
                    <measurement group_id="B10" value="7"/>
                    <measurement group_id="B11" value="5"/>
                    <measurement group_id="B12" value="10"/>
                    <measurement group_id="B13" value="9"/>
                    <measurement group_id="B14" value="6"/>
                    <measurement group_id="B15" value="27"/>
                    <measurement group_id="B16" value="28"/>
                    <measurement group_id="B17" value="27"/>
                    <measurement group_id="B18" value="25"/>
                    <measurement group_id="B19" value="29"/>
                    <measurement group_id="B20" value="29"/>
                    <measurement group_id="B21" value="26"/>
                    <measurement group_id="B22" value="25"/>
                    <measurement group_id="B23" value="29"/>
                    <measurement group_id="B24" value="29"/>
                    <measurement group_id="B25" value="28"/>
                    <measurement group_id="B26" value="29"/>
                    <measurement group_id="B27" value="29"/>
                    <measurement group_id="B28" value="17"/>
                    <measurement group_id="B29" value="23"/>
                    <measurement group_id="B30" value="20"/>
                    <measurement group_id="B31" value="25"/>
                    <measurement group_id="B32" value="24"/>
                    <measurement group_id="B33" value="22"/>
                    <measurement group_id="B34" value="22"/>
                    <measurement group_id="B35" value="23"/>
                    <measurement group_id="B36" value="26"/>
                    <measurement group_id="B37" value="26"/>
                    <measurement group_id="B38" value="26"/>
                    <measurement group_id="B39" value="20"/>
                    <measurement group_id="B40" value="29"/>
                    <measurement group_id="B41" value="771"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="6"/>
                    <measurement group_id="B4" value="2"/>
                    <measurement group_id="B5" value="3"/>
                    <measurement group_id="B6" value="3"/>
                    <measurement group_id="B7" value="7"/>
                    <measurement group_id="B8" value="5"/>
                    <measurement group_id="B9" value="4"/>
                    <measurement group_id="B10" value="5"/>
                    <measurement group_id="B11" value="7"/>
                    <measurement group_id="B12" value="2"/>
                    <measurement group_id="B13" value="3"/>
                    <measurement group_id="B14" value="6"/>
                    <measurement group_id="B15" value="14"/>
                    <measurement group_id="B16" value="14"/>
                    <measurement group_id="B17" value="14"/>
                    <measurement group_id="B18" value="15"/>
                    <measurement group_id="B19" value="12"/>
                    <measurement group_id="B20" value="12"/>
                    <measurement group_id="B21" value="15"/>
                    <measurement group_id="B22" value="16"/>
                    <measurement group_id="B23" value="12"/>
                    <measurement group_id="B24" value="12"/>
                    <measurement group_id="B25" value="13"/>
                    <measurement group_id="B26" value="12"/>
                    <measurement group_id="B27" value="12"/>
                    <measurement group_id="B28" value="23"/>
                    <measurement group_id="B29" value="18"/>
                    <measurement group_id="B30" value="20"/>
                    <measurement group_id="B31" value="17"/>
                    <measurement group_id="B32" value="16"/>
                    <measurement group_id="B33" value="18"/>
                    <measurement group_id="B34" value="19"/>
                    <measurement group_id="B35" value="18"/>
                    <measurement group_id="B36" value="14"/>
                    <measurement group_id="B37" value="15"/>
                    <measurement group_id="B38" value="16"/>
                    <measurement group_id="B39" value="23"/>
                    <measurement group_id="B40" value="12"/>
                    <measurement group_id="B41" value="462"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="2"/>
                    <measurement group_id="B4" value="1"/>
                    <measurement group_id="B5" value="1"/>
                    <measurement group_id="B6" value="1"/>
                    <measurement group_id="B7" value="2"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="2"/>
                    <measurement group_id="B10" value="1"/>
                    <measurement group_id="B11" value="1"/>
                    <measurement group_id="B12" value="2"/>
                    <measurement group_id="B13" value="1"/>
                    <measurement group_id="B14" value="0"/>
                    <measurement group_id="B15" value="4"/>
                    <measurement group_id="B16" value="5"/>
                    <measurement group_id="B17" value="7"/>
                    <measurement group_id="B18" value="5"/>
                    <measurement group_id="B19" value="4"/>
                    <measurement group_id="B20" value="7"/>
                    <measurement group_id="B21" value="6"/>
                    <measurement group_id="B22" value="5"/>
                    <measurement group_id="B23" value="3"/>
                    <measurement group_id="B24" value="5"/>
                    <measurement group_id="B25" value="6"/>
                    <measurement group_id="B26" value="4"/>
                    <measurement group_id="B27" value="3"/>
                    <measurement group_id="B28" value="2"/>
                    <measurement group_id="B29" value="1"/>
                    <measurement group_id="B30" value="2"/>
                    <measurement group_id="B31" value="1"/>
                    <measurement group_id="B32" value="3"/>
                    <measurement group_id="B33" value="3"/>
                    <measurement group_id="B34" value="4"/>
                    <measurement group_id="B35" value="3"/>
                    <measurement group_id="B36" value="1"/>
                    <measurement group_id="B37" value="5"/>
                    <measurement group_id="B38" value="2"/>
                    <measurement group_id="B39" value="1"/>
                    <measurement group_id="B40" value="5"/>
                    <measurement group_id="B41" value="112"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="10"/>
                    <measurement group_id="B4" value="11"/>
                    <measurement group_id="B5" value="11"/>
                    <measurement group_id="B6" value="11"/>
                    <measurement group_id="B7" value="8"/>
                    <measurement group_id="B8" value="12"/>
                    <measurement group_id="B9" value="10"/>
                    <measurement group_id="B10" value="11"/>
                    <measurement group_id="B11" value="11"/>
                    <measurement group_id="B12" value="10"/>
                    <measurement group_id="B13" value="10"/>
                    <measurement group_id="B14" value="12"/>
                    <measurement group_id="B15" value="37"/>
                    <measurement group_id="B16" value="37"/>
                    <measurement group_id="B17" value="34"/>
                    <measurement group_id="B18" value="35"/>
                    <measurement group_id="B19" value="37"/>
                    <measurement group_id="B20" value="34"/>
                    <measurement group_id="B21" value="35"/>
                    <measurement group_id="B22" value="36"/>
                    <measurement group_id="B23" value="38"/>
                    <measurement group_id="B24" value="36"/>
                    <measurement group_id="B25" value="35"/>
                    <measurement group_id="B26" value="36"/>
                    <measurement group_id="B27" value="38"/>
                    <measurement group_id="B28" value="38"/>
                    <measurement group_id="B29" value="39"/>
                    <measurement group_id="B30" value="38"/>
                    <measurement group_id="B31" value="41"/>
                    <measurement group_id="B32" value="37"/>
                    <measurement group_id="B33" value="37"/>
                    <measurement group_id="B34" value="37"/>
                    <measurement group_id="B35" value="37"/>
                    <measurement group_id="B36" value="39"/>
                    <measurement group_id="B37" value="36"/>
                    <measurement group_id="B38" value="40"/>
                    <measurement group_id="B39" value="40"/>
                    <measurement group_id="B40" value="36"/>
                    <measurement group_id="B41" value="1112"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="2"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="0"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="0"/>
                    <measurement group_id="B13" value="1"/>
                    <measurement group_id="B14" value="0"/>
                    <measurement group_id="B15" value="0"/>
                    <measurement group_id="B16" value="0"/>
                    <measurement group_id="B17" value="0"/>
                    <measurement group_id="B18" value="0"/>
                    <measurement group_id="B19" value="0"/>
                    <measurement group_id="B20" value="0"/>
                    <measurement group_id="B21" value="0"/>
                    <measurement group_id="B22" value="0"/>
                    <measurement group_id="B23" value="0"/>
                    <measurement group_id="B24" value="0"/>
                    <measurement group_id="B25" value="0"/>
                    <measurement group_id="B26" value="1"/>
                    <measurement group_id="B27" value="0"/>
                    <measurement group_id="B28" value="0"/>
                    <measurement group_id="B29" value="1"/>
                    <measurement group_id="B30" value="0"/>
                    <measurement group_id="B31" value="0"/>
                    <measurement group_id="B32" value="0"/>
                    <measurement group_id="B33" value="0"/>
                    <measurement group_id="B34" value="0"/>
                    <measurement group_id="B35" value="1"/>
                    <measurement group_id="B36" value="0"/>
                    <measurement group_id="B37" value="0"/>
                    <measurement group_id="B38" value="0"/>
                    <measurement group_id="B39" value="2"/>
                    <measurement group_id="B40" value="0"/>
                    <measurement group_id="B41" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="0"/>
                    <measurement group_id="B11" value="1"/>
                    <measurement group_id="B12" value="0"/>
                    <measurement group_id="B13" value="0"/>
                    <measurement group_id="B14" value="1"/>
                    <measurement group_id="B15" value="0"/>
                    <measurement group_id="B16" value="1"/>
                    <measurement group_id="B17" value="0"/>
                    <measurement group_id="B18" value="1"/>
                    <measurement group_id="B19" value="1"/>
                    <measurement group_id="B20" value="0"/>
                    <measurement group_id="B21" value="0"/>
                    <measurement group_id="B22" value="0"/>
                    <measurement group_id="B23" value="0"/>
                    <measurement group_id="B24" value="0"/>
                    <measurement group_id="B25" value="1"/>
                    <measurement group_id="B26" value="1"/>
                    <measurement group_id="B27" value="0"/>
                    <measurement group_id="B28" value="0"/>
                    <measurement group_id="B29" value="0"/>
                    <measurement group_id="B30" value="0"/>
                    <measurement group_id="B31" value="0"/>
                    <measurement group_id="B32" value="1"/>
                    <measurement group_id="B33" value="0"/>
                    <measurement group_id="B34" value="1"/>
                    <measurement group_id="B35" value="0"/>
                    <measurement group_id="B36" value="0"/>
                    <measurement group_id="B37" value="0"/>
                    <measurement group_id="B38" value="0"/>
                    <measurement group_id="B39" value="0"/>
                    <measurement group_id="B40" value="1"/>
                    <measurement group_id="B41" value="10"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="1"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="1"/>
                    <measurement group_id="B7" value="2"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="1"/>
                    <measurement group_id="B10" value="1"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="0"/>
                    <measurement group_id="B13" value="0"/>
                    <measurement group_id="B14" value="1"/>
                    <measurement group_id="B15" value="1"/>
                    <measurement group_id="B16" value="1"/>
                    <measurement group_id="B17" value="0"/>
                    <measurement group_id="B18" value="2"/>
                    <measurement group_id="B19" value="1"/>
                    <measurement group_id="B20" value="0"/>
                    <measurement group_id="B21" value="0"/>
                    <measurement group_id="B22" value="3"/>
                    <measurement group_id="B23" value="1"/>
                    <measurement group_id="B24" value="0"/>
                    <measurement group_id="B25" value="0"/>
                    <measurement group_id="B26" value="1"/>
                    <measurement group_id="B27" value="1"/>
                    <measurement group_id="B28" value="1"/>
                    <measurement group_id="B29" value="1"/>
                    <measurement group_id="B30" value="0"/>
                    <measurement group_id="B31" value="0"/>
                    <measurement group_id="B32" value="1"/>
                    <measurement group_id="B33" value="0"/>
                    <measurement group_id="B34" value="0"/>
                    <measurement group_id="B35" value="1"/>
                    <measurement group_id="B36" value="0"/>
                    <measurement group_id="B37" value="0"/>
                    <measurement group_id="B38" value="0"/>
                    <measurement group_id="B39" value="1"/>
                    <measurement group_id="B40" value="0"/>
                    <measurement group_id="B41" value="23"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="1"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="0"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="0"/>
                    <measurement group_id="B13" value="0"/>
                    <measurement group_id="B14" value="0"/>
                    <measurement group_id="B15" value="0"/>
                    <measurement group_id="B16" value="0"/>
                    <measurement group_id="B17" value="0"/>
                    <measurement group_id="B18" value="0"/>
                    <measurement group_id="B19" value="0"/>
                    <measurement group_id="B20" value="0"/>
                    <measurement group_id="B21" value="0"/>
                    <measurement group_id="B22" value="0"/>
                    <measurement group_id="B23" value="0"/>
                    <measurement group_id="B24" value="1"/>
                    <measurement group_id="B25" value="1"/>
                    <measurement group_id="B26" value="0"/>
                    <measurement group_id="B27" value="0"/>
                    <measurement group_id="B28" value="0"/>
                    <measurement group_id="B29" value="0"/>
                    <measurement group_id="B30" value="1"/>
                    <measurement group_id="B31" value="0"/>
                    <measurement group_id="B32" value="0"/>
                    <measurement group_id="B33" value="0"/>
                    <measurement group_id="B34" value="0"/>
                    <measurement group_id="B35" value="0"/>
                    <measurement group_id="B36" value="0"/>
                    <measurement group_id="B37" value="0"/>
                    <measurement group_id="B38" value="0"/>
                    <measurement group_id="B39" value="0"/>
                    <measurement group_id="B40" value="0"/>
                    <measurement group_id="B41" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="2"/>
                    <measurement group_id="B4" value="2"/>
                    <measurement group_id="B5" value="1"/>
                    <measurement group_id="B6" value="4"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="2"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="1"/>
                    <measurement group_id="B11" value="4"/>
                    <measurement group_id="B12" value="3"/>
                    <measurement group_id="B13" value="1"/>
                    <measurement group_id="B14" value="2"/>
                    <measurement group_id="B15" value="10"/>
                    <measurement group_id="B16" value="7"/>
                    <measurement group_id="B17" value="8"/>
                    <measurement group_id="B18" value="8"/>
                    <measurement group_id="B19" value="6"/>
                    <measurement group_id="B20" value="8"/>
                    <measurement group_id="B21" value="9"/>
                    <measurement group_id="B22" value="8"/>
                    <measurement group_id="B23" value="13"/>
                    <measurement group_id="B24" value="7"/>
                    <measurement group_id="B25" value="7"/>
                    <measurement group_id="B26" value="9"/>
                    <measurement group_id="B27" value="9"/>
                    <measurement group_id="B28" value="4"/>
                    <measurement group_id="B29" value="6"/>
                    <measurement group_id="B30" value="1"/>
                    <measurement group_id="B31" value="5"/>
                    <measurement group_id="B32" value="3"/>
                    <measurement group_id="B33" value="3"/>
                    <measurement group_id="B34" value="2"/>
                    <measurement group_id="B35" value="6"/>
                    <measurement group_id="B36" value="5"/>
                    <measurement group_id="B37" value="3"/>
                    <measurement group_id="B38" value="3"/>
                    <measurement group_id="B39" value="6"/>
                    <measurement group_id="B40" value="4"/>
                    <measurement group_id="B41" value="188"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="10"/>
                    <measurement group_id="B4" value="8"/>
                    <measurement group_id="B5" value="10"/>
                    <measurement group_id="B6" value="7"/>
                    <measurement group_id="B7" value="9"/>
                    <measurement group_id="B8" value="9"/>
                    <measurement group_id="B9" value="11"/>
                    <measurement group_id="B10" value="9"/>
                    <measurement group_id="B11" value="7"/>
                    <measurement group_id="B12" value="8"/>
                    <measurement group_id="B13" value="9"/>
                    <measurement group_id="B14" value="8"/>
                    <measurement group_id="B15" value="30"/>
                    <measurement group_id="B16" value="32"/>
                    <measurement group_id="B17" value="32"/>
                    <measurement group_id="B18" value="28"/>
                    <measurement group_id="B19" value="31"/>
                    <measurement group_id="B20" value="31"/>
                    <measurement group_id="B21" value="30"/>
                    <measurement group_id="B22" value="29"/>
                    <measurement group_id="B23" value="27"/>
                    <measurement group_id="B24" value="32"/>
                    <measurement group_id="B25" value="30"/>
                    <measurement group_id="B26" value="28"/>
                    <measurement group_id="B27" value="29"/>
                    <measurement group_id="B28" value="35"/>
                    <measurement group_id="B29" value="34"/>
                    <measurement group_id="B30" value="38"/>
                    <measurement group_id="B31" value="36"/>
                    <measurement group_id="B32" value="34"/>
                    <measurement group_id="B33" value="37"/>
                    <measurement group_id="B34" value="37"/>
                    <measurement group_id="B35" value="33"/>
                    <measurement group_id="B36" value="35"/>
                    <measurement group_id="B37" value="37"/>
                    <measurement group_id="B38" value="39"/>
                    <measurement group_id="B39" value="36"/>
                    <measurement group_id="B40" value="36"/>
                    <measurement group_id="B41" value="978"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="1"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="1"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="1"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="1"/>
                    <measurement group_id="B13" value="2"/>
                    <measurement group_id="B14" value="0"/>
                    <measurement group_id="B15" value="0"/>
                    <measurement group_id="B16" value="1"/>
                    <measurement group_id="B17" value="0"/>
                    <measurement group_id="B18" value="1"/>
                    <measurement group_id="B19" value="2"/>
                    <measurement group_id="B20" value="1"/>
                    <measurement group_id="B21" value="0"/>
                    <measurement group_id="B22" value="1"/>
                    <measurement group_id="B23" value="0"/>
                    <measurement group_id="B24" value="1"/>
                    <measurement group_id="B25" value="1"/>
                    <measurement group_id="B26" value="1"/>
                    <measurement group_id="B27" value="2"/>
                    <measurement group_id="B28" value="0"/>
                    <measurement group_id="B29" value="0"/>
                    <measurement group_id="B30" value="0"/>
                    <measurement group_id="B31" value="1"/>
                    <measurement group_id="B32" value="0"/>
                    <measurement group_id="B33" value="0"/>
                    <measurement group_id="B34" value="0"/>
                    <measurement group_id="B35" value="0"/>
                    <measurement group_id="B36" value="0"/>
                    <measurement group_id="B37" value="1"/>
                    <measurement group_id="B38" value="0"/>
                    <measurement group_id="B39" value="0"/>
                    <measurement group_id="B40" value="0"/>
                    <measurement group_id="B41" value="20"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="1"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="0"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="0"/>
                    <measurement group_id="B13" value="0"/>
                    <measurement group_id="B14" value="0"/>
                    <measurement group_id="B15" value="0"/>
                    <measurement group_id="B16" value="0"/>
                    <measurement group_id="B17" value="1"/>
                    <measurement group_id="B18" value="0"/>
                    <measurement group_id="B19" value="0"/>
                    <measurement group_id="B20" value="1"/>
                    <measurement group_id="B21" value="2"/>
                    <measurement group_id="B22" value="0"/>
                    <measurement group_id="B23" value="0"/>
                    <measurement group_id="B24" value="0"/>
                    <measurement group_id="B25" value="1"/>
                    <measurement group_id="B26" value="1"/>
                    <measurement group_id="B27" value="0"/>
                    <measurement group_id="B28" value="0"/>
                    <measurement group_id="B29" value="0"/>
                    <measurement group_id="B30" value="0"/>
                    <measurement group_id="B31" value="0"/>
                    <measurement group_id="B32" value="1"/>
                    <measurement group_id="B33" value="0"/>
                    <measurement group_id="B34" value="1"/>
                    <measurement group_id="B35" value="1"/>
                    <measurement group_id="B36" value="0"/>
                    <measurement group_id="B37" value="0"/>
                    <measurement group_id="B38" value="0"/>
                    <measurement group_id="B39" value="0"/>
                    <measurement group_id="B40" value="0"/>
                    <measurement group_id="B41" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Sentinel Cohort: Percentage of Participants (Aged 18 to 49 Years) With Local Reactions Within 14 Days After Vaccination</title>
        <description>Local reactions included pain at injection site, redness and swelling recorded by participants in an electronic diary (e-diary). Redness and swelling were measured and recorded in measuring device units. 1 measuring device unit =0.5 centimeter (cm) and graded as mild: 2.5 to 5.0 cm, moderate: greater than (&gt;) 5.0 to 10.0 cm and severe: &gt;10 cm. Pain at injection site was graded as mild: did not interfere with daily activity, moderate: interfere with daily activity and severe: prevented daily activity.</description>
        <time_frame>Within 14 days after vaccination</time_frame>
        <population>All participants in sentinel cohort who received at least 1 dose of the investigational products at Visit 1 and with e-dairy data available.</population>
        <group_list>
          <group group_id="O1">
            <title>Sentinel Cohort: RSV Vaccine 60 mcg Age 18-49 Years</title>
            <description>Participants aged 18-49 years received single 60-mcg dose of RSV vaccine, intramuscularly. Participants were followed up to 12 months after vaccination.</description>
          </group>
          <group group_id="O2">
            <title>Sentinel Cohort: RSV 60 mcg With Aluminum Hydroxide Age 18-49 Years</title>
            <description>Participants aged 18-49 years received single 60-mcg dose with aluminum hydroxide intramuscularly. Participants were followed up to 12 months after vaccination.</description>
          </group>
          <group group_id="O3">
            <title>Sentinel Cohort: RSV 120 mcg Age 18-49 Years</title>
            <description>Participants aged 18-49 years received single 120-mcg dose intramuscularly. Participants were followed up to 12 months after vaccination.</description>
          </group>
          <group group_id="O4">
            <title>Sentinel Cohort: RSV 120 mcg With Aluminum Hydroxide Age 18-49 Years</title>
            <description>Participants aged 18-49 years received single 120-mcg dose with aluminum hydroxide intramuscularly. Participants were followed up to 12 months after vaccination.</description>
          </group>
          <group group_id="O5">
            <title>Sentinel Cohort: RSV 240 mcg Age 18-49 Years</title>
            <description>Participants aged 18-49 years received single 240-mcg dose intramuscularly. Participants were followed up to 12 months after vaccination.</description>
          </group>
          <group group_id="O6">
            <title>Sentinel Cohort: RSV 240 mcg With Aluminum Hydroxide Age 18-49 Years</title>
            <description>Participants aged 18-49 years received single 240-mcg dose with aluminum hydroxide intramuscularly. Participants were followed up to 12 months after vaccination.</description>
          </group>
          <group group_id="O7">
            <title>Sentinel Cohort: Placebo Age 18-49 Years</title>
            <description>Participants aged 18-49 years received placebo matched to RSV vaccine intramuscularly. Participants were followed up to 12 months after vaccination</description>
          </group>
        </group_list>
        <measure>
          <title>Sentinel Cohort: Percentage of Participants (Aged 18 to 49 Years) With Local Reactions Within 14 Days After Vaccination</title>
          <description>Local reactions included pain at injection site, redness and swelling recorded by participants in an electronic diary (e-diary). Redness and swelling were measured and recorded in measuring device units. 1 measuring device unit =0.5 centimeter (cm) and graded as mild: 2.5 to 5.0 cm, moderate: greater than (&gt;) 5.0 to 10.0 cm and severe: &gt;10 cm. Pain at injection site was graded as mild: did not interfere with daily activity, moderate: interfere with daily activity and severe: prevented daily activity.</description>
          <population>All participants in sentinel cohort who received at least 1 dose of the investigational products at Visit 1 and with e-dairy data available.</population>
          <units>Percentage of participants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="12"/>
                <count group_id="O3" value="12"/>
                <count group_id="O4" value="12"/>
                <count group_id="O5" value="11"/>
                <count group_id="O6" value="12"/>
                <count group_id="O7" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pain at injection site: mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="50.0" lower_limit="21.1" upper_limit="78.9"/>
                    <measurement group_id="O2" value="58.3" lower_limit="27.7" upper_limit="84.8"/>
                    <measurement group_id="O3" value="25.0" lower_limit="5.5" upper_limit="57.2"/>
                    <measurement group_id="O4" value="75.0" lower_limit="42.8" upper_limit="94.5"/>
                    <measurement group_id="O5" value="0" lower_limit="0.0" upper_limit="28.5"/>
                    <measurement group_id="O6" value="58.3" lower_limit="27.7" upper_limit="84.8"/>
                    <measurement group_id="O7" value="16.7" lower_limit="2.1" upper_limit="48.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain at injection site: moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O2" value="16.7" lower_limit="2.1" upper_limit="48.4"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O4" value="8.3" lower_limit="0.2" upper_limit="38.5"/>
                    <measurement group_id="O5" value="18.2" lower_limit="2.3" upper_limit="51.8"/>
                    <measurement group_id="O6" value="8.3" lower_limit="0.2" upper_limit="38.5"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="26.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain at injection site: severe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O2" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O5" value="0" lower_limit="0.0" upper_limit="28.5"/>
                    <measurement group_id="O6" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="26.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Redness: mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O2" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O5" value="0" lower_limit="0.0" upper_limit="28.5"/>
                    <measurement group_id="O6" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="26.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Redness: moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O2" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O5" value="0" lower_limit="0.0" upper_limit="28.5"/>
                    <measurement group_id="O6" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="26.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Redness: severe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O2" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O5" value="0" lower_limit="0.0" upper_limit="28.5"/>
                    <measurement group_id="O6" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="26.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Swelling: mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O2" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O5" value="0" lower_limit="0.0" upper_limit="28.5"/>
                    <measurement group_id="O6" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="26.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Swelling: moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O2" value="8.3" lower_limit="0.2" upper_limit="38.5"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O4" value="8.3" lower_limit="0.2" upper_limit="38.5"/>
                    <measurement group_id="O5" value="0" lower_limit="0.0" upper_limit="28.5"/>
                    <measurement group_id="O6" value="8.3" lower_limit="0.2" upper_limit="38.5"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="26.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Swelling: severe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O2" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O5" value="0" lower_limit="0.0" upper_limit="28.5"/>
                    <measurement group_id="O6" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="26.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Sentinel Cohort: Percentage of Participants (Aged 50 to 85 Years) With Local Reactions Within 14 Days After Vaccination</title>
        <description>Local reactions included pain at injection site, redness and swelling recorded by participants in an e-diary. Redness and swelling were measured and recorded in measuring device units. 1 measuring device unit =0.5 cm and graded as mild: 2.5 to 5.0 cm, moderate: &gt; 5.0 to 10.0 cm and severe: &gt;10 cm. Pain at injection site was graded as mild: did not interfere with daily activity, moderate: interfered with daily activity and severe: prevented daily activity.</description>
        <time_frame>Within 14 days after vaccination</time_frame>
        <population>All participants in sentinel cohort who received at least 1 dose of the investigational products at Visit 1 and with e-dairy data available.</population>
        <group_list>
          <group group_id="O1">
            <title>Sentinel Cohort: RSV Vaccine 60 mcg Age 50-85 Years</title>
            <description>Participants aged 50-85 years received single 60-mcg dose of RSV vaccine, intramuscularly. Participants were followed up to 12 months after vaccination.</description>
          </group>
          <group group_id="O2">
            <title>Sentinel Cohort: RSV 60 mcg With Aluminum Hydroxide Age 50-85 Years</title>
            <description>Participants aged 50-85 years received single 60-mcg dose with aluminum hydroxide intramuscularly. Participants were followed up to 12 months after vaccination.</description>
          </group>
          <group group_id="O3">
            <title>Sentinel Cohort: RSV 120 mcg Age 50-85 Years</title>
            <description>Participants aged 50-85 years received single 120-mcg dose intramuscularly. Participants were followed up to 12 months after vaccination.</description>
          </group>
          <group group_id="O4">
            <title>Sentinel Cohort: RSV 120 mcg With Aluminum Hydroxide Age 50-85 Years</title>
            <description>Participants aged 50-85 years received single 120-mcg dose with aluminum hydroxide intramuscularly. Participants were followed up to 12 months after vaccination.</description>
          </group>
          <group group_id="O5">
            <title>Sentinel Cohort: RSV 240 mcg Age 50-85 Years</title>
            <description>Participants aged 50-85 years received single 240-mcg dose intramuscularly. Participants were followed up to 12 months after vaccination.</description>
          </group>
          <group group_id="O6">
            <title>Sentinel Cohort: RSV 240 mcg With Aluminum Hydroxide Age 50-85 Years</title>
            <description>Participants aged 50-85 years received single 240-mcg dose with aluminum hydroxide intramuscularly. Participants were followed up to 12 months after vaccination.</description>
          </group>
          <group group_id="O7">
            <title>Sentinel Cohort: Placebo Age 50-85 Years</title>
            <description>Participants aged 50-85 years received placebo matched to RSV vaccine intramuscularly. Participants were followed up to 12 months after vaccination.</description>
          </group>
        </group_list>
        <measure>
          <title>Sentinel Cohort: Percentage of Participants (Aged 50 to 85 Years) With Local Reactions Within 14 Days After Vaccination</title>
          <description>Local reactions included pain at injection site, redness and swelling recorded by participants in an e-diary. Redness and swelling were measured and recorded in measuring device units. 1 measuring device unit =0.5 cm and graded as mild: 2.5 to 5.0 cm, moderate: &gt; 5.0 to 10.0 cm and severe: &gt;10 cm. Pain at injection site was graded as mild: did not interfere with daily activity, moderate: interfered with daily activity and severe: prevented daily activity.</description>
          <population>All participants in sentinel cohort who received at least 1 dose of the investigational products at Visit 1 and with e-dairy data available.</population>
          <units>Percentage of participants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="12"/>
                <count group_id="O3" value="12"/>
                <count group_id="O4" value="12"/>
                <count group_id="O5" value="12"/>
                <count group_id="O6" value="12"/>
                <count group_id="O7" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pain at injection site: mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.7" lower_limit="2.1" upper_limit="48.4"/>
                    <measurement group_id="O2" value="16.7" lower_limit="2.1" upper_limit="48.4"/>
                    <measurement group_id="O3" value="8.3" lower_limit="0.2" upper_limit="38.5"/>
                    <measurement group_id="O4" value="16.7" lower_limit="2.1" upper_limit="48.4"/>
                    <measurement group_id="O5" value="8.3" lower_limit="0.2" upper_limit="38.5"/>
                    <measurement group_id="O6" value="8.3" lower_limit="0.2" upper_limit="38.5"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="26.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain at injection site: moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O2" value="8.3" lower_limit="0.2" upper_limit="38.5"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O4" value="25.0" lower_limit="5.5" upper_limit="57.2"/>
                    <measurement group_id="O5" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O6" value="8.3" lower_limit="0.2" upper_limit="38.5"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="26.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain at injection site: severe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O2" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O5" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O6" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="26.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Redness: mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.7" lower_limit="2.1" upper_limit="48.4"/>
                    <measurement group_id="O2" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O5" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O6" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="26.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Redness: moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O2" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O5" value="8.3" lower_limit="0.2" upper_limit="38.5"/>
                    <measurement group_id="O6" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="26.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Redness: severe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O2" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O5" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O6" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="26.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Swelling: mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O2" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O5" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O6" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="26.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Swelling: moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O2" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O5" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O6" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="26.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Swelling: severe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O2" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O5" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O6" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="26.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Expanded Cohort: Percentage of Participants (Aged 18 to 49 Years) With Local Reactions Within 14 Days After Vaccination 1</title>
        <description>Local reactions included pain at injection site, redness and swelling recorded by participants in an e-diary. Redness and swelling were measured and recorded in measuring device units. 1 measuring device unit =0.5 cm and graded as mild: 2.5 to 5.0 cm, moderate: &gt; 5.0 to 10.0 cm and severe: &gt;10 cm. Pain at injection site was graded as mild: did not interfere with daily activity, moderate: interfere with daily activity and severe: prevented daily activity.</description>
        <time_frame>Within 14 days after vaccination 1 on Day 1</time_frame>
        <population>All participants in expanded cohort who received at least 1 dose of the investigational products at Visit 1 and with e-dairy data available.</population>
        <group_list>
          <group group_id="O1">
            <title>Expanded Cohort: RSV 60 mcg With SIIV Age 18-49 Years</title>
            <description>Participants aged 18-49 years received 2 doses of RSV vaccine 60 mcg along with 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O2">
            <title>Expanded Cohort: RSV 60 mcg With Placebo Age 18-49 Years</title>
            <description>Participants aged 18-49 years received 2 doses of RSV vaccine 60 mcg along with placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O3">
            <title>Expanded Cohort: RSV 60 mcg With Aluminum Hydroxide and SIIV Age 18-49 Years</title>
            <description>Participants aged 18-49 years received 2 doses of RSV vaccine 60 mcg along with aluminum hydroxide and 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O4">
            <title>Expanded Cohort: RSV 60 mcg With Aluminum Hydroxide and Placebo Age 18-49 Years</title>
            <description>Participants aged 18-49 years received 2 doses of RSV vaccine 60 mcg along with aluminum hydroxide and placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O5">
            <title>Expanded Cohort: RSV 120 mcg With SIIV Age 18-49 Years</title>
            <description>Participants aged 18-49 years received 2 doses of RSV vaccine 120 mcg along with 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O6">
            <title>Expanded Cohort: RSV 120 mcg With Placebo Age 18-49 Years</title>
            <description>Participants aged 18-49 years received 2 doses of RSV vaccine 120 mcg along with placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O7">
            <title>Expanded Cohort: RSV 120 mcg With Aluminum Hydroxide and SIIV Age 18-49 Years</title>
            <description>Participants aged 18-49 years received 2 doses of RSV vaccine 120 mcg along with aluminum hydroxide and 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O8">
            <title>Expanded Cohort: RSV 120 mcg With Aluminum Hydroxide and Placebo Age 18-49 Years</title>
            <description>Participants aged 18-49 years received 2 doses of RSV vaccine 120 mcg along with aluminum hydroxide and placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O9">
            <title>Expanded Cohort: RSV 240 mcg With SIIV Age 18-49 Years</title>
            <description>Participants aged 18-49 years received 2 doses of RSV vaccine 240 mcg along with 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O10">
            <title>Expanded Cohort: RSV 240 mcg With Placebo Age 18-49 Years</title>
            <description>Participants aged 18-49 years received 2 doses of RSV vaccine 240 mcg along with placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O11">
            <title>Expanded Cohort: RSV 240 mcg With Aluminum Hydroxide and SIIV Age 18-49 Years</title>
            <description>Participants aged 18-49 years received 2 doses of RSV vaccine 240 mcg along with aluminum hydroxide and 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O12">
            <title>Expanded Cohort: RSV 240 mcg With Aluminum Hydroxide and Placebo Age 18-49 Years</title>
            <description>Participants aged 18-49 years received 2 doses of RSV vaccine 240 mcg along with aluminum hydroxide and placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O13">
            <title>Expanded Cohort: Placebo Age 18-49 Years</title>
            <description>Participants aged 18-49 years received placebo matched to RSV vaccine intramuscularly. Participants were followed up to 12 months after vaccination.</description>
          </group>
        </group_list>
        <measure>
          <title>Expanded Cohort: Percentage of Participants (Aged 18 to 49 Years) With Local Reactions Within 14 Days After Vaccination 1</title>
          <description>Local reactions included pain at injection site, redness and swelling recorded by participants in an e-diary. Redness and swelling were measured and recorded in measuring device units. 1 measuring device unit =0.5 cm and graded as mild: 2.5 to 5.0 cm, moderate: &gt; 5.0 to 10.0 cm and severe: &gt;10 cm. Pain at injection site was graded as mild: did not interfere with daily activity, moderate: interfere with daily activity and severe: prevented daily activity.</description>
          <population>All participants in expanded cohort who received at least 1 dose of the investigational products at Visit 1 and with e-dairy data available.</population>
          <units>Percentage of participants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="41"/>
                <count group_id="O2" value="42"/>
                <count group_id="O3" value="41"/>
                <count group_id="O4" value="40"/>
                <count group_id="O5" value="41"/>
                <count group_id="O6" value="41"/>
                <count group_id="O7" value="41"/>
                <count group_id="O8" value="40"/>
                <count group_id="O9" value="41"/>
                <count group_id="O10" value="41"/>
                <count group_id="O11" value="41"/>
                <count group_id="O12" value="41"/>
                <count group_id="O13" value="41"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pain at injection site: mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34.1" lower_limit="20.1" upper_limit="50.6"/>
                    <measurement group_id="O2" value="31.0" lower_limit="17.6" upper_limit="47.1"/>
                    <measurement group_id="O3" value="41.5" lower_limit="26.3" upper_limit="57.9"/>
                    <measurement group_id="O4" value="32.5" lower_limit="18.6" upper_limit="49.1"/>
                    <measurement group_id="O5" value="36.6" lower_limit="22.1" upper_limit="53.1"/>
                    <measurement group_id="O6" value="43.9" lower_limit="28.5" upper_limit="60.3"/>
                    <measurement group_id="O7" value="48.8" lower_limit="32.9" upper_limit="64.9"/>
                    <measurement group_id="O8" value="55.0" lower_limit="38.5" upper_limit="70.7"/>
                    <measurement group_id="O9" value="24.4" lower_limit="12.4" upper_limit="40.3"/>
                    <measurement group_id="O10" value="34.1" lower_limit="20.1" upper_limit="50.6"/>
                    <measurement group_id="O11" value="51.2" lower_limit="35.1" upper_limit="67.1"/>
                    <measurement group_id="O12" value="48.8" lower_limit="32.9" upper_limit="64.9"/>
                    <measurement group_id="O13" value="14.6" lower_limit="5.6" upper_limit="29.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain at injection site: moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.2" lower_limit="4.1" upper_limit="26.2"/>
                    <measurement group_id="O2" value="7.1" lower_limit="1.5" upper_limit="19.5"/>
                    <measurement group_id="O3" value="26.8" lower_limit="14.2" upper_limit="42.9"/>
                    <measurement group_id="O4" value="20.0" lower_limit="9.1" upper_limit="35.6"/>
                    <measurement group_id="O5" value="9.8" lower_limit="2.7" upper_limit="23.1"/>
                    <measurement group_id="O6" value="7.3" lower_limit="1.5" upper_limit="19.9"/>
                    <measurement group_id="O7" value="12.2" lower_limit="4.1" upper_limit="26.2"/>
                    <measurement group_id="O8" value="12.5" lower_limit="4.2" upper_limit="26.8"/>
                    <measurement group_id="O9" value="14.6" lower_limit="5.6" upper_limit="29.2"/>
                    <measurement group_id="O10" value="7.3" lower_limit="1.5" upper_limit="19.9"/>
                    <measurement group_id="O11" value="9.8" lower_limit="2.7" upper_limit="23.1"/>
                    <measurement group_id="O12" value="17.1" lower_limit="7.2" upper_limit="32.1"/>
                    <measurement group_id="O13" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain at injection site: severe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O2" value="0" lower_limit="0.0" upper_limit="8.4"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O5" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O6" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O8" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O9" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O10" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O11" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O12" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O13" value="0" lower_limit="0.0" upper_limit="8.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Redness: mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O2" value="4.8" lower_limit="0.6" upper_limit="16.2"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O4" value="2.5" lower_limit="0.1" upper_limit="13.2"/>
                    <measurement group_id="O5" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O6" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O7" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O8" value="7.5" lower_limit="1.6" upper_limit="20.4"/>
                    <measurement group_id="O9" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O10" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O11" value="7.3" lower_limit="1.5" upper_limit="19.9"/>
                    <measurement group_id="O12" value="4.9" lower_limit="0.6" upper_limit="16.5"/>
                    <measurement group_id="O13" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Redness: moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O2" value="2.4" lower_limit="0.1" upper_limit="12.6"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O5" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O6" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O7" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O8" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O9" value="4.9" lower_limit="0.6" upper_limit="16.5"/>
                    <measurement group_id="O10" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O11" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O12" value="9.8" lower_limit="2.7" upper_limit="23.1"/>
                    <measurement group_id="O13" value="0" lower_limit="0.0" upper_limit="8.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Redness: severe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O2" value="0" lower_limit="0.0" upper_limit="8.4"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O5" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O6" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O8" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O9" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O10" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O11" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O12" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O13" value="0" lower_limit="0.0" upper_limit="8.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Swelling: mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O2" value="4.8" lower_limit="0.6" upper_limit="16.2"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O5" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O6" value="9.8" lower_limit="2.7" upper_limit="23.1"/>
                    <measurement group_id="O7" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O8" value="5.0" lower_limit="0.6" upper_limit="16.9"/>
                    <measurement group_id="O9" value="4.9" lower_limit="0.6" upper_limit="16.5"/>
                    <measurement group_id="O10" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O11" value="4.9" lower_limit="0.6" upper_limit="16.5"/>
                    <measurement group_id="O12" value="9.8" lower_limit="2.7" upper_limit="23.1"/>
                    <measurement group_id="O13" value="0" lower_limit="0.0" upper_limit="8.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Swelling: moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O2" value="4.8" lower_limit="0.6" upper_limit="16.2"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O5" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O6" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O8" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O9" value="7.3" lower_limit="1.5" upper_limit="19.9"/>
                    <measurement group_id="O10" value="4.9" lower_limit="0.6" upper_limit="16.5"/>
                    <measurement group_id="O11" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O12" value="9.8" lower_limit="2.7" upper_limit="23.1"/>
                    <measurement group_id="O13" value="0" lower_limit="0.0" upper_limit="8.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Swelling: severe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O2" value="0" lower_limit="0.0" upper_limit="8.4"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O4" value="2.5" lower_limit="0.1" upper_limit="13.2"/>
                    <measurement group_id="O5" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O6" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O8" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O9" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O10" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O11" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O12" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O13" value="0" lower_limit="0.0" upper_limit="8.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Expanded Cohort: Percentage of Participants (Aged 65 to 85 Years) With Local Reactions Within 14 Days After Vaccination 1</title>
        <description>Local reactions included pain at injection site, redness and swelling recorded by participants in an e-diary. Redness and swelling were measured and recorded in measuring device units. 1 measuring device unit =0.5 cm and graded as mild: 2.5 to 5.0 cm, moderate: &gt; 5.0 to 10.0 cm and severe: &gt;10 cm. Pain at injection site was graded as mild: did not interfere with daily activity, moderate: interfered with daily activity and severe: prevented daily activity.</description>
        <time_frame>Within 14 days after vaccination 1 on Day 1</time_frame>
        <population>All participants in expanded cohort who received at least 1 dose of the investigational products at Visit 1 and with e-dairy data available.</population>
        <group_list>
          <group group_id="O1">
            <title>Expanded Cohort: RSV 60 mcg With SIIV Age 65-85 Years</title>
            <description>Participants aged 65-85 years received 2 doses of RSV vaccine 60 mcg along with 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O2">
            <title>Expanded Cohort: RSV 60 mcg With Placebo Age 65-85 Years</title>
            <description>Participants aged 65-85 years received 2 doses of RSV vaccine 60 mcg along with placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O3">
            <title>Expanded Cohort: RSV 60 mcg With Aluminum Hydroxide and SIIV Age 65-85 Years</title>
            <description>Participants aged 65-85 years received 2 doses of RSV vaccine 60 mcg along with aluminum hydroxide and 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O4">
            <title>Expanded Cohort: RSV 60 mcg With Aluminum Hydroxide and Placebo Age 65-85 Years</title>
            <description>Participants aged 65-85 years received 2 doses of RSV vaccine 60 mcg along with aluminum hydroxide and placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O5">
            <title>Expanded Cohort: RSV 120 mcg With SIIV Age 65-85 Years</title>
            <description>Participants aged 65-85 years received 2 doses of RSV vaccine 120 mcg along with 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O6">
            <title>Expanded Cohort: RSV 120 mcg With Placebo Age 65-85 Years</title>
            <description>Participants aged 65-85 years received 2 doses of RSV vaccine 120 mcg along with placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O7">
            <title>Expanded Cohort: RSV 120 mcg With Aluminum Hydroxide and SIIV Age 65-85 Years</title>
            <description>Participants aged 65-85 years received 2 doses of RSV vaccine 120 mcg along with aluminum hydroxide and 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O8">
            <title>Expanded Cohort: RSV 120 mcg With Aluminum Hydroxide and Placebo Age 65-85 Years</title>
            <description>Participants aged 65-85 years received 2 doses of RSV vaccine 120 mcg along with aluminum hydroxide and placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O9">
            <title>Expanded Cohort: RSV 240 mcg With SIIV Age 65-85 Years</title>
            <description>Participants aged 65-85 years received 2 doses of RSV vaccine 240 mcg along with 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O10">
            <title>Expanded Cohort: RSV 240 mcg With Placebo Age 65-85 Years</title>
            <description>Participants aged 65-85 years received 2 doses of RSV vaccine 240 mcg along with placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O11">
            <title>Expanded Cohort: RSV 240 mcg With Aluminum Hydroxide and SIIV Age 65-85 Years</title>
            <description>Participants aged 65-85 years received 2 doses of RSV vaccine 240 mcg along with aluminum hydroxide and 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O12">
            <title>Expanded Cohort: RSV 240 mcg With Aluminum Hydroxide and Placebo Age 65-85 Years</title>
            <description>Participants aged 65-85 years received 2 doses of RSV vaccine 240 mcg along with aluminum hydroxide and placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O13">
            <title>Expanded Cohort: Placebo Age 65-85 Years</title>
            <description>Participants aged 65-85 years received placebo matched to RSV vaccine intramuscularly. Participants were followed up to 12 months after vaccination.</description>
          </group>
        </group_list>
        <measure>
          <title>Expanded Cohort: Percentage of Participants (Aged 65 to 85 Years) With Local Reactions Within 14 Days After Vaccination 1</title>
          <description>Local reactions included pain at injection site, redness and swelling recorded by participants in an e-diary. Redness and swelling were measured and recorded in measuring device units. 1 measuring device unit =0.5 cm and graded as mild: 2.5 to 5.0 cm, moderate: &gt; 5.0 to 10.0 cm and severe: &gt;10 cm. Pain at injection site was graded as mild: did not interfere with daily activity, moderate: interfered with daily activity and severe: prevented daily activity.</description>
          <population>All participants in expanded cohort who received at least 1 dose of the investigational products at Visit 1 and with e-dairy data available.</population>
          <units>Percentage of participants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="40"/>
                <count group_id="O2" value="40"/>
                <count group_id="O3" value="40"/>
                <count group_id="O4" value="42"/>
                <count group_id="O5" value="40"/>
                <count group_id="O6" value="40"/>
                <count group_id="O7" value="41"/>
                <count group_id="O8" value="41"/>
                <count group_id="O9" value="40"/>
                <count group_id="O10" value="41"/>
                <count group_id="O11" value="42"/>
                <count group_id="O12" value="43"/>
                <count group_id="O13" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pain at injection site: mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25.0" lower_limit="12.7" upper_limit="41.2"/>
                    <measurement group_id="O2" value="10.0" lower_limit="2.8" upper_limit="23.7"/>
                    <measurement group_id="O3" value="22.5" lower_limit="10.8" upper_limit="38.5"/>
                    <measurement group_id="O4" value="23.8" lower_limit="12.1" upper_limit="39.5"/>
                    <measurement group_id="O5" value="22.5" lower_limit="10.8" upper_limit="38.5"/>
                    <measurement group_id="O6" value="10.0" lower_limit="2.8" upper_limit="23.7"/>
                    <measurement group_id="O7" value="26.8" lower_limit="14.2" upper_limit="42.9"/>
                    <measurement group_id="O8" value="19.5" lower_limit="8.8" upper_limit="34.9"/>
                    <measurement group_id="O9" value="32.5" lower_limit="18.6" upper_limit="49.1"/>
                    <measurement group_id="O10" value="19.5" lower_limit="8.8" upper_limit="34.9"/>
                    <measurement group_id="O11" value="19.0" lower_limit="8.6" upper_limit="34.1"/>
                    <measurement group_id="O12" value="14.0" lower_limit="5.3" upper_limit="27.9"/>
                    <measurement group_id="O13" value="5.0" lower_limit="0.6" upper_limit="16.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain at injection site: moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.5" lower_limit="0.1" upper_limit="13.2"/>
                    <measurement group_id="O2" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O3" value="5.0" lower_limit="0.6" upper_limit="16.9"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="8.4"/>
                    <measurement group_id="O5" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O6" value="2.5" lower_limit="0.1" upper_limit="13.2"/>
                    <measurement group_id="O7" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O8" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O9" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O10" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O11" value="4.8" lower_limit="0.6" upper_limit="16.2"/>
                    <measurement group_id="O12" value="4.7" lower_limit="0.6" upper_limit="15.8"/>
                    <measurement group_id="O13" value="0" lower_limit="0.0" upper_limit="8.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain at injection site: severe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O2" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="8.4"/>
                    <measurement group_id="O5" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O6" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O8" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O9" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O10" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O11" value="0" lower_limit="0.0" upper_limit="8.4"/>
                    <measurement group_id="O12" value="0" lower_limit="0.0" upper_limit="8.2"/>
                    <measurement group_id="O13" value="0" lower_limit="0.0" upper_limit="8.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Redness: mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.5" lower_limit="0.1" upper_limit="13.2"/>
                    <measurement group_id="O2" value="2.5" lower_limit="0.1" upper_limit="13.2"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O4" value="7.1" lower_limit="1.5" upper_limit="19.5"/>
                    <measurement group_id="O5" value="2.5" lower_limit="0.1" upper_limit="13.2"/>
                    <measurement group_id="O6" value="7.5" lower_limit="1.6" upper_limit="20.4"/>
                    <measurement group_id="O7" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O8" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O9" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O10" value="7.3" lower_limit="1.5" upper_limit="19.9"/>
                    <measurement group_id="O11" value="0" lower_limit="0.0" upper_limit="8.4"/>
                    <measurement group_id="O12" value="4.7" lower_limit="0.6" upper_limit="15.8"/>
                    <measurement group_id="O13" value="0" lower_limit="0.0" upper_limit="8.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Redness: moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.0" lower_limit="0.6" upper_limit="16.9"/>
                    <measurement group_id="O2" value="2.5" lower_limit="0.1" upper_limit="13.2"/>
                    <measurement group_id="O3" value="2.5" lower_limit="0.1" upper_limit="13.2"/>
                    <measurement group_id="O4" value="2.4" lower_limit="0.1" upper_limit="12.6"/>
                    <measurement group_id="O5" value="5.0" lower_limit="0.6" upper_limit="16.9"/>
                    <measurement group_id="O6" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O7" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O8" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O9" value="2.5" lower_limit="0.1" upper_limit="13.2"/>
                    <measurement group_id="O10" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O11" value="2.4" lower_limit="0.1" upper_limit="12.6"/>
                    <measurement group_id="O12" value="2.3" lower_limit="0.1" upper_limit="12.3"/>
                    <measurement group_id="O13" value="0" lower_limit="0.0" upper_limit="8.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Redness: severe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O2" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="8.4"/>
                    <measurement group_id="O5" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O6" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O8" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O9" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O10" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O11" value="0" lower_limit="0.0" upper_limit="8.4"/>
                    <measurement group_id="O12" value="0" lower_limit="0.0" upper_limit="8.2"/>
                    <measurement group_id="O13" value="0" lower_limit="0.0" upper_limit="8.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Swelling: mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.5" lower_limit="1.6" upper_limit="20.4"/>
                    <measurement group_id="O2" value="5.0" lower_limit="0.6" upper_limit="16.9"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O4" value="4.8" lower_limit="0.6" upper_limit="16.2"/>
                    <measurement group_id="O5" value="2.5" lower_limit="0.1" upper_limit="13.2"/>
                    <measurement group_id="O6" value="5.0" lower_limit="0.6" upper_limit="16.9"/>
                    <measurement group_id="O7" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O8" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O9" value="5.0" lower_limit="0.6" upper_limit="16.9"/>
                    <measurement group_id="O10" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O11" value="2.4" lower_limit="0.1" upper_limit="12.6"/>
                    <measurement group_id="O12" value="2.3" lower_limit="0.1" upper_limit="12.3"/>
                    <measurement group_id="O13" value="2.5" lower_limit="0.1" upper_limit="13.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Swelling: moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O2" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="8.4"/>
                    <measurement group_id="O5" value="5.0" lower_limit="0.6" upper_limit="16.9"/>
                    <measurement group_id="O6" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O8" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O9" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O10" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O11" value="2.4" lower_limit="0.1" upper_limit="12.6"/>
                    <measurement group_id="O12" value="2.3" lower_limit="0.1" upper_limit="12.3"/>
                    <measurement group_id="O13" value="0" lower_limit="0.0" upper_limit="8.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Swelling: severe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O2" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="8.4"/>
                    <measurement group_id="O5" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O6" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O8" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O9" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O10" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O11" value="0" lower_limit="0.0" upper_limit="8.4"/>
                    <measurement group_id="O12" value="2.3" lower_limit="0.1" upper_limit="12.3"/>
                    <measurement group_id="O13" value="0" lower_limit="0.0" upper_limit="8.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Sentinel Cohort: Percentage of Participants (Aged 18 to 49 Years) With Systemic Reactions Within 14 Days After Vaccination</title>
        <description>Systemic reactions:fever, fatigue/tiredness, headache, nausea, muscle pain, joint pain, vomiting, diarrhea and any systemic event recorded by participants in an e-diary. Fever: greater than equal to (&gt;=)38.0 degrees (deg) Celsius (C), mild (&gt;=38.0 to 38.4 deg C, &gt;38.4 to 38.9 deg C), moderate (&gt;38.9 to 40.0 deg C and &gt;40.0 deg C), severe (&gt;38.9 deg C to 40.0 deg C) and grade 4 (&gt;40.0 deg C). Fatigue, headache, nausea, muscle pain and joint pain were graded as mild: did not interfere with activity, moderate: some interference with activity and severe: prevented daily routine activity. Vomiting was graded as mild: 1 to 2 times in 24 hours(h), moderate: &gt;2 times in 24h and severe: requires intravenous hydration. Diarrhea was graded as mild: 2 to 3 loose stools in 24h, moderate: 4 to 5 loose stools in 24h and severe: 6 or more loose stools in 24h.</description>
        <time_frame>Within 14 days after vaccination</time_frame>
        <population>All participants in sentinel cohort who received at least 1 dose of the investigational products at Visit 1 and with e-dairy data available.</population>
        <group_list>
          <group group_id="O1">
            <title>Sentinel Cohort: RSV Vaccine 60 mcg Age 18-49 Years</title>
            <description>Participants aged 18-49 years received single 60-mcg dose of RSV vaccine, intramuscularly. Participants were followed up to 12 months after vaccination.</description>
          </group>
          <group group_id="O2">
            <title>Sentinel Cohort: RSV 60 mcg With Aluminum Hydroxide Age 18-49 Years</title>
            <description>Participants aged 18-49 years received single 60-mcg dose with aluminum hydroxide intramuscularly. Participants were followed up to 12 months after vaccination.</description>
          </group>
          <group group_id="O3">
            <title>Sentinel Cohort: RSV 120 mcg Age 18-49 Years</title>
            <description>Participants aged 18-49 years received single 120-mcg dose intramuscularly. Participants were followed up to 12 months after vaccination.</description>
          </group>
          <group group_id="O4">
            <title>Sentinel Cohort: RSV 120 mcg With Aluminum Hydroxide Age 18-49 Years</title>
            <description>Participants aged 18-49 years received single 120-mcg dose with aluminum hydroxide intramuscularly. Participants were followed up to 12 months after vaccination.</description>
          </group>
          <group group_id="O5">
            <title>Sentinel Cohort: RSV 240 mcg Age 18-49 Years</title>
            <description>Participants aged 18-49 years received single 240-mcg dose intramuscularly. Participants were followed up to 12 months after vaccination.</description>
          </group>
          <group group_id="O6">
            <title>Sentinel Cohort: RSV 240 mcg With Aluminum Hydroxide Age 18-49 Years</title>
            <description>Participants aged 18-49 years received single 240-mcg dose with aluminum hydroxide intramuscularly. Participants were followed up to 12 months after vaccination.</description>
          </group>
          <group group_id="O7">
            <title>Sentinel Cohort: Placebo Age 18-49 Years</title>
            <description>Participants aged 18-49 years received placebo matched to RSV vaccine intramuscularly. Participants were followed up to 12 months after vaccination.</description>
          </group>
        </group_list>
        <measure>
          <title>Sentinel Cohort: Percentage of Participants (Aged 18 to 49 Years) With Systemic Reactions Within 14 Days After Vaccination</title>
          <description>Systemic reactions:fever, fatigue/tiredness, headache, nausea, muscle pain, joint pain, vomiting, diarrhea and any systemic event recorded by participants in an e-diary. Fever: greater than equal to (&gt;=)38.0 degrees (deg) Celsius (C), mild (&gt;=38.0 to 38.4 deg C, &gt;38.4 to 38.9 deg C), moderate (&gt;38.9 to 40.0 deg C and &gt;40.0 deg C), severe (&gt;38.9 deg C to 40.0 deg C) and grade 4 (&gt;40.0 deg C). Fatigue, headache, nausea, muscle pain and joint pain were graded as mild: did not interfere with activity, moderate: some interference with activity and severe: prevented daily routine activity. Vomiting was graded as mild: 1 to 2 times in 24 hours(h), moderate: &gt;2 times in 24h and severe: requires intravenous hydration. Diarrhea was graded as mild: 2 to 3 loose stools in 24h, moderate: 4 to 5 loose stools in 24h and severe: 6 or more loose stools in 24h.</description>
          <population>All participants in sentinel cohort who received at least 1 dose of the investigational products at Visit 1 and with e-dairy data available.</population>
          <units>Percentage of participants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="12"/>
                <count group_id="O3" value="12"/>
                <count group_id="O4" value="12"/>
                <count group_id="O5" value="11"/>
                <count group_id="O6" value="12"/>
                <count group_id="O7" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Fever: &gt;=38.0 degree C</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O2" value="8.3" lower_limit="0.2" upper_limit="38.5"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O5" value="0" lower_limit="0.0" upper_limit="28.5"/>
                    <measurement group_id="O6" value="8.3" lower_limit="0.2" upper_limit="38.5"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="26.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fever: mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O2" value="8.3" lower_limit="0.2" upper_limit="38.5"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O5" value="0" lower_limit="0.0" upper_limit="28.5"/>
                    <measurement group_id="O6" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="26.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fever: moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O2" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O5" value="0" lower_limit="0.0" upper_limit="28.5"/>
                    <measurement group_id="O6" value="8.3" lower_limit="0.2" upper_limit="38.5"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="26.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fever: severe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O2" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O5" value="0" lower_limit="0.0" upper_limit="28.5"/>
                    <measurement group_id="O6" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="26.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fever: Grade 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O2" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O5" value="0" lower_limit="0.0" upper_limit="28.5"/>
                    <measurement group_id="O6" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="26.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fatigue: mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.3" lower_limit="0.2" upper_limit="38.5"/>
                    <measurement group_id="O2" value="41.7" lower_limit="15.2" upper_limit="72.3"/>
                    <measurement group_id="O3" value="16.7" lower_limit="2.1" upper_limit="48.4"/>
                    <measurement group_id="O4" value="33.3" lower_limit="9.9" upper_limit="65.1"/>
                    <measurement group_id="O5" value="9.1" lower_limit="0.2" upper_limit="41.3"/>
                    <measurement group_id="O6" value="16.7" lower_limit="2.1" upper_limit="48.4"/>
                    <measurement group_id="O7" value="25.0" lower_limit="5.5" upper_limit="57.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fatigue: moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25.0" lower_limit="5.5" upper_limit="57.2"/>
                    <measurement group_id="O2" value="8.3" lower_limit="0.2" upper_limit="38.5"/>
                    <measurement group_id="O3" value="25.0" lower_limit="5.5" upper_limit="57.2"/>
                    <measurement group_id="O4" value="25.0" lower_limit="5.5" upper_limit="57.2"/>
                    <measurement group_id="O5" value="36.4" lower_limit="10.9" upper_limit="69.2"/>
                    <measurement group_id="O6" value="33.3" lower_limit="9.9" upper_limit="65.1"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="26.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fatigue: severe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.3" lower_limit="0.2" upper_limit="38.5"/>
                    <measurement group_id="O2" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O5" value="9.1" lower_limit="0.2" upper_limit="41.3"/>
                    <measurement group_id="O6" value="8.3" lower_limit="0.2" upper_limit="38.5"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="26.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Headache: mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.7" lower_limit="2.1" upper_limit="48.4"/>
                    <measurement group_id="O2" value="16.7" lower_limit="2.1" upper_limit="48.4"/>
                    <measurement group_id="O3" value="8.3" lower_limit="0.2" upper_limit="38.5"/>
                    <measurement group_id="O4" value="33.3" lower_limit="9.9" upper_limit="65.1"/>
                    <measurement group_id="O5" value="27.3" lower_limit="6.0" upper_limit="61.0"/>
                    <measurement group_id="O6" value="8.3" lower_limit="0.2" upper_limit="38.5"/>
                    <measurement group_id="O7" value="8.3" lower_limit="0.2" upper_limit="38.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Headache: moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25.0" lower_limit="5.5" upper_limit="57.2"/>
                    <measurement group_id="O2" value="25.0" lower_limit="5.5" upper_limit="57.2"/>
                    <measurement group_id="O3" value="16.7" lower_limit="2.1" upper_limit="48.4"/>
                    <measurement group_id="O4" value="8.3" lower_limit="0.2" upper_limit="38.5"/>
                    <measurement group_id="O5" value="27.3" lower_limit="6.0" upper_limit="61.0"/>
                    <measurement group_id="O6" value="33.3" lower_limit="9.9" upper_limit="65.1"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="26.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Headache: severe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O2" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O5" value="9.1" lower_limit="0.2" upper_limit="41.3"/>
                    <measurement group_id="O6" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="26.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Nausea: mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.3" lower_limit="0.2" upper_limit="38.5"/>
                    <measurement group_id="O2" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O3" value="8.3" lower_limit="0.2" upper_limit="38.5"/>
                    <measurement group_id="O4" value="16.7" lower_limit="2.1" upper_limit="48.4"/>
                    <measurement group_id="O5" value="0" lower_limit="0.0" upper_limit="28.5"/>
                    <measurement group_id="O6" value="16.7" lower_limit="2.1" upper_limit="48.4"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="26.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Nausea: moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.7" lower_limit="2.1" upper_limit="48.4"/>
                    <measurement group_id="O2" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O3" value="8.3" lower_limit="0.2" upper_limit="38.5"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O5" value="18.2" lower_limit="2.3" upper_limit="51.8"/>
                    <measurement group_id="O6" value="8.3" lower_limit="0.2" upper_limit="38.5"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="26.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Nausea: severe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.3" lower_limit="0.2" upper_limit="38.5"/>
                    <measurement group_id="O2" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O5" value="0" lower_limit="0.0" upper_limit="28.5"/>
                    <measurement group_id="O6" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="26.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Muscle pain: mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="50.0" lower_limit="21.1" upper_limit="78.9"/>
                    <measurement group_id="O2" value="25.0" lower_limit="5.5" upper_limit="57.2"/>
                    <measurement group_id="O3" value="25.0" lower_limit="5.5" upper_limit="57.2"/>
                    <measurement group_id="O4" value="33.3" lower_limit="9.9" upper_limit="65.1"/>
                    <measurement group_id="O5" value="0" lower_limit="0.0" upper_limit="28.5"/>
                    <measurement group_id="O6" value="41.7" lower_limit="15.2" upper_limit="72.3"/>
                    <measurement group_id="O7" value="8.3" lower_limit="0.2" upper_limit="38.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Muscle pain: moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O2" value="8.3" lower_limit="0.2" upper_limit="38.5"/>
                    <measurement group_id="O3" value="8.3" lower_limit="0.2" upper_limit="38.5"/>
                    <measurement group_id="O4" value="16.7" lower_limit="2.1" upper_limit="48.4"/>
                    <measurement group_id="O5" value="9.1" lower_limit="0.2" upper_limit="41.3"/>
                    <measurement group_id="O6" value="16.7" lower_limit="2.1" upper_limit="48.4"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="26.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Muscle pain: severe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O2" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O5" value="9.1" lower_limit="0.2" upper_limit="41.3"/>
                    <measurement group_id="O6" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="26.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Joint pain: mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.3" lower_limit="0.2" upper_limit="38.5"/>
                    <measurement group_id="O2" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O4" value="16.7" lower_limit="2.1" upper_limit="48.4"/>
                    <measurement group_id="O5" value="0" lower_limit="0.0" upper_limit="28.5"/>
                    <measurement group_id="O6" value="16.7" lower_limit="2.1" upper_limit="48.4"/>
                    <measurement group_id="O7" value="8.3" lower_limit="0.2" upper_limit="38.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Joint pain: moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O2" value="8.3" lower_limit="0.2" upper_limit="38.5"/>
                    <measurement group_id="O3" value="16.7" lower_limit="2.1" upper_limit="48.4"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O5" value="9.1" lower_limit="0.2" upper_limit="41.3"/>
                    <measurement group_id="O6" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="26.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Joint pain: severe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O2" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O5" value="9.1" lower_limit="0.2" upper_limit="41.3"/>
                    <measurement group_id="O6" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="26.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Vomiting: mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.3" lower_limit="0.2" upper_limit="38.5"/>
                    <measurement group_id="O2" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O5" value="18.2" lower_limit="2.3" upper_limit="51.8"/>
                    <measurement group_id="O6" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="26.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Vomiting: moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O2" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O5" value="0" lower_limit="0.0" upper_limit="28.5"/>
                    <measurement group_id="O6" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="26.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Vomiting: severe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O2" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O5" value="0" lower_limit="0.0" upper_limit="28.5"/>
                    <measurement group_id="O6" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="26.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Diarrhea: mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O2" value="16.7" lower_limit="2.1" upper_limit="48.4"/>
                    <measurement group_id="O3" value="16.7" lower_limit="2.1" upper_limit="48.4"/>
                    <measurement group_id="O4" value="8.3" lower_limit="0.2" upper_limit="38.5"/>
                    <measurement group_id="O5" value="27.3" lower_limit="6.0" upper_limit="61.0"/>
                    <measurement group_id="O6" value="8.3" lower_limit="0.2" upper_limit="38.5"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="26.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Diarrhea: moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.3" lower_limit="0.2" upper_limit="38.5"/>
                    <measurement group_id="O2" value="8.3" lower_limit="0.2" upper_limit="38.5"/>
                    <measurement group_id="O3" value="0.0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O4" value="8.3" lower_limit="0.2" upper_limit="38.5"/>
                    <measurement group_id="O5" value="0" lower_limit="0.0" upper_limit="28.5"/>
                    <measurement group_id="O6" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O7" value="8.3" lower_limit="0.2" upper_limit="38.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Diarrhea: severe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O2" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O5" value="0" lower_limit="0.0" upper_limit="28.5"/>
                    <measurement group_id="O6" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="26.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Sentinel Cohort: Percentage of Participants (Aged 50 to 85 Years) With Systemic Reactions Within 14 Days After Vaccination</title>
        <description>Systemic reactions: fever, fatigue/tiredness, headache, nausea, muscle pain, joint pain, vomiting, diarrhea and any systemic event recorded by participants in an e-diary. Fever: &gt;= 38.0 deg C, mild (&gt;=38.0 to 38.4 deg C, &gt;38.4 to 38.9 deg C), moderate (&gt;38.9 to 40.0 deg C and &gt;40.0 deg C), severe (&gt;38.9 deg C to 40.0 deg C) and grade 4 (&gt;40.0 deg C). Fatigue, headache, nausea, muscle pain and joint pain were graded as mild: did not interfere with activity, moderate: some interference with activity and severe: prevented daily routine activity. Vomiting was graded as mild: 1 to 2 times in 24 h, moderate: &gt;2 times in 24h and severe: requires intravenous hydration. Diarrhea was graded as mild: 2 to 3 loose stools in 24h, moderate: 4 to 5 loose stools in 24h and severe: 6 or more loose stools in 24h.</description>
        <time_frame>Within 14 days after vaccination</time_frame>
        <population>All participants in sentinel cohort who received at least 1 dose of the investigational products at Visit 1 and with e-dairy data available.</population>
        <group_list>
          <group group_id="O1">
            <title>Sentinel Cohort: RSV Vaccine 60 mcg Age 50-85 Years</title>
            <description>Participants aged 50-85 years received single 60-mcg dose of RSV vaccine, intramuscularly. Participants were followed up to 12 months after vaccination.</description>
          </group>
          <group group_id="O2">
            <title>Sentinel Cohort: RSV 60 mcg With Aluminum Hydroxide Age 50-85 Years</title>
            <description>Participants aged 50-85 years received single 60-mcg dose with aluminum hydroxide intramuscularly. Participants were followed up to 12 months after vaccination.</description>
          </group>
          <group group_id="O3">
            <title>Sentinel Cohort: RSV 120 mcg Age 50-85 Years</title>
            <description>Participants aged 50-85 years received single 120-mcg dose intramuscularly. Participants were followed up to 12 months after vaccination.</description>
          </group>
          <group group_id="O4">
            <title>Sentinel Cohort: RSV 120 mcg With Aluminum Hydroxide Age 50-85 Years</title>
            <description>Participants aged 50-85 years received single 120-mcg dose with aluminum hydroxide intramuscularly. Participants were followed up to 12 months after vaccination.</description>
          </group>
          <group group_id="O5">
            <title>Sentinel Cohort: RSV 240 mcg Age 50-85 Years</title>
            <description>Participants aged 50-85 years received single 240-mcg dose intramuscularly. Participants were followed up to 12 months after vaccination.</description>
          </group>
          <group group_id="O6">
            <title>Sentinel Cohort: RSV 240 mcg With Aluminum Hydroxide Age 50-85 Years</title>
            <description>Participants aged 50-85 years received single 240-mcg dose with aluminum hydroxide intramuscularly. Participants were followed up to 12 months after vaccination.</description>
          </group>
          <group group_id="O7">
            <title>Sentinel Cohort: Placebo Age 50-85 Years</title>
            <description>Participants aged 50-85 years received placebo matched to RSV vaccine intramuscularly. Participants were followed up to 12 months after vaccination.</description>
          </group>
        </group_list>
        <measure>
          <title>Sentinel Cohort: Percentage of Participants (Aged 50 to 85 Years) With Systemic Reactions Within 14 Days After Vaccination</title>
          <description>Systemic reactions: fever, fatigue/tiredness, headache, nausea, muscle pain, joint pain, vomiting, diarrhea and any systemic event recorded by participants in an e-diary. Fever: &gt;= 38.0 deg C, mild (&gt;=38.0 to 38.4 deg C, &gt;38.4 to 38.9 deg C), moderate (&gt;38.9 to 40.0 deg C and &gt;40.0 deg C), severe (&gt;38.9 deg C to 40.0 deg C) and grade 4 (&gt;40.0 deg C). Fatigue, headache, nausea, muscle pain and joint pain were graded as mild: did not interfere with activity, moderate: some interference with activity and severe: prevented daily routine activity. Vomiting was graded as mild: 1 to 2 times in 24 h, moderate: &gt;2 times in 24h and severe: requires intravenous hydration. Diarrhea was graded as mild: 2 to 3 loose stools in 24h, moderate: 4 to 5 loose stools in 24h and severe: 6 or more loose stools in 24h.</description>
          <population>All participants in sentinel cohort who received at least 1 dose of the investigational products at Visit 1 and with e-dairy data available.</population>
          <units>Percentage of participants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="12"/>
                <count group_id="O3" value="12"/>
                <count group_id="O4" value="12"/>
                <count group_id="O5" value="12"/>
                <count group_id="O6" value="12"/>
                <count group_id="O7" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Fever: &gt;=38.0 degree C</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O2" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O5" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O6" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="26.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fever: mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O2" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O5" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O6" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="26.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fever: moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O2" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O5" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O6" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="26.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fever: severe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O2" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O5" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O6" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="26.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fever: Grade 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O2" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O5" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O6" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="26.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fatigue: mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="41.7" lower_limit="15.2" upper_limit="72.3"/>
                    <measurement group_id="O2" value="16.7" lower_limit="2.1" upper_limit="48.4"/>
                    <measurement group_id="O3" value="33.3" lower_limit="9.9" upper_limit="65.1"/>
                    <measurement group_id="O4" value="8.3" lower_limit="0.2" upper_limit="38.5"/>
                    <measurement group_id="O5" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O6" value="16.7" lower_limit="2.1" upper_limit="48.4"/>
                    <measurement group_id="O7" value="16.7" lower_limit="2.1" upper_limit="48.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fatigue: moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O2" value="33.3" lower_limit="9.9" upper_limit="65.1"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O4" value="25.0" lower_limit="5.5" upper_limit="57.2"/>
                    <measurement group_id="O5" value="8.3" lower_limit="0.2" upper_limit="38.5"/>
                    <measurement group_id="O6" value="8.3" lower_limit="0.2" upper_limit="38.5"/>
                    <measurement group_id="O7" value="16.7" lower_limit="2.1" upper_limit="48.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fatigue: severe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O2" value="8.3" lower_limit="0.2" upper_limit="38.5"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O5" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O6" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="26.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Headache: mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O2" value="8.3" lower_limit="0.2" upper_limit="38.5"/>
                    <measurement group_id="O3" value="8.3" lower_limit="0.2" upper_limit="38.5"/>
                    <measurement group_id="O4" value="25.0" lower_limit="5.5" upper_limit="57.2"/>
                    <measurement group_id="O5" value="16.7" lower_limit="2.1" upper_limit="48.4"/>
                    <measurement group_id="O6" value="8.3" lower_limit="0.2" upper_limit="38.5"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="26.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Headache: moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.3" lower_limit="0.2" upper_limit="38.5"/>
                    <measurement group_id="O2" value="16.7" lower_limit="2.1" upper_limit="48.4"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O5" value="8.3" lower_limit="0.2" upper_limit="38.5"/>
                    <measurement group_id="O6" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O7" value="8.3" lower_limit="0.2" upper_limit="38.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Headache: severe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O2" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O5" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O6" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="26.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Nausea: mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.7" lower_limit="2.1" upper_limit="48.4"/>
                    <measurement group_id="O2" value="8.3" lower_limit="0.2" upper_limit="38.5"/>
                    <measurement group_id="O3" value="16.7" lower_limit="2.1" upper_limit="48.4"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O5" value="8.3" lower_limit="0.2" upper_limit="38.5"/>
                    <measurement group_id="O6" value="8.3" lower_limit="0.2" upper_limit="38.5"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="26.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Nausea: moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O2" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O4" value="8.3" lower_limit="0.2" upper_limit="38.5"/>
                    <measurement group_id="O5" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O6" value="8.3" lower_limit="0.2" upper_limit="38.5"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="26.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Nausea: severe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O2" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O5" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O6" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="26.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Muscle pain: mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33.3" lower_limit="9.9" upper_limit="65.1"/>
                    <measurement group_id="O2" value="33.3" lower_limit="9.9" upper_limit="65.1"/>
                    <measurement group_id="O3" value="8.3" lower_limit="0.2" upper_limit="38.5"/>
                    <measurement group_id="O4" value="25.0" lower_limit="5.5" upper_limit="57.2"/>
                    <measurement group_id="O5" value="8.3" lower_limit="0.2" upper_limit="38.5"/>
                    <measurement group_id="O6" value="25.0" lower_limit="5.5" upper_limit="57.2"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="26.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Muscle pain:moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O2" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O4" value="25.0" lower_limit="5.5" upper_limit="57.2"/>
                    <measurement group_id="O5" value="8.3" lower_limit="0.2" upper_limit="38.5"/>
                    <measurement group_id="O6" value="8.3" lower_limit="0.2" upper_limit="38.5"/>
                    <measurement group_id="O7" value="8.3" lower_limit="0.2" upper_limit="38.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Muscle pain: severe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O2" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O5" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O6" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="26.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Joint pain: mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.3" lower_limit="0.2" upper_limit="38.5"/>
                    <measurement group_id="O2" value="16.7" lower_limit="2.1" upper_limit="48.4"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O4" value="16.7" lower_limit="2.1" upper_limit="48.4"/>
                    <measurement group_id="O5" value="8.3" lower_limit="0.2" upper_limit="38.5"/>
                    <measurement group_id="O6" value="8.3" lower_limit="0.2" upper_limit="38.5"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="26.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Joint pain: moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.3" lower_limit="0.2" upper_limit="38.5"/>
                    <measurement group_id="O2" value="16.7" lower_limit="2.1" upper_limit="48.4"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O4" value="16.7" lower_limit="2.1" upper_limit="48.4"/>
                    <measurement group_id="O5" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O6" value="8.3" lower_limit="0.2" upper_limit="38.5"/>
                    <measurement group_id="O7" value="8.3" lower_limit="0.2" upper_limit="38.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Joint pain: severe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O2" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O5" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O6" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="26.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Vomiting: mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O2" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O3" value="8.3" lower_limit="0.2" upper_limit="38.5"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O5" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O6" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="26.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Vomiting: moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O2" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O5" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O6" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="26.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Vomiting: severe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O2" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O5" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O6" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="26.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Diarrhea: mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O2" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O3" value="16.7" lower_limit="2.1" upper_limit="48.4"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O5" value="25.0" lower_limit="5.5" upper_limit="57.2"/>
                    <measurement group_id="O6" value="8.3" lower_limit="0.2" upper_limit="38.5"/>
                    <measurement group_id="O7" value="8.3" lower_limit="0.2" upper_limit="38.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Diarrhea: moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O2" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O4" value="8.3" lower_limit="0.2" upper_limit="38.5"/>
                    <measurement group_id="O5" value="8.3" lower_limit="0.2" upper_limit="38.5"/>
                    <measurement group_id="O6" value="8.3" lower_limit="0.2" upper_limit="38.5"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="26.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Diarrhea: severe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O2" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O5" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O6" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="26.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Expanded Cohort: Percentage of Participants (Aged 18 to 49 Years) With Systemic Reactions Within 14 Days After Vaccination 1</title>
        <description>Systemic reactions: fever, fatigue/tiredness, headache, nausea, muscle pain, joint pain, vomiting, diarrhea and any systemic event recorded by participants in an e-diary. Fever: &gt;= 38.0 deg C, mild (&gt;=38.0 to 38.4 deg C, &gt;38.4 to 38.9 deg C), moderate (&gt;38.9 to 40.0 deg C and &gt;40.0 deg C), severe (&gt;38.9 deg C to 40.0 deg C) and grade 4 (&gt;40.0 deg C). Fatigue, headache, nausea, muscle pain and joint pain were graded as mild: did not interfere with activity, moderate: some interference with activity and severe: prevented daily routine activity. Vomiting was graded as mild: 1 to 2 times in 24 h, moderate: &gt;2 times in 24h and severe: requires intravenous hydration. Diarrhea was graded as mild: 2 to 3 loose stools in 24h, moderate: 4 to 5 loose stools in 24h and severe: 6 or more loose stools in 24h.</description>
        <time_frame>Within 14 days after vaccination 1 on Day 1</time_frame>
        <population>All participants in expanded cohort who received at least 1 dose of the investigational products at Visit 1 and with e-dairy data available.</population>
        <group_list>
          <group group_id="O1">
            <title>Expanded Cohort: RSV 60 mcg With SIIV Age 18-49 Years</title>
            <description>Participants aged 18-49 years received 2 doses of RSV vaccine 60 mcg along with 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O2">
            <title>Expanded Cohort: RSV 60 mcg With Placebo Age 18-49 Years</title>
            <description>Participants aged 18-49 years received 2 doses of RSV vaccine 60 mcg along with placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O3">
            <title>Expanded Cohort: RSV 60 mcg With Aluminum Hydroxide and SIIV Age 18-49 Years</title>
            <description>Participants aged 18-49 years received 2 doses of RSV vaccine 60 mcg along with aluminum hydroxide and 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O4">
            <title>Expanded Cohort: RSV 60 mcg With Aluminum Hydroxide and Placebo Age 18-49 Years</title>
            <description>Participants aged 18-49 years received 2 doses of RSV vaccine 60 mcg along with aluminum hydroxide and placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O5">
            <title>Expanded Cohort: RSV 120 mcg With SIIV Age 18-49 Years</title>
            <description>Participants aged 18-49 years received 2 doses of RSV vaccine 120 mcg along with 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O6">
            <title>Expanded Cohort: RSV 120 mcg With Placebo Age 18-49 Years</title>
            <description>Participants aged 18-49 years received 2 doses of RSV vaccine 120 mcg along with placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O7">
            <title>Expanded Cohort: RSV 120 mcg With Aluminum Hydroxide and SIIV Age 18-49 Years</title>
            <description>Participants aged 18-49 years received 2 doses of RSV vaccine 120 mcg along with aluminum hydroxide and 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O8">
            <title>Expanded Cohort: RSV 120 mcg With Aluminum Hydroxide and Placebo Age 18-49 Years</title>
            <description>Participants aged 18-49 years received 2 doses of RSV vaccine 120 mcg along with aluminum hydroxide and placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O9">
            <title>Expanded Cohort: RSV 240 mcg With SIIV Age 18-49 Years</title>
            <description>Participants aged 18-49 years received 2 doses of RSV vaccine 240 mcg along with 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O10">
            <title>Expanded Cohort: RSV 240 mcg With Placebo Age 18-49 Years</title>
            <description>Participants aged 18-49 years received 2 doses of RSV vaccine 240 mcg along with placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O11">
            <title>Expanded Cohort: RSV 240 mcg With Aluminum Hydroxide and SIIV Age 18-49 Years</title>
            <description>Participants aged 18-49 years received 2 doses of RSV vaccine 240 mcg along with aluminum hydroxide and 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O12">
            <title>Expanded Cohort: RSV 240 mcg With Aluminum Hydroxide and Placebo Age 18-49 Years</title>
            <description>Participants aged 18-49 years received 2 doses of RSV vaccine 240 mcg along with aluminum hydroxide and placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O13">
            <title>Expanded Cohort: Placebo Age 18-49 Years</title>
            <description>Participants aged 18-49 years received placebo matched to RSV vaccine intramuscularly. Participants were followed up to 12 months after vaccination.</description>
          </group>
        </group_list>
        <measure>
          <title>Expanded Cohort: Percentage of Participants (Aged 18 to 49 Years) With Systemic Reactions Within 14 Days After Vaccination 1</title>
          <description>Systemic reactions: fever, fatigue/tiredness, headache, nausea, muscle pain, joint pain, vomiting, diarrhea and any systemic event recorded by participants in an e-diary. Fever: &gt;= 38.0 deg C, mild (&gt;=38.0 to 38.4 deg C, &gt;38.4 to 38.9 deg C), moderate (&gt;38.9 to 40.0 deg C and &gt;40.0 deg C), severe (&gt;38.9 deg C to 40.0 deg C) and grade 4 (&gt;40.0 deg C). Fatigue, headache, nausea, muscle pain and joint pain were graded as mild: did not interfere with activity, moderate: some interference with activity and severe: prevented daily routine activity. Vomiting was graded as mild: 1 to 2 times in 24 h, moderate: &gt;2 times in 24h and severe: requires intravenous hydration. Diarrhea was graded as mild: 2 to 3 loose stools in 24h, moderate: 4 to 5 loose stools in 24h and severe: 6 or more loose stools in 24h.</description>
          <population>All participants in expanded cohort who received at least 1 dose of the investigational products at Visit 1 and with e-dairy data available.</population>
          <units>Percentage of participants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="41"/>
                <count group_id="O2" value="42"/>
                <count group_id="O3" value="41"/>
                <count group_id="O4" value="40"/>
                <count group_id="O5" value="41"/>
                <count group_id="O6" value="41"/>
                <count group_id="O7" value="41"/>
                <count group_id="O8" value="40"/>
                <count group_id="O9" value="41"/>
                <count group_id="O10" value="41"/>
                <count group_id="O11" value="41"/>
                <count group_id="O12" value="41"/>
                <count group_id="O13" value="41"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Fever: &gt;=38.0 degree C</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O2" value="0" lower_limit="0.0" upper_limit="8.4"/>
                    <measurement group_id="O3" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O4" value="2.5" lower_limit="0.1" upper_limit="13.2"/>
                    <measurement group_id="O5" value="12.2" lower_limit="4.1" upper_limit="26.2"/>
                    <measurement group_id="O6" value="4.9" lower_limit="0.6" upper_limit="16.5"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O8" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O9" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O10" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O11" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O12" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O13" value="0" lower_limit="0.0" upper_limit="8.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fever: mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O2" value="0" lower_limit="0.0" upper_limit="8.4"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O4" value="2.5" lower_limit="0.1" upper_limit="13.2"/>
                    <measurement group_id="O5" value="4.9" lower_limit="0.6" upper_limit="16.5"/>
                    <measurement group_id="O6" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O8" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O9" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O10" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O11" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O12" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O13" value="0" lower_limit="0.0" upper_limit="8.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fever: moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O2" value="0" lower_limit="0.0" upper_limit="8.4"/>
                    <measurement group_id="O3" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O5" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O6" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O8" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O9" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O10" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O11" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O12" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O13" value="0" lower_limit="0.0" upper_limit="8.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fever: severe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O2" value="0" lower_limit="0.0" upper_limit="8.4"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O5" value="4.9" lower_limit="0.6" upper_limit="16.5"/>
                    <measurement group_id="O6" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O8" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O9" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O10" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O11" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O12" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O13" value="0" lower_limit="0.0" upper_limit="8.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fever: Grade 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O2" value="0" lower_limit="0.0" upper_limit="8.4"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O5" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O6" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O8" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O9" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O10" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O11" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O12" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O13" value="0" lower_limit="0.0" upper_limit="8.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fatigue: mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.6" lower_limit="5.6" upper_limit="29.2"/>
                    <measurement group_id="O2" value="16.7" lower_limit="7.0" upper_limit="31.4"/>
                    <measurement group_id="O3" value="17.1" lower_limit="7.2" upper_limit="32.1"/>
                    <measurement group_id="O4" value="17.5" lower_limit="7.3" upper_limit="32.8"/>
                    <measurement group_id="O5" value="17.1" lower_limit="7.2" upper_limit="32.1"/>
                    <measurement group_id="O6" value="9.8" lower_limit="2.7" upper_limit="23.1"/>
                    <measurement group_id="O7" value="29.3" lower_limit="16.1" upper_limit="45.5"/>
                    <measurement group_id="O8" value="27.5" lower_limit="14.6" upper_limit="43.9"/>
                    <measurement group_id="O9" value="14.6" lower_limit="5.6" upper_limit="29.2"/>
                    <measurement group_id="O10" value="14.6" lower_limit="5.6" upper_limit="29.2"/>
                    <measurement group_id="O11" value="29.3" lower_limit="16.1" upper_limit="45.5"/>
                    <measurement group_id="O12" value="19.5" lower_limit="8.8" upper_limit="34.9"/>
                    <measurement group_id="O13" value="12.2" lower_limit="4.1" upper_limit="26.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fatigue: moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="31.7" lower_limit="18.1" upper_limit="48.1"/>
                    <measurement group_id="O2" value="28.6" lower_limit="15.7" upper_limit="44.6"/>
                    <measurement group_id="O3" value="24.4" lower_limit="12.4" upper_limit="40.3"/>
                    <measurement group_id="O4" value="22.5" lower_limit="10.8" upper_limit="38.5"/>
                    <measurement group_id="O5" value="19.5" lower_limit="8.8" upper_limit="34.9"/>
                    <measurement group_id="O6" value="26.8" lower_limit="14.2" upper_limit="42.9"/>
                    <measurement group_id="O7" value="14.6" lower_limit="5.6" upper_limit="29.2"/>
                    <measurement group_id="O8" value="22.5" lower_limit="10.8" upper_limit="38.5"/>
                    <measurement group_id="O9" value="29.3" lower_limit="16.1" upper_limit="45.5"/>
                    <measurement group_id="O10" value="39.0" lower_limit="24.2" upper_limit="55.5"/>
                    <measurement group_id="O11" value="19.5" lower_limit="8.8" upper_limit="34.9"/>
                    <measurement group_id="O12" value="22.0" lower_limit="10.6" upper_limit="37.6"/>
                    <measurement group_id="O13" value="19.5" lower_limit="8.8" upper_limit="34.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fatigue: severe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O2" value="0" lower_limit="0.0" upper_limit="8.4"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O5" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O6" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O8" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O9" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O10" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O11" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O12" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O13" value="0" lower_limit="0.0" upper_limit="8.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Headache: mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.2" lower_limit="4.1" upper_limit="26.2"/>
                    <measurement group_id="O2" value="28.6" lower_limit="15.7" upper_limit="44.6"/>
                    <measurement group_id="O3" value="19.5" lower_limit="8.8" upper_limit="34.9"/>
                    <measurement group_id="O4" value="32.5" lower_limit="18.6" upper_limit="49.1"/>
                    <measurement group_id="O5" value="29.3" lower_limit="16.1" upper_limit="45.5"/>
                    <measurement group_id="O6" value="17.1" lower_limit="7.2" upper_limit="32.1"/>
                    <measurement group_id="O7" value="29.3" lower_limit="16.1" upper_limit="45.5"/>
                    <measurement group_id="O8" value="27.5" lower_limit="14.6" upper_limit="43.9"/>
                    <measurement group_id="O9" value="19.5" lower_limit="8.8" upper_limit="34.9"/>
                    <measurement group_id="O10" value="7.3" lower_limit="1.5" upper_limit="19.9"/>
                    <measurement group_id="O11" value="26.8" lower_limit="14.2" upper_limit="42.9"/>
                    <measurement group_id="O12" value="24.4" lower_limit="12.4" upper_limit="40.3"/>
                    <measurement group_id="O13" value="19.5" lower_limit="8.8" upper_limit="34.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Headache: moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="29.3" lower_limit="16.1" upper_limit="45.5"/>
                    <measurement group_id="O2" value="21.4" lower_limit="10.3" upper_limit="36.8"/>
                    <measurement group_id="O3" value="19.5" lower_limit="8.8" upper_limit="34.9"/>
                    <measurement group_id="O4" value="10.0" lower_limit="2.8" upper_limit="23.7"/>
                    <measurement group_id="O5" value="19.5" lower_limit="8.8" upper_limit="34.9"/>
                    <measurement group_id="O6" value="24.4" lower_limit="12.4" upper_limit="40.3"/>
                    <measurement group_id="O7" value="17.1" lower_limit="7.2" upper_limit="32.1"/>
                    <measurement group_id="O8" value="20.0" lower_limit="9.1" upper_limit="35.6"/>
                    <measurement group_id="O9" value="29.3" lower_limit="16.1" upper_limit="45.5"/>
                    <measurement group_id="O10" value="29.3" lower_limit="16.1" upper_limit="45.5"/>
                    <measurement group_id="O11" value="17.1" lower_limit="7.2" upper_limit="32.1"/>
                    <measurement group_id="O12" value="14.6" lower_limit="5.6" upper_limit="29.2"/>
                    <measurement group_id="O13" value="12.2" lower_limit="4.1" upper_limit="26.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Headache: severe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O2" value="4.8" lower_limit="0.6" upper_limit="16.2"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O4" value="2.5" lower_limit="0.1" upper_limit="13.2"/>
                    <measurement group_id="O5" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O6" value="7.3" lower_limit="1.5" upper_limit="19.9"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O8" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O9" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O10" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O11" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O12" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O13" value="0" lower_limit="0.0" upper_limit="8.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Nausea: mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.9" lower_limit="0.6" upper_limit="16.5"/>
                    <measurement group_id="O2" value="7.1" lower_limit="1.5" upper_limit="19.5"/>
                    <measurement group_id="O3" value="12.2" lower_limit="4.1" upper_limit="26.2"/>
                    <measurement group_id="O4" value="12.5" lower_limit="4.2" upper_limit="26.8"/>
                    <measurement group_id="O5" value="9.8" lower_limit="2.7" upper_limit="23.1"/>
                    <measurement group_id="O6" value="19.5" lower_limit="8.8" upper_limit="34.9"/>
                    <measurement group_id="O7" value="7.3" lower_limit="1.5" upper_limit="19.9"/>
                    <measurement group_id="O8" value="7.5" lower_limit="1.6" upper_limit="20.4"/>
                    <measurement group_id="O9" value="14.6" lower_limit="5.6" upper_limit="29.2"/>
                    <measurement group_id="O10" value="14.6" lower_limit="5.6" upper_limit="29.2"/>
                    <measurement group_id="O11" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O12" value="9.8" lower_limit="2.7" upper_limit="23.1"/>
                    <measurement group_id="O13" value="9.8" lower_limit="2.7" upper_limit="23.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Nausea: moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.8" lower_limit="2.7" upper_limit="23.1"/>
                    <measurement group_id="O2" value="7.1" lower_limit="1.5" upper_limit="19.5"/>
                    <measurement group_id="O3" value="7.3" lower_limit="1.5" upper_limit="19.9"/>
                    <measurement group_id="O4" value="2.5" lower_limit="0.1" upper_limit="13.2"/>
                    <measurement group_id="O5" value="4.9" lower_limit="0.6" upper_limit="16.5"/>
                    <measurement group_id="O6" value="7.3" lower_limit="1.5" upper_limit="19.9"/>
                    <measurement group_id="O7" value="4.9" lower_limit="0.6" upper_limit="16.5"/>
                    <measurement group_id="O8" value="12.5" lower_limit="4.2" upper_limit="26.8"/>
                    <measurement group_id="O9" value="4.9" lower_limit="0.6" upper_limit="16.5"/>
                    <measurement group_id="O10" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O11" value="7.3" lower_limit="1.5" upper_limit="19.9"/>
                    <measurement group_id="O12" value="7.3" lower_limit="1.5" upper_limit="19.9"/>
                    <measurement group_id="O13" value="4.9" lower_limit="0.6" upper_limit="16.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Nausea: severe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O2" value="0" lower_limit="0.0" upper_limit="8.4"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O5" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O6" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O8" value="2.5" lower_limit="0.1" upper_limit="13.2"/>
                    <measurement group_id="O9" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O10" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O11" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O12" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O13" value="0" lower_limit="0.0" upper_limit="8.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Muscle pain: mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24.4" lower_limit="12.4" upper_limit="40.3"/>
                    <measurement group_id="O2" value="16.7" lower_limit="7.0" upper_limit="31.4"/>
                    <measurement group_id="O3" value="34.1" lower_limit="20.1" upper_limit="50.6"/>
                    <measurement group_id="O4" value="27.5" lower_limit="14.6" upper_limit="43.9"/>
                    <measurement group_id="O5" value="29.3" lower_limit="16.1" upper_limit="45.5"/>
                    <measurement group_id="O6" value="22.0" lower_limit="10.6" upper_limit="37.6"/>
                    <measurement group_id="O7" value="43.9" lower_limit="28.5" upper_limit="60.3"/>
                    <measurement group_id="O8" value="37.5" lower_limit="22.7" upper_limit="54.2"/>
                    <measurement group_id="O9" value="19.5" lower_limit="8.8" upper_limit="34.9"/>
                    <measurement group_id="O10" value="24.4" lower_limit="12.4" upper_limit="40.3"/>
                    <measurement group_id="O11" value="36.6" lower_limit="22.1" upper_limit="53.1"/>
                    <measurement group_id="O12" value="26.8" lower_limit="14.2" upper_limit="42.9"/>
                    <measurement group_id="O13" value="12.2" lower_limit="4.1" upper_limit="26.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Muscle pain: moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.6" lower_limit="5.6" upper_limit="29.2"/>
                    <measurement group_id="O2" value="14.3" lower_limit="5.4" upper_limit="28.5"/>
                    <measurement group_id="O3" value="22.0" lower_limit="10.6" upper_limit="37.6"/>
                    <measurement group_id="O4" value="10.0" lower_limit="2.8" upper_limit="23.7"/>
                    <measurement group_id="O5" value="4.9" lower_limit="0.6" upper_limit="16.5"/>
                    <measurement group_id="O6" value="19.5" lower_limit="8.8" upper_limit="34.9"/>
                    <measurement group_id="O7" value="17.1" lower_limit="7.2" upper_limit="32.1"/>
                    <measurement group_id="O8" value="12.5" lower_limit="4.2" upper_limit="26.8"/>
                    <measurement group_id="O9" value="19.5" lower_limit="8.8" upper_limit="34.9"/>
                    <measurement group_id="O10" value="12.2" lower_limit="4.1" upper_limit="26.2"/>
                    <measurement group_id="O11" value="7.3" lower_limit="1.5" upper_limit="19.9"/>
                    <measurement group_id="O12" value="19.5" lower_limit="8.8" upper_limit="34.9"/>
                    <measurement group_id="O13" value="0" lower_limit="0.0" upper_limit="8.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Muscle pain: severe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O2" value="0" lower_limit="0.0" upper_limit="8.4"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O5" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O6" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O8" value="2.5" lower_limit="0.1" upper_limit="13.2"/>
                    <measurement group_id="O9" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O10" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O11" value="4.9" lower_limit="0.6" upper_limit="16.5"/>
                    <measurement group_id="O12" value="4.9" lower_limit="0.6" upper_limit="16.5"/>
                    <measurement group_id="O13" value="0" lower_limit="0.0" upper_limit="8.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Joint pain: mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.2" lower_limit="4.1" upper_limit="26.2"/>
                    <measurement group_id="O2" value="4.8" lower_limit="0.6" upper_limit="16.2"/>
                    <measurement group_id="O3" value="14.6" lower_limit="5.6" upper_limit="29.2"/>
                    <measurement group_id="O4" value="2.5" lower_limit="0.1" upper_limit="13.2"/>
                    <measurement group_id="O5" value="12.2" lower_limit="4.1" upper_limit="26.2"/>
                    <measurement group_id="O6" value="4.9" lower_limit="0.6" upper_limit="16.5"/>
                    <measurement group_id="O7" value="14.6" lower_limit="5.6" upper_limit="29.2"/>
                    <measurement group_id="O8" value="12.5" lower_limit="4.2" upper_limit="26.8"/>
                    <measurement group_id="O9" value="7.3" lower_limit="1.5" upper_limit="19.9"/>
                    <measurement group_id="O10" value="4.9" lower_limit="0.6" upper_limit="16.5"/>
                    <measurement group_id="O11" value="9.8" lower_limit="2.7" upper_limit="23.1"/>
                    <measurement group_id="O12" value="7.3" lower_limit="1.5" upper_limit="19.9"/>
                    <measurement group_id="O13" value="4.9" lower_limit="0.6" upper_limit="16.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Joint pain: moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.3" lower_limit="1.5" upper_limit="19.9"/>
                    <measurement group_id="O2" value="7.1" lower_limit="1.5" upper_limit="19.5"/>
                    <measurement group_id="O3" value="9.8" lower_limit="2.7" upper_limit="23.1"/>
                    <measurement group_id="O4" value="2.5" lower_limit="0.1" upper_limit="13.2"/>
                    <measurement group_id="O5" value="7.3" lower_limit="1.5" upper_limit="19.9"/>
                    <measurement group_id="O6" value="7.3" lower_limit="1.5" upper_limit="19.9"/>
                    <measurement group_id="O7" value="9.8" lower_limit="2.7" upper_limit="23.1"/>
                    <measurement group_id="O8" value="17.5" lower_limit="7.3" upper_limit="32.8"/>
                    <measurement group_id="O9" value="9.8" lower_limit="2.7" upper_limit="23.1"/>
                    <measurement group_id="O10" value="12.2" lower_limit="4.1" upper_limit="26.2"/>
                    <measurement group_id="O11" value="7.3" lower_limit="1.5" upper_limit="19.9"/>
                    <measurement group_id="O12" value="9.8" lower_limit="2.7" upper_limit="23.1"/>
                    <measurement group_id="O13" value="0" lower_limit="0.0" upper_limit="8.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Joint pain: severe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O2" value="0" lower_limit="0.0" upper_limit="8.4"/>
                    <measurement group_id="O3" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O5" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O6" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O8" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O9" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O10" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O11" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O12" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O13" value="0" lower_limit="0.0" upper_limit="8.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Vomiting: mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O2" value="0" lower_limit="0.0" upper_limit="8.4"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O4" value="2.5" lower_limit="0.1" upper_limit="13.2"/>
                    <measurement group_id="O5" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O6" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O8" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O9" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O10" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O11" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O12" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O13" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Vomiting: moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O2" value="0" lower_limit="0.0" upper_limit="8.4"/>
                    <measurement group_id="O3" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O5" value="4.9" lower_limit="0.6" upper_limit="16.5"/>
                    <measurement group_id="O6" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O7" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O8" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O9" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O10" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O11" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O12" value="4.9" lower_limit="0.6" upper_limit="16.5"/>
                    <measurement group_id="O13" value="0" lower_limit="0.0" upper_limit="8.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Vomiting: severe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O2" value="0" lower_limit="0.0" upper_limit="8.4"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O5" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O6" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O8" value="2.5" lower_limit="0.1" upper_limit="13.2"/>
                    <measurement group_id="O9" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O10" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O11" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O12" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O13" value="0" lower_limit="0.0" upper_limit="8.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Diarrhea: mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.3" lower_limit="1.5" upper_limit="19.9"/>
                    <measurement group_id="O2" value="11.9" lower_limit="4.0" upper_limit="25.6"/>
                    <measurement group_id="O3" value="19.5" lower_limit="8.8" upper_limit="34.9"/>
                    <measurement group_id="O4" value="12.5" lower_limit="4.2" upper_limit="26.8"/>
                    <measurement group_id="O5" value="22.0" lower_limit="10.6" upper_limit="37.6"/>
                    <measurement group_id="O6" value="17.1" lower_limit="7.2" upper_limit="32.1"/>
                    <measurement group_id="O7" value="19.5" lower_limit="8.8" upper_limit="34.9"/>
                    <measurement group_id="O8" value="22.5" lower_limit="10.8" upper_limit="38.5"/>
                    <measurement group_id="O9" value="12.2" lower_limit="4.1" upper_limit="26.2"/>
                    <measurement group_id="O10" value="19.5" lower_limit="8.8" upper_limit="34.9"/>
                    <measurement group_id="O11" value="7.3" lower_limit="1.5" upper_limit="19.9"/>
                    <measurement group_id="O12" value="17.1" lower_limit="7.2" upper_limit="32.1"/>
                    <measurement group_id="O13" value="9.8" lower_limit="2.7" upper_limit="23.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Diarrhea: moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.3" lower_limit="1.5" upper_limit="19.9"/>
                    <measurement group_id="O2" value="11.9" lower_limit="4.0" upper_limit="25.6"/>
                    <measurement group_id="O3" value="4.9" lower_limit="0.6" upper_limit="16.5"/>
                    <measurement group_id="O4" value="2.5" lower_limit="0.1" upper_limit="13.2"/>
                    <measurement group_id="O5" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O6" value="7.3" lower_limit="1.5" upper_limit="19.9"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O8" value="2.5" lower_limit="0.1" upper_limit="13.2"/>
                    <measurement group_id="O9" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O10" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O11" value="4.9" lower_limit="0.6" upper_limit="16.5"/>
                    <measurement group_id="O12" value="7.3" lower_limit="1.5" upper_limit="19.9"/>
                    <measurement group_id="O13" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Diarrhea: severe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O2" value="0" lower_limit="0.0" upper_limit="8.4"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O4" value="2.5" lower_limit="0.1" upper_limit="13.2"/>
                    <measurement group_id="O5" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O6" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O8" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O9" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O10" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O11" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O12" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O13" value="0" lower_limit="0.0" upper_limit="8.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Expanded Cohort: Percentage of Participants (Aged 65 to 85 Years) With Systemic Reactions Within 14 Days After Vaccination 1</title>
        <description>Systemic reactions: fever, fatigue/tiredness, headache, nausea, muscle pain, joint pain, vomiting, diarrhea and any systemic event recorded by participants in an e-diary. Fever: &gt;= 38.0 deg C, mild (&gt;=38.0 to 38.4 deg C, &gt;38.4 to 38.9 deg C), moderate (&gt;38.9 to 40.0 deg C and &gt;40.0 deg C), severe (&gt;38.9 deg C to 40.0 deg C) and grade 4 (&gt;40.0 deg C). Fatigue, headache, nausea, muscle pain and joint pain were graded as mild: did not interfere with activity, moderate: some interference with activity and severe: prevented daily routine activity. Vomiting was graded as mild: 1 to 2 times in 24 h, moderate: &gt;2 times in 24h and severe: requires intravenous hydration. Diarrhea was graded as mild: 2 to 3 loose stools in 24h, moderate: 4 to 5 loose stools in 24h and severe: 6 or more loose stools in 24h.</description>
        <time_frame>Within 14 days after vaccination 1 on Day 1</time_frame>
        <population>All participants in expanded cohort who received at least 1 dose of the investigational products at Visit 1 and with e-dairy data available.</population>
        <group_list>
          <group group_id="O1">
            <title>Expanded Cohort: RSV 60 mcg With SIIV Age 65-85 Years</title>
            <description>Participants aged 65-85 years received 2 doses of RSV vaccine 60 mcg along with 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O2">
            <title>Expanded Cohort: RSV 60 mcg With Placebo Age 65-85 Years</title>
            <description>Participants aged 65-85 years received 2 doses of RSV vaccine 60 mcg along with placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O3">
            <title>Expanded Cohort: RSV 60 mcg With Aluminum Hydroxide and SIIV Age 65-85 Years</title>
            <description>Participants aged 65-85 years received 2 doses of RSV vaccine 60 mcg along with aluminum hydroxide and 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O4">
            <title>Expanded Cohort: RSV 60 mcg With Aluminum Hydroxide and Placebo Age 65-85 Years</title>
            <description>Participants aged 65-85 years received 2 doses of RSV vaccine 60 mcg along with aluminum hydroxide and placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O5">
            <title>Expanded Cohort: RSV 120 mcg With SIIV Age 65-85 Years</title>
            <description>Participants aged 65-85 years received 2 doses of RSV vaccine 120 mcg along with 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O6">
            <title>Expanded Cohort: RSV 120 mcg With Placebo Age 65-85 Years</title>
            <description>Participants aged 65-85 years received 2 doses of RSV vaccine 120 mcg along with placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O7">
            <title>Expanded Cohort: RSV 120 mcg With Aluminum Hydroxide and SIIV Age 65-85 Years</title>
            <description>Participants aged 65-85 years received 2 doses of RSV vaccine 120 mcg along with aluminum hydroxide and 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O8">
            <title>Expanded Cohort: RSV 120 mcg With Aluminum Hydroxide and Placebo Age 65-85 Years</title>
            <description>Participants aged 65-85 years received 2 doses of RSV vaccine 120 mcg along with aluminum hydroxide and placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O9">
            <title>Expanded Cohort: RSV 240 mcg With SIIV Age 65-85 Years</title>
            <description>Participants aged 65-85 years received 2 doses of RSV vaccine 240 mcg along with 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O10">
            <title>Expanded Cohort: RSV 240 mcg With Placebo Age 65-85 Years</title>
            <description>Participants aged 65-85 years received 2 doses of RSV vaccine 240 mcg along with placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O11">
            <title>Expanded Cohort: RSV 240 mcg With Aluminum Hydroxide and SIIV Age 65-85 Years</title>
            <description>Participants aged 65-85 years received 2 doses of RSV vaccine 240 mcg along with aluminum hydroxide and 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O12">
            <title>Expanded Cohort: RSV 240 mcg With Aluminum Hydroxide and Placebo Age 65-85 Years</title>
            <description>Participants aged 65-85 years received 2 doses of RSV vaccine 240 mcg along with aluminum hydroxide and placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O13">
            <title>Expanded Cohort: Placebo Age 65-85 Years</title>
            <description>Participants aged 65-85 years received placebo matched to RSV vaccine intramuscularly. Participants were followed up to 12 months after vaccination.</description>
          </group>
        </group_list>
        <measure>
          <title>Expanded Cohort: Percentage of Participants (Aged 65 to 85 Years) With Systemic Reactions Within 14 Days After Vaccination 1</title>
          <description>Systemic reactions: fever, fatigue/tiredness, headache, nausea, muscle pain, joint pain, vomiting, diarrhea and any systemic event recorded by participants in an e-diary. Fever: &gt;= 38.0 deg C, mild (&gt;=38.0 to 38.4 deg C, &gt;38.4 to 38.9 deg C), moderate (&gt;38.9 to 40.0 deg C and &gt;40.0 deg C), severe (&gt;38.9 deg C to 40.0 deg C) and grade 4 (&gt;40.0 deg C). Fatigue, headache, nausea, muscle pain and joint pain were graded as mild: did not interfere with activity, moderate: some interference with activity and severe: prevented daily routine activity. Vomiting was graded as mild: 1 to 2 times in 24 h, moderate: &gt;2 times in 24h and severe: requires intravenous hydration. Diarrhea was graded as mild: 2 to 3 loose stools in 24h, moderate: 4 to 5 loose stools in 24h and severe: 6 or more loose stools in 24h.</description>
          <population>All participants in expanded cohort who received at least 1 dose of the investigational products at Visit 1 and with e-dairy data available.</population>
          <units>Percentage of participants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="40"/>
                <count group_id="O2" value="40"/>
                <count group_id="O3" value="40"/>
                <count group_id="O4" value="42"/>
                <count group_id="O5" value="40"/>
                <count group_id="O6" value="40"/>
                <count group_id="O7" value="41"/>
                <count group_id="O8" value="41"/>
                <count group_id="O9" value="40"/>
                <count group_id="O10" value="41"/>
                <count group_id="O11" value="42"/>
                <count group_id="O12" value="43"/>
                <count group_id="O13" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Fever: &gt;=38.0 degree C</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O2" value="2.5" lower_limit="0.1" upper_limit="13.2"/>
                    <measurement group_id="O3" value="2.5" lower_limit="0.1" upper_limit="13.2"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="8.4"/>
                    <measurement group_id="O5" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O6" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O7" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O8" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O9" value="2.5" lower_limit="0.1" upper_limit="13.2"/>
                    <measurement group_id="O10" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O11" value="4.8" lower_limit="0.6" upper_limit="16.2"/>
                    <measurement group_id="O12" value="4.7" lower_limit="0.6" upper_limit="15.8"/>
                    <measurement group_id="O13" value="0" lower_limit="0.0" upper_limit="8.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fever: mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O2" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="8.4"/>
                    <measurement group_id="O5" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O6" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O7" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O8" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O9" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O10" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O11" value="4.8" lower_limit="0.6" upper_limit="16.2"/>
                    <measurement group_id="O12" value="2.3" lower_limit="0.1" upper_limit="12.3"/>
                    <measurement group_id="O13" value="0" lower_limit="0.0" upper_limit="8.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fever: moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O2" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O3" value="2.5" lower_limit="0.1" upper_limit="13.2"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="8.4"/>
                    <measurement group_id="O5" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O6" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O8" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O9" value="2.5" lower_limit="0.1" upper_limit="13.2"/>
                    <measurement group_id="O10" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O11" value="0" lower_limit="0.0" upper_limit="8.4"/>
                    <measurement group_id="O12" value="2.3" lower_limit="0.1" upper_limit="12.3"/>
                    <measurement group_id="O13" value="0" lower_limit="0.0" upper_limit="8.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fever: severe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O2" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="8.4"/>
                    <measurement group_id="O5" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O6" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O8" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O9" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O10" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O11" value="0" lower_limit="0.0" upper_limit="8.4"/>
                    <measurement group_id="O12" value="0" lower_limit="0.0" upper_limit="8.2"/>
                    <measurement group_id="O13" value="0" lower_limit="0.0" upper_limit="8.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fever: Grade 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O2" value="2.5" lower_limit="0.1" upper_limit="13.2"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="8.4"/>
                    <measurement group_id="O5" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O6" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O8" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O9" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O10" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O11" value="0" lower_limit="0.0" upper_limit="8.4"/>
                    <measurement group_id="O12" value="0" lower_limit="0.0" upper_limit="8.2"/>
                    <measurement group_id="O13" value="0" lower_limit="0.0" upper_limit="8.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fatigue: mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.5" lower_limit="1.6" upper_limit="20.4"/>
                    <measurement group_id="O2" value="12.5" lower_limit="4.2" upper_limit="26.8"/>
                    <measurement group_id="O3" value="12.5" lower_limit="4.2" upper_limit="26.8"/>
                    <measurement group_id="O4" value="26.2" lower_limit="13.9" upper_limit="42.0"/>
                    <measurement group_id="O5" value="10.0" lower_limit="2.8" upper_limit="23.7"/>
                    <measurement group_id="O6" value="7.5" lower_limit="1.6" upper_limit="20.4"/>
                    <measurement group_id="O7" value="14.6" lower_limit="5.6" upper_limit="29.2"/>
                    <measurement group_id="O8" value="14.6" lower_limit="5.6" upper_limit="29.2"/>
                    <measurement group_id="O9" value="22.5" lower_limit="10.8" upper_limit="38.5"/>
                    <measurement group_id="O10" value="19.5" lower_limit="8.8" upper_limit="34.9"/>
                    <measurement group_id="O11" value="23.8" lower_limit="12.1" upper_limit="39.5"/>
                    <measurement group_id="O12" value="20.9" lower_limit="10.0" upper_limit="36.0"/>
                    <measurement group_id="O13" value="7.5" lower_limit="1.6" upper_limit="20.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fatigue: moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.5" lower_limit="4.2" upper_limit="26.8"/>
                    <measurement group_id="O2" value="10.0" lower_limit="2.8" upper_limit="23.7"/>
                    <measurement group_id="O3" value="15.0" lower_limit="5.7" upper_limit="29.8"/>
                    <measurement group_id="O4" value="11.9" lower_limit="4.0" upper_limit="25.6"/>
                    <measurement group_id="O5" value="12.5" lower_limit="4.2" upper_limit="26.8"/>
                    <measurement group_id="O6" value="10.0" lower_limit="2.8" upper_limit="23.7"/>
                    <measurement group_id="O7" value="19.5" lower_limit="8.8" upper_limit="34.9"/>
                    <measurement group_id="O8" value="14.6" lower_limit="5.6" upper_limit="29.2"/>
                    <measurement group_id="O9" value="20.0" lower_limit="9.1" upper_limit="35.6"/>
                    <measurement group_id="O10" value="4.9" lower_limit="0.6" upper_limit="16.5"/>
                    <measurement group_id="O11" value="21.4" lower_limit="10.3" upper_limit="36.8"/>
                    <measurement group_id="O12" value="4.7" lower_limit="0.6" upper_limit="15.8"/>
                    <measurement group_id="O13" value="7.5" lower_limit="1.6" upper_limit="20.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fatigue: severe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O2" value="2.5" lower_limit="0.1" upper_limit="13.2"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="8.4"/>
                    <measurement group_id="O5" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O6" value="2.5" lower_limit="0.1" upper_limit="13.2"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O8" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O9" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O10" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O11" value="2.4" lower_limit="0.1" upper_limit="12.6"/>
                    <measurement group_id="O12" value="0" lower_limit="0.0" upper_limit="8.2"/>
                    <measurement group_id="O13" value="0" lower_limit="0.0" upper_limit="8.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Headache: mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17.5" lower_limit="7.3" upper_limit="32.8"/>
                    <measurement group_id="O2" value="7.5" lower_limit="1.6" upper_limit="20.4"/>
                    <measurement group_id="O3" value="7.5" lower_limit="1.6" upper_limit="20.4"/>
                    <measurement group_id="O4" value="14.3" lower_limit="5.4" upper_limit="28.5"/>
                    <measurement group_id="O5" value="15.0" lower_limit="5.7" upper_limit="29.8"/>
                    <measurement group_id="O6" value="12.5" lower_limit="4.2" upper_limit="26.8"/>
                    <measurement group_id="O7" value="7.3" lower_limit="1.5" upper_limit="19.9"/>
                    <measurement group_id="O8" value="22.0" lower_limit="10.6" upper_limit="37.6"/>
                    <measurement group_id="O9" value="10.0" lower_limit="2.8" upper_limit="23.7"/>
                    <measurement group_id="O10" value="24.4" lower_limit="12.4" upper_limit="40.3"/>
                    <measurement group_id="O11" value="21.4" lower_limit="10.3" upper_limit="36.8"/>
                    <measurement group_id="O12" value="9.3" lower_limit="2.6" upper_limit="22.1"/>
                    <measurement group_id="O13" value="20.0" lower_limit="9.1" upper_limit="35.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Headache: moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.5" lower_limit="1.6" upper_limit="20.4"/>
                    <measurement group_id="O2" value="5.0" lower_limit="0.6" upper_limit="16.9"/>
                    <measurement group_id="O3" value="5.0" lower_limit="0.6" upper_limit="16.9"/>
                    <measurement group_id="O4" value="2.4" lower_limit="0.1" upper_limit="12.6"/>
                    <measurement group_id="O5" value="2.5" lower_limit="0.1" upper_limit="13.2"/>
                    <measurement group_id="O6" value="5.0" lower_limit="0.6" upper_limit="16.9"/>
                    <measurement group_id="O7" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O8" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O9" value="5.0" lower_limit="0.6" upper_limit="16.9"/>
                    <measurement group_id="O10" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O11" value="11.9" lower_limit="4.0" upper_limit="25.6"/>
                    <measurement group_id="O12" value="11.6" lower_limit="3.9" upper_limit="25.1"/>
                    <measurement group_id="O13" value="2.5" lower_limit="0.1" upper_limit="13.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Headache: severe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O2" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="8.4"/>
                    <measurement group_id="O5" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O6" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O8" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O9" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O10" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O11" value="0" lower_limit="0.0" upper_limit="8.4"/>
                    <measurement group_id="O12" value="0" lower_limit="0.0" upper_limit="8.2"/>
                    <measurement group_id="O13" value="0" lower_limit="0.0" upper_limit="8.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Nausea: mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.0" lower_limit="0.6" upper_limit="16.9"/>
                    <measurement group_id="O2" value="7.5" lower_limit="1.6" upper_limit="20.4"/>
                    <measurement group_id="O3" value="2.5" lower_limit="0.1" upper_limit="13.2"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="8.4"/>
                    <measurement group_id="O5" value="5.0" lower_limit="0.6" upper_limit="16.9"/>
                    <measurement group_id="O6" value="5.0" lower_limit="0.6" upper_limit="16.9"/>
                    <measurement group_id="O7" value="7.3" lower_limit="1.5" upper_limit="19.9"/>
                    <measurement group_id="O8" value="4.9" lower_limit="0.6" upper_limit="16.5"/>
                    <measurement group_id="O9" value="7.5" lower_limit="1.6" upper_limit="20.4"/>
                    <measurement group_id="O10" value="9.8" lower_limit="2.7" upper_limit="23.1"/>
                    <measurement group_id="O11" value="2.4" lower_limit="0.1" upper_limit="12.6"/>
                    <measurement group_id="O12" value="2.3" lower_limit="0.1" upper_limit="12.3"/>
                    <measurement group_id="O13" value="5.0" lower_limit="0.6" upper_limit="16.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Nausea: moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O2" value="2.5" lower_limit="0.1" upper_limit="13.2"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O4" value="2.4" lower_limit="0.1" upper_limit="12.6"/>
                    <measurement group_id="O5" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O6" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O7" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O8" value="14.6" lower_limit="5.6" upper_limit="29.2"/>
                    <measurement group_id="O9" value="5.0" lower_limit="0.6" upper_limit="16.9"/>
                    <measurement group_id="O10" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O11" value="4.8" lower_limit="0.6" upper_limit="16.2"/>
                    <measurement group_id="O12" value="2.3" lower_limit="0.1" upper_limit="12.3"/>
                    <measurement group_id="O13" value="0" lower_limit="0.0" upper_limit="8.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Nausea: severe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O2" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="8.4"/>
                    <measurement group_id="O5" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O6" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O8" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O9" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O10" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O11" value="0" lower_limit="0.0" upper_limit="8.4"/>
                    <measurement group_id="O12" value="0" lower_limit="0.0" upper_limit="8.2"/>
                    <measurement group_id="O13" value="0" lower_limit="0.0" upper_limit="8.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Muscle pain: mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.0" lower_limit="5.7" upper_limit="29.8"/>
                    <measurement group_id="O2" value="7.5" lower_limit="1.6" upper_limit="20.4"/>
                    <measurement group_id="O3" value="10.0" lower_limit="2.8" upper_limit="23.7"/>
                    <measurement group_id="O4" value="14.3" lower_limit="5.4" upper_limit="28.5"/>
                    <measurement group_id="O5" value="15.0" lower_limit="5.7" upper_limit="29.8"/>
                    <measurement group_id="O6" value="5.0" lower_limit="0.6" upper_limit="16.9"/>
                    <measurement group_id="O7" value="14.6" lower_limit="5.6" upper_limit="29.2"/>
                    <measurement group_id="O8" value="19.5" lower_limit="8.8" upper_limit="34.9"/>
                    <measurement group_id="O9" value="17.5" lower_limit="7.3" upper_limit="32.8"/>
                    <measurement group_id="O10" value="17.1" lower_limit="7.2" upper_limit="32.1"/>
                    <measurement group_id="O11" value="19.0" lower_limit="8.6" upper_limit="34.1"/>
                    <measurement group_id="O12" value="4.7" lower_limit="0.6" upper_limit="15.8"/>
                    <measurement group_id="O13" value="7.5" lower_limit="1.6" upper_limit="20.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Muscle pain: moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.5" lower_limit="0.1" upper_limit="13.2"/>
                    <measurement group_id="O2" value="7.5" lower_limit="1.6" upper_limit="20.4"/>
                    <measurement group_id="O3" value="5.0" lower_limit="0.6" upper_limit="16.9"/>
                    <measurement group_id="O4" value="2.4" lower_limit="0.1" upper_limit="12.6"/>
                    <measurement group_id="O5" value="7.5" lower_limit="1.6" upper_limit="20.4"/>
                    <measurement group_id="O6" value="7.5" lower_limit="1.6" upper_limit="20.4"/>
                    <measurement group_id="O7" value="4.9" lower_limit="0.6" upper_limit="16.5"/>
                    <measurement group_id="O8" value="4.9" lower_limit="0.6" upper_limit="16.5"/>
                    <measurement group_id="O9" value="15.0" lower_limit="5.7" upper_limit="29.8"/>
                    <measurement group_id="O10" value="9.8" lower_limit="2.7" upper_limit="23.1"/>
                    <measurement group_id="O11" value="16.7" lower_limit="7.0" upper_limit="31.4"/>
                    <measurement group_id="O12" value="16.3" lower_limit="6.8" upper_limit="30.7"/>
                    <measurement group_id="O13" value="0" lower_limit="0.0" upper_limit="8.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Muscle pain: severe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O2" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="8.4"/>
                    <measurement group_id="O5" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O6" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O8" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O9" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O10" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O11" value="0" lower_limit="0.0" upper_limit="8.4"/>
                    <measurement group_id="O12" value="0" lower_limit="0.0" upper_limit="8.2"/>
                    <measurement group_id="O13" value="2.5" lower_limit="0.1" upper_limit="13.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Joint pain: mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.5" lower_limit="4.2" upper_limit="26.8"/>
                    <measurement group_id="O2" value="10.0" lower_limit="2.8" upper_limit="23.7"/>
                    <measurement group_id="O3" value="5.0" lower_limit="0.6" upper_limit="16.9"/>
                    <measurement group_id="O4" value="9.5" lower_limit="2.7" upper_limit="22.6"/>
                    <measurement group_id="O5" value="10.0" lower_limit="2.8" upper_limit="23.7"/>
                    <measurement group_id="O6" value="7.5" lower_limit="1.6" upper_limit="20.4"/>
                    <measurement group_id="O7" value="7.3" lower_limit="1.5" upper_limit="19.9"/>
                    <measurement group_id="O8" value="7.3" lower_limit="1.5" upper_limit="19.9"/>
                    <measurement group_id="O9" value="12.5" lower_limit="4.2" upper_limit="26.8"/>
                    <measurement group_id="O10" value="7.3" lower_limit="1.5" upper_limit="19.9"/>
                    <measurement group_id="O11" value="21.4" lower_limit="10.3" upper_limit="36.8"/>
                    <measurement group_id="O12" value="2.3" lower_limit="0.1" upper_limit="12.3"/>
                    <measurement group_id="O13" value="7.5" lower_limit="1.6" upper_limit="20.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Joint pain: moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.5" lower_limit="1.6" upper_limit="20.4"/>
                    <measurement group_id="O2" value="5.0" lower_limit="0.6" upper_limit="16.9"/>
                    <measurement group_id="O3" value="5.0" lower_limit="0.6" upper_limit="16.9"/>
                    <measurement group_id="O4" value="9.5" lower_limit="2.7" upper_limit="22.6"/>
                    <measurement group_id="O5" value="5.0" lower_limit="0.6" upper_limit="16.9"/>
                    <measurement group_id="O6" value="7.5" lower_limit="1.6" upper_limit="20.4"/>
                    <measurement group_id="O7" value="4.9" lower_limit="0.6" upper_limit="16.5"/>
                    <measurement group_id="O8" value="7.3" lower_limit="1.5" upper_limit="19.9"/>
                    <measurement group_id="O9" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O10" value="9.8" lower_limit="2.7" upper_limit="23.1"/>
                    <measurement group_id="O11" value="7.1" lower_limit="1.5" upper_limit="19.5"/>
                    <measurement group_id="O12" value="4.7" lower_limit="0.6" upper_limit="15.8"/>
                    <measurement group_id="O13" value="7.5" lower_limit="1.6" upper_limit="20.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Joint pain: severe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O2" value="2.5" lower_limit="0.1" upper_limit="13.2"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="8.4"/>
                    <measurement group_id="O5" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O6" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O8" value="4.9" lower_limit="0.6" upper_limit="16.5"/>
                    <measurement group_id="O9" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O10" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O11" value="0" lower_limit="0.0" upper_limit="8.4"/>
                    <measurement group_id="O12" value="0" lower_limit="0.0" upper_limit="8.2"/>
                    <measurement group_id="O13" value="0" lower_limit="0.0" upper_limit="8.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Vomiting: mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O2" value="2.5" lower_limit="0.1" upper_limit="13.2"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="8.4"/>
                    <measurement group_id="O5" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O6" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O8" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O9" value="2.5" lower_limit="0.1" upper_limit="13.2"/>
                    <measurement group_id="O10" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O11" value="0" lower_limit="0.0" upper_limit="8.4"/>
                    <measurement group_id="O12" value="2.3" lower_limit="0.1" upper_limit="12.3"/>
                    <measurement group_id="O13" value="0" lower_limit="0.0" upper_limit="8.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Vomiting: moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O2" value="2.5" lower_limit="0.1" upper_limit="13.2"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="8.4"/>
                    <measurement group_id="O5" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O6" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O8" value="4.9" lower_limit="0.6" upper_limit="16.5"/>
                    <measurement group_id="O9" value="2.5" lower_limit="0.1" upper_limit="13.2"/>
                    <measurement group_id="O10" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O11" value="0" lower_limit="0.0" upper_limit="8.4"/>
                    <measurement group_id="O12" value="0" lower_limit="0.0" upper_limit="8.2"/>
                    <measurement group_id="O13" value="0" lower_limit="0.0" upper_limit="8.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Vomiting: severe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O2" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="8.4"/>
                    <measurement group_id="O5" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O6" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O8" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O9" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O10" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O11" value="0" lower_limit="0.0" upper_limit="8.4"/>
                    <measurement group_id="O12" value="0" lower_limit="0.0" upper_limit="8.2"/>
                    <measurement group_id="O13" value="0" lower_limit="0.0" upper_limit="8.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Diarrhea: mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.0" lower_limit="0.6" upper_limit="16.9"/>
                    <measurement group_id="O2" value="15.0" lower_limit="5.7" upper_limit="29.8"/>
                    <measurement group_id="O3" value="20.0" lower_limit="9.1" upper_limit="35.6"/>
                    <measurement group_id="O4" value="7.1" lower_limit="1.5" upper_limit="19.5"/>
                    <measurement group_id="O5" value="5.0" lower_limit="0.6" upper_limit="16.9"/>
                    <measurement group_id="O6" value="2.5" lower_limit="0.1" upper_limit="13.2"/>
                    <measurement group_id="O7" value="7.3" lower_limit="1.5" upper_limit="19.9"/>
                    <measurement group_id="O8" value="7.3" lower_limit="1.5" upper_limit="19.9"/>
                    <measurement group_id="O9" value="17.5" lower_limit="7.3" upper_limit="32.8"/>
                    <measurement group_id="O10" value="7.3" lower_limit="1.5" upper_limit="19.9"/>
                    <measurement group_id="O11" value="14.3" lower_limit="5.4" upper_limit="28.5"/>
                    <measurement group_id="O12" value="2.3" lower_limit="0.1" upper_limit="12.3"/>
                    <measurement group_id="O13" value="5.0" lower_limit="0.6" upper_limit="16.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Diarrhea: moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.5" lower_limit="0.1" upper_limit="13.2"/>
                    <measurement group_id="O2" value="2.5" lower_limit="0.1" upper_limit="13.2"/>
                    <measurement group_id="O3" value="2.5" lower_limit="0.1" upper_limit="13.2"/>
                    <measurement group_id="O4" value="2.4" lower_limit="0.1" upper_limit="12.6"/>
                    <measurement group_id="O5" value="5.0" lower_limit="0.6" upper_limit="16.9"/>
                    <measurement group_id="O6" value="2.5" lower_limit="0.1" upper_limit="13.2"/>
                    <measurement group_id="O7" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O8" value="7.3" lower_limit="1.5" upper_limit="19.9"/>
                    <measurement group_id="O9" value="7.5" lower_limit="1.6" upper_limit="20.4"/>
                    <measurement group_id="O10" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O11" value="0" lower_limit="0.0" upper_limit="8.4"/>
                    <measurement group_id="O12" value="4.7" lower_limit="0.6" upper_limit="15.8"/>
                    <measurement group_id="O13" value="0" lower_limit="0.0" upper_limit="8.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Diarrhea: severe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O2" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O4" value="2.4" lower_limit="0.1" upper_limit="12.6"/>
                    <measurement group_id="O5" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O6" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O8" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O9" value="0" lower_limit="0.0" upper_limit="8.8"/>
                    <measurement group_id="O10" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O11" value="0" lower_limit="0.0" upper_limit="8.4"/>
                    <measurement group_id="O12" value="2.3" lower_limit="0.1" upper_limit="12.3"/>
                    <measurement group_id="O13" value="2.5" lower_limit="0.1" upper_limit="13.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Sentinel Cohort: Percentage of Participants (Aged 18 to 49 Years) With Adverse Events (AEs) Within 1 Month After Vaccination</title>
        <description>An AE was any untoward medical occurrence in a participant who received investigational product without regard to possibility of causal relationship. AEs included both serious and non-serious adverse events. Serious adverse event (SAE) was an AE resulting in any of the following outcomes or deemed significant for any other reason: death; initial or prolonged inpatient hospitalization; life-threatening experience (immediate risk of dying); persistent or significant disability/incapacity; congenital anomaly.</description>
        <time_frame>Within 1 month after vaccination (up to 35 days)</time_frame>
        <population>All participants in sentinel cohort who received at least 1 dose of the investigational products at Visit 1.</population>
        <group_list>
          <group group_id="O1">
            <title>Sentinel Cohort: RSV Vaccine 60 mcg Age 18-49 Years</title>
            <description>Participants aged 18-49 years received single 60-mcg dose of RSV vaccine, intramuscularly. Participants were followed up to 12 months after vaccination.</description>
          </group>
          <group group_id="O2">
            <title>Sentinel Cohort: RSV 60 mcg With Aluminum Hydroxide Age 18-49 Years</title>
            <description>Participants aged 18-49 years received single 60-mcg dose with aluminum hydroxide intramuscularly. Participants were followed up to 12 months after vaccination.</description>
          </group>
          <group group_id="O3">
            <title>Sentinel Cohort: RSV 120 mcg Age 18-49 Years</title>
            <description>Participants aged 18-49 years received single 120-mcg dose intramuscularly. Participants were followed up to 12 months after vaccination.</description>
          </group>
          <group group_id="O4">
            <title>Sentinel Cohort: RSV 120 mcg With Aluminum Hydroxide Age 18-49 Years</title>
            <description>Participants aged 18-49 years received single 120-mcg dose with aluminum hydroxide intramuscularly. Participants were followed up to 12 months after vaccination.</description>
          </group>
          <group group_id="O5">
            <title>Sentinel Cohort: RSV 240 mcg Age 18-49 Years</title>
            <description>Participants aged 18-49 years received single 240-mcg dose intramuscularly. Participants were followed up to 12 months after vaccination.</description>
          </group>
          <group group_id="O6">
            <title>Sentinel Cohort: RSV 240 mcg With Aluminum Hydroxide Age 18-49 Years</title>
            <description>Participants aged 18-49 years received single 240-mcg dose with aluminum hydroxide intramuscularly. Participants were followed up to 12 months after vaccination.</description>
          </group>
          <group group_id="O7">
            <title>Sentinel Cohort: Placebo Age 18-49 Years</title>
            <description>Participants aged 18-49 years received placebo matched to RSV vaccine intramuscularly. Participants were followed up to 12 months after vaccination.</description>
          </group>
        </group_list>
        <measure>
          <title>Sentinel Cohort: Percentage of Participants (Aged 18 to 49 Years) With Adverse Events (AEs) Within 1 Month After Vaccination</title>
          <description>An AE was any untoward medical occurrence in a participant who received investigational product without regard to possibility of causal relationship. AEs included both serious and non-serious adverse events. Serious adverse event (SAE) was an AE resulting in any of the following outcomes or deemed significant for any other reason: death; initial or prolonged inpatient hospitalization; life-threatening experience (immediate risk of dying); persistent or significant disability/incapacity; congenital anomaly.</description>
          <population>All participants in sentinel cohort who received at least 1 dose of the investigational products at Visit 1.</population>
          <units>Percentage of participants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="12"/>
                <count group_id="O3" value="12"/>
                <count group_id="O4" value="12"/>
                <count group_id="O5" value="12"/>
                <count group_id="O6" value="12"/>
                <count group_id="O7" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.7" lower_limit="2.1" upper_limit="48.4"/>
                    <measurement group_id="O2" value="16.7" lower_limit="2.1" upper_limit="48.4"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O5" value="8.3" lower_limit="0.2" upper_limit="38.5"/>
                    <measurement group_id="O6" value="16.7" lower_limit="2.1" upper_limit="48.4"/>
                    <measurement group_id="O7" value="8.3" lower_limit="0.2" upper_limit="38.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Sentinel Cohort: Percentage of Participants (Aged 50 to 85 Years) With AEs Within 1 Month After Vaccination</title>
        <description>An AE was any untoward medical occurrence in a participant who received investigational product without regard to possibility of causal relationship. AEs included both serious and non-serious adverse events. SAE was an AE resulting in any of the following outcomes or deemed significant for any other reason: death; initial or prolonged inpatient hospitalization; life-threatening experience (immediate risk of dying); persistent or significant disability/incapacity; congenital anomaly.</description>
        <time_frame>Within 1 month after vaccination (up to 35 days)</time_frame>
        <population>All participants in sentinel cohort who received at least 1 dose of the investigational products at Visit 1.</population>
        <group_list>
          <group group_id="O1">
            <title>Sentinel Cohort: RSV Vaccine 60 mcg Age 50-85 Years</title>
            <description>Participants aged 50-85 years received single 60-mcg dose of RSV vaccine, intramuscularly. Participants were followed up to 12 months after vaccination.</description>
          </group>
          <group group_id="O2">
            <title>Sentinel Cohort: RSV 60 mcg With Aluminum Hydroxide Age 50-85 Years</title>
            <description>Participants aged 50-85 years received single 60-mcg dose with aluminum hydroxide intramuscularly. Participants were followed up to 12 months after vaccination.</description>
          </group>
          <group group_id="O3">
            <title>Sentinel Cohort: RSV 120 mcg Age 50-85 Years</title>
            <description>Participants aged 50-85 years received single 120-mcg dose intramuscularly. Participants were followed up to 12 months after vaccination.</description>
          </group>
          <group group_id="O4">
            <title>Sentinel Cohort: RSV 120 mcg With Aluminum Hydroxide Age 50-85 Years</title>
            <description>Participants aged 50-85 years received single 120-mcg dose with aluminum hydroxide intramuscularly. Participants were followed up to 12 months after vaccination.</description>
          </group>
          <group group_id="O5">
            <title>Sentinel Cohort: RSV 240 mcg Age 50-85 Years</title>
            <description>Participants aged 50-85 years received single 240-mcg dose intramuscularly. Participants were followed up to 12 months after vaccination</description>
          </group>
          <group group_id="O6">
            <title>Sentinel Cohort: RSV 240 mcg With Aluminum Hydroxide Age 50-85 Years</title>
            <description>Participants aged 50-85 years received single 240-mcg dose with aluminum hydroxide intramuscularly. Participants were followed up to 12 months after vaccination.</description>
          </group>
          <group group_id="O7">
            <title>Sentinel Cohort: Placebo Age 50-85 Years</title>
            <description>Participants aged 50-85 years received placebo matched to RSV vaccine intramuscularly. Participants were followed up to 12 months after vaccination.</description>
          </group>
        </group_list>
        <measure>
          <title>Sentinel Cohort: Percentage of Participants (Aged 50 to 85 Years) With AEs Within 1 Month After Vaccination</title>
          <description>An AE was any untoward medical occurrence in a participant who received investigational product without regard to possibility of causal relationship. AEs included both serious and non-serious adverse events. SAE was an AE resulting in any of the following outcomes or deemed significant for any other reason: death; initial or prolonged inpatient hospitalization; life-threatening experience (immediate risk of dying); persistent or significant disability/incapacity; congenital anomaly.</description>
          <population>All participants in sentinel cohort who received at least 1 dose of the investigational products at Visit 1.</population>
          <units>Percentage of participants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="12"/>
                <count group_id="O3" value="12"/>
                <count group_id="O4" value="12"/>
                <count group_id="O5" value="12"/>
                <count group_id="O6" value="12"/>
                <count group_id="O7" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25.0" lower_limit="5.5" upper_limit="57.2"/>
                    <measurement group_id="O2" value="25.0" lower_limit="5.5" upper_limit="57.2"/>
                    <measurement group_id="O3" value="8.3" lower_limit="0.2" upper_limit="38.5"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O5" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O6" value="8.3" lower_limit="0.2" upper_limit="38.5"/>
                    <measurement group_id="O7" value="0.0" lower_limit="0.0" upper_limit="26.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Expanded Cohort: Percentage of Participants (Aged 18 to 49 Years) With AE Within 1 Month After Vaccination 1</title>
        <description>An AE was any untoward medical occurrence in a participant who received investigational product without regard to possibility of causal relationship. AEs included both serious and non-serious adverse events. SAE was an AE resulting in any of the following outcomes or deemed significant for any other reason: death; initial or prolonged inpatient hospitalization; life-threatening experience (immediate risk of dying); persistent or significant disability/incapacity; congenital anomaly.</description>
        <time_frame>Within 1 month after vaccination 1 (up to 35 days)</time_frame>
        <population>All participants in expanded cohort who received at least 1 dose of the investigational products at Visit 1.</population>
        <group_list>
          <group group_id="O1">
            <title>Expanded Cohort: RSV 60 mcg With SIIV Age 18-49 Years</title>
            <description>Participants aged 18-49 years received 2 doses of RSV vaccine 60 mcg along with 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O2">
            <title>Expanded Cohort: RSV 60 mcg With Placebo Age 18-49 Years</title>
            <description>Participants aged 18-49 years received 2 doses of RSV vaccine 60 mcg along with placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O3">
            <title>Expanded Cohort: RSV 60 mcg With Aluminum Hydroxide and SIIV Age 18-49 Years</title>
            <description>Participants aged 18-49 years received 2 doses of RSV vaccine 60 mcg along with aluminum hydroxide and 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O4">
            <title>Expanded Cohort: RSV 60 mcg With Aluminum Hydroxide and Placebo Age 18-49 Years</title>
            <description>Participants aged 18-49 years received 2 doses of RSV vaccine 60 mcg along with aluminum hydroxide and placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O5">
            <title>Expanded Cohort: RSV 120 mcg With SIIV Age 18-49 Years</title>
            <description>Participants aged 18-49 years received 2 doses of RSV vaccine 120 mcg along with 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O6">
            <title>Expanded Cohort: RSV 120 mcg With Placebo Age 18-49 Years</title>
            <description>Participants aged 18-49 years received 2 doses of RSV vaccine 120 mcg along with placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O7">
            <title>Expanded Cohort: RSV 120 mcg With Aluminum Hydroxide and SIIV Age 18-49 Years</title>
            <description>Participants aged 18-49 years received 2 doses of RSV vaccine 120 mcg along with aluminum hydroxide and 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O8">
            <title>Expanded Cohort: RSV 120 mcg With Aluminum Hydroxide and Placebo Age 18-49 Years</title>
            <description>Participants aged 18-49 years received 2 doses of RSV vaccine 120 mcg along with aluminum hydroxide and placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O9">
            <title>Expanded Cohort: RSV 240 mcg With SIIV Age 18-49 Years</title>
            <description>Participants aged 18-49 years received 2 doses of RSV vaccine 240 mcg along with 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O10">
            <title>Expanded Cohort: RSV 240 mcg With Placebo Age 18-49 Years</title>
            <description>Participants aged 18-49 years received 2 doses of RSV vaccine 240 mcg along with placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O11">
            <title>Expanded Cohort: RSV 240 mcg With Aluminum Hydroxide and SIIV Age 18-49 Years</title>
            <description>Participants aged 18-49 years received 2 doses of RSV vaccine 240 mcg along with aluminum hydroxide and 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O12">
            <title>Expanded Cohort: RSV 240 mcg With Aluminum Hydroxide and Placebo Age 18-49 Years</title>
            <description>Participants aged 18-49 years received 2 doses of RSV vaccine 240 mcg along with aluminum hydroxide and placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O13">
            <title>Expanded Cohort: Placebo Age 18-49 Years</title>
            <description>Participants aged 18-49 years received placebo matched to RSV vaccine intramuscularly. Participants were followed up to 12 months after vaccination.</description>
          </group>
        </group_list>
        <measure>
          <title>Expanded Cohort: Percentage of Participants (Aged 18 to 49 Years) With AE Within 1 Month After Vaccination 1</title>
          <description>An AE was any untoward medical occurrence in a participant who received investigational product without regard to possibility of causal relationship. AEs included both serious and non-serious adverse events. SAE was an AE resulting in any of the following outcomes or deemed significant for any other reason: death; initial or prolonged inpatient hospitalization; life-threatening experience (immediate risk of dying); persistent or significant disability/incapacity; congenital anomaly.</description>
          <population>All participants in expanded cohort who received at least 1 dose of the investigational products at Visit 1.</population>
          <units>Percentage of participants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="41"/>
                <count group_id="O2" value="42"/>
                <count group_id="O3" value="41"/>
                <count group_id="O4" value="40"/>
                <count group_id="O5" value="41"/>
                <count group_id="O6" value="41"/>
                <count group_id="O7" value="41"/>
                <count group_id="O8" value="41"/>
                <count group_id="O9" value="41"/>
                <count group_id="O10" value="41"/>
                <count group_id="O11" value="41"/>
                <count group_id="O12" value="41"/>
                <count group_id="O13" value="41"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17.1" lower_limit="7.2" upper_limit="32.1"/>
                    <measurement group_id="O2" value="16.7" lower_limit="7.0" upper_limit="31.4"/>
                    <measurement group_id="O3" value="14.6" lower_limit="5.6" upper_limit="29.2"/>
                    <measurement group_id="O4" value="22.5" lower_limit="10.8" upper_limit="38.5"/>
                    <measurement group_id="O5" value="24.4" lower_limit="12.4" upper_limit="40.3"/>
                    <measurement group_id="O6" value="22.0" lower_limit="10.6" upper_limit="37.6"/>
                    <measurement group_id="O7" value="7.3" lower_limit="1.5" upper_limit="19.9"/>
                    <measurement group_id="O8" value="22.0" lower_limit="10.6" upper_limit="37.6"/>
                    <measurement group_id="O9" value="9.8" lower_limit="2.7" upper_limit="23.1"/>
                    <measurement group_id="O10" value="12.2" lower_limit="4.1" upper_limit="26.2"/>
                    <measurement group_id="O11" value="12.2" lower_limit="4.1" upper_limit="26.2"/>
                    <measurement group_id="O12" value="17.1" lower_limit="7.2" upper_limit="32.1"/>
                    <measurement group_id="O13" value="9.8" lower_limit="2.7" upper_limit="23.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Expanded Cohort: Percentage of Participants (Aged 65 to 85 Years) With AE Within 1 Month After Vaccination</title>
        <description>An AE was any untoward medical occurrence in a participant who received investigational product without regard to possibility of causal relationship. AEs included both serious and non-serious adverse events. SAE was an AE resulting in any of the following outcomes or deemed significant for any other reason: death; initial or prolonged inpatient hospitalization; life-threatening experience (immediate risk of dying); persistent or significant disability/incapacity; congenital anomaly.</description>
        <time_frame>Within 1 month after vaccination 1 (up to 35 days)</time_frame>
        <population>All participants in expanded cohort who received at least 1 dose of the investigational products at Visit 1.</population>
        <group_list>
          <group group_id="O1">
            <title>Expanded Cohort: RSV 60 mcg With SIIV Age 65-85 Years</title>
            <description>Participants aged 65-85 years received 2 doses of RSV vaccine 60 mcg along with 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O2">
            <title>Expanded Cohort: RSV 60 mcg With Placebo Age 65-85 Years</title>
            <description>Participants aged 65-85 years received 2 doses of RSV vaccine 60 mcg along with placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O3">
            <title>Expanded Cohort: RSV 60 mcg With Aluminum Hydroxide and SIIV Age 65-85 Years</title>
            <description>Participants aged 65-85 years received 2 doses of RSV vaccine 60 mcg along with aluminum hydroxide and 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O4">
            <title>Expanded Cohort: RSV 60 mcg With Aluminum Hydroxide and Placebo Age 65-85 Years</title>
            <description>Participants aged 65-85 years received 2 doses of RSV vaccine 60 mcg along with aluminum hydroxide and placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O5">
            <title>Expanded Cohort: RSV 120 mcg With SIIV Age 65-85 Years</title>
            <description>Participants aged 65-85 years received 2 doses of RSV vaccine 120 mcg along with 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O6">
            <title>Expanded Cohort: RSV 120 mcg With Placebo Age 65-85 Years</title>
            <description>Participants aged 65-85 years received 2 doses of RSV vaccine 120 mcg along with placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O7">
            <title>Expanded Cohort: RSV 120 mcg With Aluminum Hydroxide and SIIV Age 65-85 Years</title>
            <description>Participants aged 65-85 years received 2 doses of RSV vaccine 120 mcg along with aluminum hydroxide and 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O8">
            <title>Expanded Cohort: RSV 120 mcg With Aluminum Hydroxide and Placebo Age 65-85 Years</title>
            <description>Participants aged 65-85 years received 2 doses of RSV vaccine 120 mcg along with aluminum hydroxide and placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O9">
            <title>Expanded Cohort: RSV 240 mcg With SIIV Age 65-85 Years</title>
            <description>Participants aged 65-85 years received 2 doses of RSV vaccine 240 mcg along with 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O10">
            <title>Expanded Cohort: RSV 240 mcg With Placebo Age 65-85 Years</title>
            <description>Participants aged 65-85 years received 2 doses of RSV vaccine 240 mcg along with placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O11">
            <title>Expanded Cohort: RSV 240 mcg With Aluminum Hydroxide and SIIV Age 65-85 Years</title>
            <description>Participants aged 65-85 years received 2 doses of RSV vaccine 240 mcg along with aluminum hydroxide and 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O12">
            <title>Expanded Cohort: RSV 240 mcg With Aluminum Hydroxide and Placebo Age 65-85 Years</title>
            <description>Participants aged 65-85 years received 2 doses of RSV vaccine 240 mcg along with aluminum hydroxide and placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O13">
            <title>Expanded Cohort: Placebo Age 65-85 Years</title>
            <description>Participants aged 65-85 years received placebo matched to RSV vaccine intramuscularly. Participants were followed up to 12 months after vaccination.</description>
          </group>
        </group_list>
        <measure>
          <title>Expanded Cohort: Percentage of Participants (Aged 65 to 85 Years) With AE Within 1 Month After Vaccination</title>
          <description>An AE was any untoward medical occurrence in a participant who received investigational product without regard to possibility of causal relationship. AEs included both serious and non-serious adverse events. SAE was an AE resulting in any of the following outcomes or deemed significant for any other reason: death; initial or prolonged inpatient hospitalization; life-threatening experience (immediate risk of dying); persistent or significant disability/incapacity; congenital anomaly.</description>
          <population>All participants in expanded cohort who received at least 1 dose of the investigational products at Visit 1.</population>
          <units>Percentage of participants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="40"/>
                <count group_id="O2" value="41"/>
                <count group_id="O3" value="40"/>
                <count group_id="O4" value="42"/>
                <count group_id="O5" value="40"/>
                <count group_id="O6" value="40"/>
                <count group_id="O7" value="41"/>
                <count group_id="O8" value="41"/>
                <count group_id="O9" value="40"/>
                <count group_id="O10" value="41"/>
                <count group_id="O11" value="42"/>
                <count group_id="O12" value="43"/>
                <count group_id="O13" value="41"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.0" lower_limit="2.8" upper_limit="23.7"/>
                    <measurement group_id="O2" value="14.6" lower_limit="5.6" upper_limit="29.2"/>
                    <measurement group_id="O3" value="5.0" lower_limit="0.6" upper_limit="16.9"/>
                    <measurement group_id="O4" value="26.2" lower_limit="13.9" upper_limit="42.0"/>
                    <measurement group_id="O5" value="22.5" lower_limit="10.8" upper_limit="38.5"/>
                    <measurement group_id="O6" value="20.0" lower_limit="9.1" upper_limit="35.6"/>
                    <measurement group_id="O7" value="14.6" lower_limit="5.6" upper_limit="29.2"/>
                    <measurement group_id="O8" value="14.6" lower_limit="5.6" upper_limit="29.2"/>
                    <measurement group_id="O9" value="15.0" lower_limit="5.7" upper_limit="29.8"/>
                    <measurement group_id="O10" value="9.8" lower_limit="2.7" upper_limit="23.1"/>
                    <measurement group_id="O11" value="11.9" lower_limit="4.0" upper_limit="25.6"/>
                    <measurement group_id="O12" value="16.3" lower_limit="6.8" upper_limit="30.7"/>
                    <measurement group_id="O13" value="12.2" lower_limit="4.1" upper_limit="26.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Sentinel Cohort: Percentage of Participants (Aged 18 to 49 Years) With Medically Attended Adverse Events (MAEs) and Serious Adverse Events (SAEs) Upto 12 Months After Vaccination</title>
        <description>MAE was defined as a non-serious AE that resulted in an evaluation at a medical facility. SAE was an AE resulting in any of the following outcomes or deemed significant for any other reason: death; initial or prolonged inpatient hospitalization; life-threatening experience (immediate risk of dying); persistent or significant disability/incapacity; congenital anomaly.</description>
        <time_frame>Upto 12 months after vaccination (up to 378 days)</time_frame>
        <population>All participants in sentinel cohort who received at least 1 dose of the investigational products at Visit 1.</population>
        <group_list>
          <group group_id="O1">
            <title>Sentinel Cohort: RSV Vaccine 60 mcg Age 18-49 Years</title>
            <description>Participants aged 18-49 years received single 60-mcg dose of RSV vaccine, intramuscularly. Participants were followed up to 12 months after vaccination.</description>
          </group>
          <group group_id="O2">
            <title>Sentinel Cohort: RSV 60 mcg With Aluminum Hydroxide Age 18-49 Years</title>
            <description>Participants aged 18-49 years received single 60-mcg dose with aluminum hydroxide intramuscularly. Participants were followed up to 12 months after vaccination.</description>
          </group>
          <group group_id="O3">
            <title>Sentinel Cohort: RSV 120 mcg Age 18-49 Years</title>
            <description>Participants aged 18-49 years received single 120-mcg dose intramuscularly. Participants were followed up to 12 months after vaccination.</description>
          </group>
          <group group_id="O4">
            <title>Sentinel Cohort: RSV 120 mcg With Aluminum Hydroxide Age 18-49 Years</title>
            <description>Participants aged 18-49 years received single 120-mcg dose with aluminum hydroxide intramuscularly. Participants were followed up to 12 months after vaccination.</description>
          </group>
          <group group_id="O5">
            <title>Sentinel Cohort: RSV 240 mcg Age 18-49 Years</title>
            <description>Participants aged 18-49 years received single 240-mcg dose intramuscularly. Participants were followed up to 12 months after vaccination.</description>
          </group>
          <group group_id="O6">
            <title>Sentinel Cohort: RSV 240 mcg With Aluminum Hydroxide Age 18-49 Years</title>
            <description>Participants aged 18-49 years received single 240-mcg dose with aluminum hydroxide intramuscularly. Participants were followed up to 12 months after vaccination.</description>
          </group>
          <group group_id="O7">
            <title>Sentinel Cohort: Placebo Age 18-49 Years</title>
            <description>Participants aged 18-49 years received placebo matched to RSV vaccine intramuscularly. Participants were followed up to 12 months after vaccination.</description>
          </group>
        </group_list>
        <measure>
          <title>Sentinel Cohort: Percentage of Participants (Aged 18 to 49 Years) With Medically Attended Adverse Events (MAEs) and Serious Adverse Events (SAEs) Upto 12 Months After Vaccination</title>
          <description>MAE was defined as a non-serious AE that resulted in an evaluation at a medical facility. SAE was an AE resulting in any of the following outcomes or deemed significant for any other reason: death; initial or prolonged inpatient hospitalization; life-threatening experience (immediate risk of dying); persistent or significant disability/incapacity; congenital anomaly.</description>
          <population>All participants in sentinel cohort who received at least 1 dose of the investigational products at Visit 1.</population>
          <units>Percentage of participants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="12"/>
                <count group_id="O3" value="12"/>
                <count group_id="O4" value="12"/>
                <count group_id="O5" value="12"/>
                <count group_id="O6" value="12"/>
                <count group_id="O7" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>MAEs</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33.3" lower_limit="9.9" upper_limit="65.1"/>
                    <measurement group_id="O2" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O3" value="25.0" lower_limit="5.5" upper_limit="57.2"/>
                    <measurement group_id="O4" value="16.7" lower_limit="2.1" upper_limit="48.4"/>
                    <measurement group_id="O5" value="8.3" lower_limit="0.2" upper_limit="38.5"/>
                    <measurement group_id="O6" value="25.0" lower_limit="5.5" upper_limit="57.2"/>
                    <measurement group_id="O7" value="16.7" lower_limit="2.1" upper_limit="48.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SAEs</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O2" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O5" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O6" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="26.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Sentinel Cohort: Percentage of Participants (Aged 50 to 85 Years) With MAEs and SAEs Upto 12 Months After Vaccination</title>
        <description>MAE was defined as a non-serious AE that resulted in an evaluation at a medical facility. SAE was an AE resulting in any of the following outcomes or deemed significant for any other reason: death; initial or prolonged inpatient hospitalization; life-threatening experience (immediate risk of dying); persistent or significant disability/incapacity; congenital anomaly.</description>
        <time_frame>Upto 12 months after vaccination (upto 378 days)</time_frame>
        <population>All participants in sentinel cohort who received at least 1 dose of the investigational products at Visit 1.</population>
        <group_list>
          <group group_id="O1">
            <title>Sentinel Cohort: RSV Vaccine 60 mcg Age 50-85 Years:</title>
            <description>Participants aged 50-85 years received single 60-mcg dose of RSV vaccine, intramuscularly. Participants were followed up to 12 months after vaccination.</description>
          </group>
          <group group_id="O2">
            <title>Sentinel Cohort: RSV 60 mcg With Aluminum Hydroxide Age 50-85 Years</title>
            <description>Participants aged 50-85 years received single 60-mcg dose with aluminum hydroxide intramuscularly. Participants were followed up to 12 months after vaccination.</description>
          </group>
          <group group_id="O3">
            <title>Sentinel Cohort: RSV 120 mcg Age 50-85 Years</title>
            <description>Participants aged 50-85 years received single 120-mcg dose intramuscularly. Participants were followed up to 12 months after vaccination.</description>
          </group>
          <group group_id="O4">
            <title>Sentinel Cohort: RSV 120 mcg With Aluminum Hydroxide Age 50-85 Years</title>
            <description>Participants aged 50-85 years received single 120-mcg dose with aluminum hydroxide intramuscularly. Participants were followed up to 12 months after vaccination.</description>
          </group>
          <group group_id="O5">
            <title>Sentinel Cohort: RSV 240 mcg Age 50-85 Years</title>
            <description>Participants aged 50-85 years received single 240-mcg dose intramuscularly. Participants were followed up to 12 months after vaccination.</description>
          </group>
          <group group_id="O6">
            <title>Sentinel Cohort: RSV 240 mcg With Aluminum Hydroxide Age 50-85 Years</title>
            <description>Participants aged 50-85 years received single 240-mcg dose with aluminum hydroxide intramuscularly. Participants were followed up to 12 months after vaccination.</description>
          </group>
          <group group_id="O7">
            <title>Sentinel Cohort: Placebo Age 50-85 Years</title>
            <description>Participants aged 50-85 years received placebo matched to RSV vaccine intramuscularly. Participants were followed up to 12 months after vaccination.</description>
          </group>
        </group_list>
        <measure>
          <title>Sentinel Cohort: Percentage of Participants (Aged 50 to 85 Years) With MAEs and SAEs Upto 12 Months After Vaccination</title>
          <description>MAE was defined as a non-serious AE that resulted in an evaluation at a medical facility. SAE was an AE resulting in any of the following outcomes or deemed significant for any other reason: death; initial or prolonged inpatient hospitalization; life-threatening experience (immediate risk of dying); persistent or significant disability/incapacity; congenital anomaly.</description>
          <population>All participants in sentinel cohort who received at least 1 dose of the investigational products at Visit 1.</population>
          <units>Percentage of participants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="12"/>
                <count group_id="O3" value="12"/>
                <count group_id="O4" value="12"/>
                <count group_id="O5" value="12"/>
                <count group_id="O6" value="12"/>
                <count group_id="O7" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>MAEs</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25.0" lower_limit="5.5" upper_limit="57.2"/>
                    <measurement group_id="O2" value="50.0" lower_limit="21.1" upper_limit="78.9"/>
                    <measurement group_id="O3" value="25.0" lower_limit="5.5" upper_limit="57.2"/>
                    <measurement group_id="O4" value="25.0" lower_limit="5.5" upper_limit="57.2"/>
                    <measurement group_id="O5" value="25.0" lower_limit="5.5" upper_limit="57.2"/>
                    <measurement group_id="O6" value="16.7" lower_limit="2.1" upper_limit="48.4"/>
                    <measurement group_id="O7" value="16.7" lower_limit="2.1" upper_limit="48.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SAEs</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O2" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O4" value="0" lower_limit="0.0" upper_limit="26.5"/>
                    <measurement group_id="O5" value="8.3" lower_limit="0.2" upper_limit="38.5"/>
                    <measurement group_id="O6" value="16.7" lower_limit="2.1" upper_limit="48.4"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="26.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Expanded Cohort: Percentage of Participants (Aged 18 to 49 Years) With MAEs and SAEs Upto 12 Months After Vaccination 1</title>
        <description>MAE was defined as a non-serious AE that resulted in an evaluation at a medical facility. SAE was an AE resulting in any of the following outcomes or deemed significant for any other reason: death; initial or prolonged inpatient hospitalization; life-threatening experience (immediate risk of dying); persistent or significant disability/incapacity; congenital anomaly.</description>
        <time_frame>Upto 12 months after vaccination 1 (upto 378 days)</time_frame>
        <population>All participants in expanded cohort who received at least 1 dose of the investigational products at Visit 1.</population>
        <group_list>
          <group group_id="O1">
            <title>Expanded Cohort: RSV 60 mcg With SIIV Age 18-49 Years</title>
            <description>Participants aged 18-49 years received 2 doses of RSV vaccine 60 mcg along with 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O2">
            <title>Expanded Cohort: RSV 60 mcg With Placebo Age 18-49 Years</title>
            <description>Participants aged 18-49 years received 2 doses of RSV vaccine 60 mcg along with placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O3">
            <title>Expanded Cohort: RSV 60 mcg With Aluminum Hydroxide and SIIV Age 18-49 Years</title>
            <description>Participants aged 18-49 years received 2 doses of RSV vaccine 60 mcg along with aluminum hydroxide and 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O4">
            <title>Expanded Cohort: RSV 60 mcg With Aluminum Hydroxide and Placebo Age 18-49 Years</title>
            <description>Participants aged 18-49 years received 2 doses of RSV vaccine 60 mcg along with aluminum hydroxide and placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O5">
            <title>Expanded Cohort: RSV 120 mcg With SIIV Age 18-49 Years</title>
            <description>Participants aged 18-49 years received 2 doses of RSV vaccine 120 mcg along with 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O6">
            <title>Expanded Cohort: RSV 120 mcg With Placebo Age 18-49 Years</title>
            <description>Participants aged 18-49 years received 2 doses of RSV vaccine 120 mcg along with placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O7">
            <title>Expanded Cohort: RSV 120 mcg With Aluminum Hydroxide and SIIV Age 18-49 Years</title>
            <description>Participants aged 18-49 years received 2 doses of RSV vaccine 120 mcg along with aluminum hydroxide and 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O8">
            <title>Expanded Cohort: RSV 120 mcg With Aluminum Hydroxide and Placebo Age 18-49 Years</title>
            <description>Participants aged 18-49 years received 2 doses of RSV vaccine 120 mcg along with aluminum hydroxide and placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O9">
            <title>Expanded Cohort: RSV 240 mcg With SIIV Age 18-49 Years</title>
            <description>Participants aged 18-49 years received 2 doses of RSV vaccine 240 mcg along with 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O10">
            <title>Expanded Cohort: RSV 240 mcg With Placebo Age 18-49 Years</title>
            <description>Participants aged 18-49 years received 2 doses of RSV vaccine 240 mcg along with placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O11">
            <title>Expanded Cohort: RSV 240 mcg With Aluminum Hydroxide and SIIV Age 18-49 Years</title>
            <description>Participants aged 18-49 years received 2 doses of RSV vaccine 240 mcg along with aluminum hydroxide and 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O12">
            <title>Expanded Cohort: RSV 240 mcg With Aluminum Hydroxide and Placebo Age 18-49 Years</title>
            <description>Participants aged 18-49 years received 2 doses of RSV vaccine 240 mcg along with aluminum hydroxide and placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O13">
            <title>Expanded Cohort: Placebo Age 18-49 Years</title>
            <description>Participants aged 18-49 years received placebo matched to RSV vaccine intramuscularly. Participants were followed up to 12 months after vaccination.</description>
          </group>
        </group_list>
        <measure>
          <title>Expanded Cohort: Percentage of Participants (Aged 18 to 49 Years) With MAEs and SAEs Upto 12 Months After Vaccination 1</title>
          <description>MAE was defined as a non-serious AE that resulted in an evaluation at a medical facility. SAE was an AE resulting in any of the following outcomes or deemed significant for any other reason: death; initial or prolonged inpatient hospitalization; life-threatening experience (immediate risk of dying); persistent or significant disability/incapacity; congenital anomaly.</description>
          <population>All participants in expanded cohort who received at least 1 dose of the investigational products at Visit 1.</population>
          <units>Percentage of participants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="41"/>
                <count group_id="O2" value="42"/>
                <count group_id="O3" value="41"/>
                <count group_id="O4" value="40"/>
                <count group_id="O5" value="41"/>
                <count group_id="O6" value="41"/>
                <count group_id="O7" value="41"/>
                <count group_id="O8" value="41"/>
                <count group_id="O9" value="41"/>
                <count group_id="O10" value="41"/>
                <count group_id="O11" value="41"/>
                <count group_id="O12" value="41"/>
                <count group_id="O13" value="41"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>MAEs</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22.0" lower_limit="10.6" upper_limit="37.6"/>
                    <measurement group_id="O2" value="14.3" lower_limit="5.4" upper_limit="28.5"/>
                    <measurement group_id="O3" value="9.8" lower_limit="2.7" upper_limit="23.1"/>
                    <measurement group_id="O4" value="17.5" lower_limit="7.3" upper_limit="32.8"/>
                    <measurement group_id="O5" value="22.0" lower_limit="10.6" upper_limit="37.6"/>
                    <measurement group_id="O6" value="19.5" lower_limit="8.8" upper_limit="34.9"/>
                    <measurement group_id="O7" value="12.2" lower_limit="4.1" upper_limit="26.2"/>
                    <measurement group_id="O8" value="24.4" lower_limit="12.4" upper_limit="40.3"/>
                    <measurement group_id="O9" value="24.4" lower_limit="12.4" upper_limit="40.3"/>
                    <measurement group_id="O10" value="22.0" lower_limit="10.6" upper_limit="40.3"/>
                    <measurement group_id="O11" value="24.4" lower_limit="12.4" upper_limit="40.3"/>
                    <measurement group_id="O12" value="22.0" lower_limit="10.6" upper_limit="37.6"/>
                    <measurement group_id="O13" value="22.0" lower_limit="10.6" upper_limit="37.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SAEs</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O2" value="0" lower_limit="0.0" upper_limit="8.4"/>
                    <measurement group_id="O3" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O4" value="2.5" lower_limit="0.1" upper_limit="13.2"/>
                    <measurement group_id="O5" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O6" value="4.9" lower_limit="0.6" upper_limit="16.5"/>
                    <measurement group_id="O7" value="0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O8" value="4.9" lower_limit="0.6" upper_limit="16.5"/>
                    <measurement group_id="O9" value="4.9" lower_limit="0.6" upper_limit="16.5"/>
                    <measurement group_id="O10" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O11" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                    <measurement group_id="O12" value="7.3" lower_limit="1.5" upper_limit="19.9"/>
                    <measurement group_id="O13" value="2.4" lower_limit="0.1" upper_limit="12.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Expanded Cohort: Percentage of Participants (Aged 65 to 85 Years) With MAEs and SAEs 12 Months After Vaccination 1</title>
        <description>MAE was defined as a non-serious AE that resulted in an evaluation at a medical facility. SAE was an AE resulting in any of the following outcomes or deemed significant for any other reason: death; initial or prolonged inpatient hospitalization; life-threatening experience (immediate risk of dying); persistent or significant disability/incapacity; congenital anomaly.</description>
        <time_frame>Upto 12 months after vaccination 1 (upto 378 days)</time_frame>
        <population>All participants in expanded cohort who received at least 1 dose of the investigational products at Visit 1.</population>
        <group_list>
          <group group_id="O1">
            <title>Expanded Cohort: RSV 60 mcg With SIIV Age 65-85 Years</title>
            <description>Participants aged 65-85 years received 2 doses of RSV vaccine 60 mcg along with 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O2">
            <title>Expanded Cohort: RSV 60 mcg With Placebo Age 65-85 Years</title>
            <description>Participants aged 65-85 years received 2 doses of RSV vaccine 60 mcg along with placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O3">
            <title>Expanded Cohort: RSV 60 mcg With Aluminum Hydroxide and SIIV Age 65-85 Years</title>
            <description>Participants aged 65-85 years received 2 doses of RSV vaccine 60 mcg along with aluminum hydroxide and 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O4">
            <title>Expanded Cohort: RSV 60 mcg With Aluminum Hydroxide and Placebo Age 65-85 Years</title>
            <description>Participants aged 65-85 years received 2 doses of RSV vaccine 60 mcg along with aluminum hydroxide and placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O5">
            <title>Expanded Cohort: RSV 120 mcg With SIIV Age 65-85 Years</title>
            <description>Participants aged 65-85 years received 2 doses of RSV vaccine 120 mcg along with 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O6">
            <title>Expanded Cohort: RSV 120 mcg With Placebo Age 65-85 Years</title>
            <description>Participants aged 65-85 years received 2 doses of RSV vaccine 120 mcg along with placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O7">
            <title>Expanded Cohort: RSV 120 mcg With Aluminum Hydroxide and SIIV Age 65-85 Years</title>
            <description>Participants aged 65-85 years received 2 doses of RSV vaccine 120 mcg along with aluminum hydroxide and 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O8">
            <title>Expanded Cohort: RSV 120 mcg With Aluminum Hydroxide and Placebo Age 65-85 Years</title>
            <description>Participants aged 65-85 years received 2 doses of RSV vaccine 120 mcg along with aluminum hydroxide and placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O9">
            <title>Expanded Cohort: RSV 240 mcg With SIIV Age 65-85 Years</title>
            <description>Participants aged 65-85 years received 2 doses of RSV vaccine 240 mcg along with 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O10">
            <title>Expanded Cohort: RSV 240 mcg With Placebo Age 65-85 Years</title>
            <description>Participants aged 65-85 years received 2 doses of RSV vaccine 240 mcg along with placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O11">
            <title>Expanded Cohort: RSV 240 mcg With Aluminum Hydroxide and SIIV Age 65-85 Years</title>
            <description>Participants aged 65-85 years received 2 doses of RSV vaccine 240 mcg along with aluminum hydroxide and 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O12">
            <title>Expanded Cohort: RSV 240 mcg With Aluminum Hydroxide and Placebo Age 65-85 Years</title>
            <description>Participants aged 65-85 years received 2 doses of RSV vaccine 240 mcg along with aluminum hydroxide and placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O13">
            <title>Expanded Cohort: Placebo Age 65-85 Years</title>
            <description>Participants aged 65-85 years received placebo matched to RSV vaccine intramuscularly. Participants were followed up to 12 months after vaccination.</description>
          </group>
        </group_list>
        <measure>
          <title>Expanded Cohort: Percentage of Participants (Aged 65 to 85 Years) With MAEs and SAEs 12 Months After Vaccination 1</title>
          <description>MAE was defined as a non-serious AE that resulted in an evaluation at a medical facility. SAE was an AE resulting in any of the following outcomes or deemed significant for any other reason: death; initial or prolonged inpatient hospitalization; life-threatening experience (immediate risk of dying); persistent or significant disability/incapacity; congenital anomaly.</description>
          <population>All participants in expanded cohort who received at least 1 dose of the investigational products at Visit 1.</population>
          <units>Percentage of participants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="40"/>
                <count group_id="O2" value="41"/>
                <count group_id="O3" value="40"/>
                <count group_id="O4" value="42"/>
                <count group_id="O5" value="40"/>
                <count group_id="O6" value="40"/>
                <count group_id="O7" value="41"/>
                <count group_id="O8" value="41"/>
                <count group_id="O9" value="40"/>
                <count group_id="O10" value="41"/>
                <count group_id="O11" value="42"/>
                <count group_id="O12" value="43"/>
                <count group_id="O13" value="41"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>MAEs</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.0" lower_limit="5.7" upper_limit="29.8"/>
                    <measurement group_id="O2" value="24.4" lower_limit="12.4" upper_limit="40.3"/>
                    <measurement group_id="O3" value="30.0" lower_limit="16.6" upper_limit="46.5"/>
                    <measurement group_id="O4" value="31.0" lower_limit="17.6" upper_limit="47.1"/>
                    <measurement group_id="O5" value="22.5" lower_limit="10.8" upper_limit="38.5"/>
                    <measurement group_id="O6" value="22.5" lower_limit="10.8" upper_limit="38.5"/>
                    <measurement group_id="O7" value="17.1" lower_limit="7.2" upper_limit="32.1"/>
                    <measurement group_id="O8" value="34.1" lower_limit="20.1" upper_limit="50.6"/>
                    <measurement group_id="O9" value="47.5" lower_limit="31.5" upper_limit="63.9"/>
                    <measurement group_id="O10" value="43.9" lower_limit="28.5" upper_limit="60.3"/>
                    <measurement group_id="O11" value="28.6" lower_limit="15.7" upper_limit="44.6"/>
                    <measurement group_id="O12" value="25.6" lower_limit="13.5" upper_limit="41.2"/>
                    <measurement group_id="O13" value="14.6" lower_limit="5.6" upper_limit="29.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SAEs</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.0" lower_limit="0.6" upper_limit="16.9"/>
                    <measurement group_id="O2" value="17.1" lower_limit="7.2" upper_limit="32.1"/>
                    <measurement group_id="O3" value="10.0" lower_limit="2.8" upper_limit="23.7"/>
                    <measurement group_id="O4" value="19.0" lower_limit="8.6" upper_limit="34.1"/>
                    <measurement group_id="O5" value="10.0" lower_limit="2.8" upper_limit="23.7"/>
                    <measurement group_id="O6" value="5.0" lower_limit="0.6" upper_limit="16.9"/>
                    <measurement group_id="O7" value="17.1" lower_limit="7.2" upper_limit="32.1"/>
                    <measurement group_id="O8" value="4.9" lower_limit="0.6" upper_limit="16.5"/>
                    <measurement group_id="O9" value="10.0" lower_limit="2.8" upper_limit="23.7"/>
                    <measurement group_id="O10" value="7.3" lower_limit="1.5" upper_limit="19.9"/>
                    <measurement group_id="O11" value="7.1" lower_limit="1.5" upper_limit="19.5"/>
                    <measurement group_id="O12" value="7.0" lower_limit="1.5" upper_limit="19.1"/>
                    <measurement group_id="O13" value="7.3" lower_limit="1.5" upper_limit="19.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Expanded Cohort: Percentage of Participants (Aged 18 to 49 Years) With AEs Within 1 Month After Vaccination 2</title>
        <description>An AE was any untoward medical occurrence in a participant who received investigational product without regard to possibility of causal relationship. AEs included both serious and non-serious adverse events.</description>
        <time_frame>Within 1 month after vaccination 2 (upto Day 70)</time_frame>
        <population>All participants in expanded cohort who received at least 1 dose of the investigational products at Visit 1.</population>
        <group_list>
          <group group_id="O1">
            <title>Expanded Cohort: RSV 60 mcg With SIIV Age 18-49 Years</title>
            <description>Participants aged 18-49 years received 2 doses of RSV vaccine 60 mcg along with 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O2">
            <title>Expanded Cohort: RSV 60 mcg With Placebo Age 18-49 Years</title>
            <description>Participants aged 18-49 years received 2 doses of RSV vaccine 60 mcg along with placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O3">
            <title>Expanded Cohort: RSV 60 mcg With Aluminum Hydroxide and SIIV Age 18-49 Years</title>
            <description>Participants aged 18-49 years received 2 doses of RSV vaccine 60 mcg along with aluminum hydroxide and 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O4">
            <title>Expanded Cohort: RSV 60 mcg With Aluminum Hydroxide and Placebo Age 18-49 Years</title>
            <description>Participants aged 18-49 years received 2 doses of RSV vaccine 60 mcg along with aluminum hydroxide and placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O5">
            <title>Expanded Cohort: RSV 120 mcg With SIIV Age 18-49 Years</title>
            <description>Participants aged 18-49 years received 2 doses of RSV vaccine 120 mcg along with 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O6">
            <title>Expanded Cohort: RSV 120 mcg With Placebo Age 18-49 Years</title>
            <description>Participants aged 18-49 years received 2 doses of RSV vaccine 120 mcg along with placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O7">
            <title>Expanded Cohort: RSV 120 mcg With Aluminum Hydroxide and SIIV Age 18-49 Years</title>
            <description>Participants aged 18-49 years received 2 doses of RSV vaccine 120 mcg along with aluminum hydroxide and 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O8">
            <title>Expanded Cohort: RSV 120 mcg With Aluminum Hydroxide and Placebo Age 18-49 Years</title>
            <description>Participants aged 18-49 years received 2 doses of RSV vaccine 120 mcg along with aluminum hydroxide and placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O9">
            <title>Expanded Cohort: RSV 240 mcg With SIIV Age 18-49 Years</title>
            <description>Participants aged 18-49 years received 2 doses of RSV vaccine 240 mcg along with 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O10">
            <title>Expanded Cohort: RSV 240 mcg With Placebo Age 18-49 Years</title>
            <description>Participants aged 18-49 years received 2 doses of RSV vaccine 240 mcg along with placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O11">
            <title>Expanded Cohort: RSV 240 mcg With Aluminum Hydroxide and SIIV Age 18-49 Years</title>
            <description>Participants aged 18-49 years received 2 doses of RSV vaccine 240 mcg along with aluminum hydroxide and 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O12">
            <title>Expanded Cohort: RSV 240 mcg With Aluminum Hydroxide and Placebo Age 18-49 Years</title>
            <description>Participants aged 18-49 years received 2 doses of RSV vaccine 240 mcg along with aluminum hydroxide and placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O13">
            <title>Expanded Cohort: Placebo Age 18-49 Years</title>
            <description>Participants aged 18-49 years received placebo matched to RSV vaccine intramuscularly. Participants were followed up to 12 months after vaccination.</description>
          </group>
        </group_list>
        <measure>
          <title>Expanded Cohort: Percentage of Participants (Aged 18 to 49 Years) With AEs Within 1 Month After Vaccination 2</title>
          <description>An AE was any untoward medical occurrence in a participant who received investigational product without regard to possibility of causal relationship. AEs included both serious and non-serious adverse events.</description>
          <population>All participants in expanded cohort who received at least 1 dose of the investigational products at Visit 1.</population>
          <units>Percentage of participants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="41"/>
                <count group_id="O2" value="42"/>
                <count group_id="O3" value="41"/>
                <count group_id="O4" value="40"/>
                <count group_id="O5" value="41"/>
                <count group_id="O6" value="41"/>
                <count group_id="O7" value="41"/>
                <count group_id="O8" value="41"/>
                <count group_id="O9" value="41"/>
                <count group_id="O10" value="41"/>
                <count group_id="O11" value="41"/>
                <count group_id="O12" value="41"/>
                <count group_id="O13" value="41"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19.5" lower_limit="8.8" upper_limit="34.9"/>
                    <measurement group_id="O2" value="14.3" lower_limit="5.4" upper_limit="28.5"/>
                    <measurement group_id="O3" value="19.5" lower_limit="8.8" upper_limit="34.9"/>
                    <measurement group_id="O4" value="10.0" lower_limit="2.8" upper_limit="23.7"/>
                    <measurement group_id="O5" value="7.3" lower_limit="1.5" upper_limit="19.9"/>
                    <measurement group_id="O6" value="17.1" lower_limit="7.2" upper_limit="32.1"/>
                    <measurement group_id="O7" value="22.0" lower_limit="10.6" upper_limit="37.6"/>
                    <measurement group_id="O8" value="14.6" lower_limit="5.6" upper_limit="29.2"/>
                    <measurement group_id="O9" value="26.8" lower_limit="14.2" upper_limit="42.9"/>
                    <measurement group_id="O10" value="26.8" lower_limit="14.2" upper_limit="42.9"/>
                    <measurement group_id="O11" value="19.5" lower_limit="8.8" upper_limit="34.9"/>
                    <measurement group_id="O12" value="17.1" lower_limit="7.2" upper_limit="32.1"/>
                    <measurement group_id="O13" value="9.8" lower_limit="2.7" upper_limit="23.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Expanded Cohort: Percentage of Participants (Aged 65 to 85 Years) With AEs Within 1 Month After Vaccination 2</title>
        <description>An AE was any untoward medical occurrence in a participant who received investigational product without regard to possibility of causal relationship. AEs included both serious and non-serious adverse events.</description>
        <time_frame>Within 1 month after vaccination 2 (upto Day 70)</time_frame>
        <population>All participants in expanded cohort who received at least 1 dose of the investigational products at Visit 1.</population>
        <group_list>
          <group group_id="O1">
            <title>Expanded Cohort: RSV 60 mcg With SIIV Age 65-85 Years</title>
            <description>Participants aged 65-85 years received 2 doses of RSV vaccine 60 mcg along with 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O2">
            <title>Expanded Cohort: RSV 60 mcg With Placebo Age 65-85 Years</title>
            <description>Participants aged 65-85 years received 2 doses of RSV vaccine 60 mcg along with placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O3">
            <title>Expanded Cohort: RSV 60 mcg With Aluminum Hydroxide and SIIV Age 65-85 Years</title>
            <description>Participants aged 65-85 years received 2 doses of RSV vaccine 60 mcg along with aluminum hydroxide and 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O4">
            <title>Expanded Cohort: RSV 60 mcg With Aluminum Hydroxide and Placebo Age 65-85 Years</title>
            <description>Participants aged 65-85 years received 2 doses of RSV vaccine 60 mcg along with aluminum hydroxide and placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O5">
            <title>Expanded Cohort: RSV 120 mcg With SIIV Age 65-85 Years</title>
            <description>Participants aged 65-85 years received 2 doses of RSV vaccine 120 mcg along with 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O6">
            <title>Expanded Cohort: RSV 120 mcg With Placebo Age 65-85 Years</title>
            <description>Participants aged 65-85 years received 2 doses of RSV vaccine 120 mcg along with placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O7">
            <title>Expanded Cohort: RSV 120 mcg With Aluminum Hydroxide and SIIV Age 65-85 Years</title>
            <description>Participants aged 65-85 years received 2 doses of RSV vaccine 120 mcg along with aluminum hydroxide and 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O8">
            <title>Expanded Cohort: RSV 120 mcg With Aluminum Hydroxide and Placebo Age 65-85 Years</title>
            <description>Participants aged 65-85 years received 2 doses of RSV vaccine 120 mcg along with aluminum hydroxide and placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O9">
            <title>Expanded Cohort: RSV 240 mcg With SIIV Age 65-85 Years</title>
            <description>Participants aged 65-85 years received 2 doses of RSV vaccine 240 mcg along with 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O10">
            <title>Expanded Cohort: RSV 240 mcg With Placebo Age 65-85 Years</title>
            <description>Participants aged 65-85 years received 2 doses of RSV vaccine 240 mcg along with placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O11">
            <title>Expanded Cohort: RSV 240 mcg With Aluminum Hydroxide and SIIV Age 65-85 Years</title>
            <description>Participants aged 65-85 years received 2 doses of RSV vaccine 240 mcg along with aluminum hydroxide and 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O12">
            <title>Expanded Cohort: RSV 240 mcg With Aluminum Hydroxide and Placebo Age 65-85 Years</title>
            <description>Participants aged 65-85 years received 2 doses of RSV vaccine 240 mcg along with aluminum hydroxide and placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O13">
            <title>Expanded Cohort: Placebo Age 65-85 Years</title>
            <description>Participants aged 65-85 years received placebo matched to RSV vaccine intramuscularly. Participants were followed up to 12 months after vaccination.</description>
          </group>
        </group_list>
        <measure>
          <title>Expanded Cohort: Percentage of Participants (Aged 65 to 85 Years) With AEs Within 1 Month After Vaccination 2</title>
          <description>An AE was any untoward medical occurrence in a participant who received investigational product without regard to possibility of causal relationship. AEs included both serious and non-serious adverse events.</description>
          <population>All participants in expanded cohort who received at least 1 dose of the investigational products at Visit 1.</population>
          <units>Percentage of participants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="40"/>
                <count group_id="O2" value="41"/>
                <count group_id="O3" value="40"/>
                <count group_id="O4" value="42"/>
                <count group_id="O5" value="40"/>
                <count group_id="O6" value="40"/>
                <count group_id="O7" value="41"/>
                <count group_id="O8" value="41"/>
                <count group_id="O9" value="40"/>
                <count group_id="O10" value="41"/>
                <count group_id="O11" value="42"/>
                <count group_id="O12" value="43"/>
                <count group_id="O13" value="41"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.0" lower_limit="2.8" upper_limit="23.7"/>
                    <measurement group_id="O2" value="7.3" lower_limit="1.5" upper_limit="19.9"/>
                    <measurement group_id="O3" value="20.0" lower_limit="9.1" upper_limit="35.6"/>
                    <measurement group_id="O4" value="21.4" lower_limit="10.3" upper_limit="36.8"/>
                    <measurement group_id="O5" value="25.0" lower_limit="12.7" upper_limit="41.2"/>
                    <measurement group_id="O6" value="30.0" lower_limit="16.6" upper_limit="46.5"/>
                    <measurement group_id="O7" value="12.2" lower_limit="4.1" upper_limit="26.2"/>
                    <measurement group_id="O8" value="9.8" lower_limit="2.7" upper_limit="23.1"/>
                    <measurement group_id="O9" value="32.5" lower_limit="18.6" upper_limit="49.1"/>
                    <measurement group_id="O10" value="24.4" lower_limit="12.4" upper_limit="40.3"/>
                    <measurement group_id="O11" value="11.9" lower_limit="4.0" upper_limit="25.6"/>
                    <measurement group_id="O12" value="18.6" lower_limit="8.4" upper_limit="33.4"/>
                    <measurement group_id="O13" value="17.1" lower_limit="7.2" upper_limit="32.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Sentinel Cohort: Geometric Mean Titers (GMTs) of Respiratory Syncytial Virus Subgroup A (RSV A) and RSV B Antigens Following Vaccination in Participants (Aged 18 to 49 Years)</title>
        <description>GMTs of RSV A and RSV B antigens were measured using neutralizing assay. The neutralizing titer lower limit of quantitation (LLOQ) values were: A = 50 and B = 70. Assay results below the LLOQ were set to 0.5*LLOQ. Titers were expressed in terms of 1/dilution.</description>
        <time_frame>Before vaccination, and 2 weeks and 1, 2, 3, and 6 months after vaccination</time_frame>
        <population>Evaluable immunogenicity population (EIP): participants who were eligible, received all RSV vaccine or placebo to which they were randomized, had blood drawn for assay testing within 27 to 42 days after Visit 1, had at least 1 valid and determinate assay result at 1-month-postvaccination visit and no major protocol violations. Here, &quot;number analyzed&quot; signifies participants evaluable at specific rows.</population>
        <group_list>
          <group group_id="O1">
            <title>Sentinel Cohort: RSV Vaccine 60 mcg Age 18-49 Years</title>
            <description>Participants aged 18-49 years received single 60-mcg dose of RSV vaccine, intramuscularly. Participants were followed up to 12 months after vaccination.</description>
          </group>
          <group group_id="O2">
            <title>Sentinel Cohort: RSV 60 mcg With Aluminum Hydroxide Age 18-49 Years</title>
            <description>Participants aged 18-49 years received single 60-mcg dose with aluminum hydroxide intramuscularly. Participants were followed up to 12 months after vaccination.</description>
          </group>
          <group group_id="O3">
            <title>Sentinel Cohort: RSV 120 mcg Age 18-49 Years</title>
            <description>Participants aged 18-49 years received single 120-mcg dose intramuscularly. Participants were followed up to 12 months after vaccination.</description>
          </group>
          <group group_id="O4">
            <title>Sentinel Cohort: RSV 120 mcg With Aluminum Hydroxide Age 18-49 Years</title>
            <description>Participants aged 18-49 years received single 120-mcg dose with aluminum hydroxide intramuscularly. Participants were followed up to 12 months after vaccination.</description>
          </group>
          <group group_id="O5">
            <title>Sentinel Cohort: RSV 240 mcg Age 18-49 Years</title>
            <description>Participants aged 18-49 years received single 240-mcg dose intramuscularly. Participants were followed up to 12 months after vaccination.</description>
          </group>
          <group group_id="O6">
            <title>Sentinel Cohort: RSV 240 mcg With Aluminum Hydroxide Age 18-49 Years</title>
            <description>Participants aged 18-49 years received single 240-mcg dose with aluminum hydroxide intramuscularly. Participants were followed up to 12 months after vaccination.</description>
          </group>
          <group group_id="O7">
            <title>Sentinel Cohort: Placebo Age 18-49 Years</title>
            <description>Participants aged 18-49 years received placebo matched to RSV vaccine intramuscularly. Participants were followed up to 12 months after vaccination.</description>
          </group>
        </group_list>
        <measure>
          <title>Sentinel Cohort: Geometric Mean Titers (GMTs) of Respiratory Syncytial Virus Subgroup A (RSV A) and RSV B Antigens Following Vaccination in Participants (Aged 18 to 49 Years)</title>
          <description>GMTs of RSV A and RSV B antigens were measured using neutralizing assay. The neutralizing titer lower limit of quantitation (LLOQ) values were: A = 50 and B = 70. Assay results below the LLOQ were set to 0.5*LLOQ. Titers were expressed in terms of 1/dilution.</description>
          <population>Evaluable immunogenicity population (EIP): participants who were eligible, received all RSV vaccine or placebo to which they were randomized, had blood drawn for assay testing within 27 to 42 days after Visit 1, had at least 1 valid and determinate assay result at 1-month-postvaccination visit and no major protocol violations. Here, &quot;number analyzed&quot; signifies participants evaluable at specific rows.</population>
          <units>Titers</units>
          <param>Geometric Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="12"/>
                <count group_id="O3" value="12"/>
                <count group_id="O4" value="12"/>
                <count group_id="O5" value="11"/>
                <count group_id="O6" value="11"/>
                <count group_id="O7" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>RSV A: before vaccination 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="12"/>
                    <count group_id="O2" value="12"/>
                    <count group_id="O3" value="12"/>
                    <count group_id="O4" value="12"/>
                    <count group_id="O5" value="11"/>
                    <count group_id="O6" value="11"/>
                    <count group_id="O7" value="12"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1319" lower_limit="639.4" upper_limit="2720.0"/>
                    <measurement group_id="O2" value="1754" lower_limit="1053.6" upper_limit="2919.0"/>
                    <measurement group_id="O3" value="1090" lower_limit="636.6" upper_limit="1867.2"/>
                    <measurement group_id="O4" value="1531" lower_limit="939.0" upper_limit="2495.5"/>
                    <measurement group_id="O5" value="2029" lower_limit="1186.2" upper_limit="3471.1"/>
                    <measurement group_id="O6" value="1553" lower_limit="997.5" upper_limit="2416.8"/>
                    <measurement group_id="O7" value="1229" lower_limit="666.0" upper_limit="2267.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV A: 2 Weeks after vaccination 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="12"/>
                    <count group_id="O2" value="12"/>
                    <count group_id="O3" value="12"/>
                    <count group_id="O4" value="12"/>
                    <count group_id="O5" value="11"/>
                    <count group_id="O6" value="11"/>
                    <count group_id="O7" value="12"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20936" lower_limit="16760.8" upper_limit="26151.7"/>
                    <measurement group_id="O2" value="24970" lower_limit="15120.8" upper_limit="41235.7"/>
                    <measurement group_id="O3" value="31584" lower_limit="19599.9" upper_limit="50897.0"/>
                    <measurement group_id="O4" value="31193" lower_limit="18221.6" upper_limit="53399.1"/>
                    <measurement group_id="O5" value="44866" lower_limit="27431.6" upper_limit="73379.3"/>
                    <measurement group_id="O6" value="52339" lower_limit="41244.0" upper_limit="66419.5"/>
                    <measurement group_id="O7" value="2817" lower_limit="1279.8" upper_limit="6200.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV A: 1 Month after vaccination 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="12"/>
                    <count group_id="O2" value="12"/>
                    <count group_id="O3" value="12"/>
                    <count group_id="O4" value="12"/>
                    <count group_id="O5" value="11"/>
                    <count group_id="O6" value="11"/>
                    <count group_id="O7" value="12"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16730" lower_limit="10482.1" upper_limit="26701.2"/>
                    <measurement group_id="O2" value="20512" lower_limit="10692.1" upper_limit="39349.2"/>
                    <measurement group_id="O3" value="10021" lower_limit="5439.7" upper_limit="18461.5"/>
                    <measurement group_id="O4" value="16521" lower_limit="8363.4" upper_limit="32634.1"/>
                    <measurement group_id="O5" value="27892" lower_limit="11836.8" upper_limit="65726.0"/>
                    <measurement group_id="O6" value="28453" lower_limit="17960.2" upper_limit="45076.0"/>
                    <measurement group_id="O7" value="2430" lower_limit="1059.5" upper_limit="5572.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV A: 2 Months after vaccination 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="12"/>
                    <count group_id="O2" value="12"/>
                    <count group_id="O3" value="12"/>
                    <count group_id="O4" value="12"/>
                    <count group_id="O5" value="11"/>
                    <count group_id="O6" value="11"/>
                    <count group_id="O7" value="12"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12702" lower_limit="7774.1" upper_limit="20752.2"/>
                    <measurement group_id="O2" value="28577" lower_limit="17569.4" upper_limit="46482.7"/>
                    <measurement group_id="O3" value="11171" lower_limit="7299.6" upper_limit="17095.6"/>
                    <measurement group_id="O4" value="15529" lower_limit="8421.5" upper_limit="28636.3"/>
                    <measurement group_id="O5" value="23033" lower_limit="15199.1" upper_limit="34905.6"/>
                    <measurement group_id="O6" value="18883" lower_limit="11903.1" upper_limit="29955.5"/>
                    <measurement group_id="O7" value="1851" lower_limit="872.8" upper_limit="3925.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV A:3 Months after vaccination 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="12"/>
                    <count group_id="O2" value="12"/>
                    <count group_id="O3" value="11"/>
                    <count group_id="O4" value="12"/>
                    <count group_id="O5" value="11"/>
                    <count group_id="O6" value="11"/>
                    <count group_id="O7" value="12"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8258" lower_limit="5436.7" upper_limit="12544.3"/>
                    <measurement group_id="O2" value="15276" lower_limit="8311.3" upper_limit="28077.4"/>
                    <measurement group_id="O3" value="10800" lower_limit="5629.4" upper_limit="20720.5"/>
                    <measurement group_id="O4" value="12421" lower_limit="6536.5" upper_limit="23602.4"/>
                    <measurement group_id="O5" value="19654" lower_limit="11887.0" upper_limit="32494.6"/>
                    <measurement group_id="O6" value="12922" lower_limit="8416.3" upper_limit="19839.5"/>
                    <measurement group_id="O7" value="1560" lower_limit="871.7" upper_limit="2791.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV A:6 Months after vaccination 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="12"/>
                    <count group_id="O2" value="12"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="12"/>
                    <count group_id="O5" value="11"/>
                    <count group_id="O6" value="11"/>
                    <count group_id="O7" value="12"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11466" lower_limit="7413.8" upper_limit="17733.3"/>
                    <measurement group_id="O2" value="22737" lower_limit="13621.9" upper_limit="37952.6"/>
                    <measurement group_id="O3" value="12034" lower_limit="6531.3" upper_limit="22173.9"/>
                    <measurement group_id="O4" value="9707" lower_limit="5968.0" upper_limit="15788.1"/>
                    <measurement group_id="O5" value="13672" lower_limit="8854.3" upper_limit="21111.5"/>
                    <measurement group_id="O6" value="8237" lower_limit="5457.7" upper_limit="12430.7"/>
                    <measurement group_id="O7" value="2658" lower_limit="1713.6" upper_limit="4121.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV A: 12 Months after vaccination 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="12"/>
                    <count group_id="O2" value="12"/>
                    <count group_id="O3" value="11"/>
                    <count group_id="O4" value="12"/>
                    <count group_id="O5" value="11"/>
                    <count group_id="O6" value="11"/>
                    <count group_id="O7" value="12"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4430" lower_limit="1406.2" upper_limit="13954.0"/>
                    <measurement group_id="O2" value="11052" lower_limit="6489.0" upper_limit="18822.7"/>
                    <measurement group_id="O3" value="6147" lower_limit="3027.2" upper_limit="12480.5"/>
                    <measurement group_id="O4" value="5849" lower_limit="2465.2" upper_limit="13876.7"/>
                    <measurement group_id="O5" value="9851" lower_limit="6172.1" upper_limit="15722.6"/>
                    <measurement group_id="O6" value="8707" lower_limit="5584.9" upper_limit="13573.9"/>
                    <measurement group_id="O7" value="2043" lower_limit="1043.0" upper_limit="4002.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV B: before vaccination 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="12"/>
                    <count group_id="O2" value="12"/>
                    <count group_id="O3" value="12"/>
                    <count group_id="O4" value="12"/>
                    <count group_id="O5" value="11"/>
                    <count group_id="O6" value="11"/>
                    <count group_id="O7" value="12"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1427" lower_limit="696.9" upper_limit="2921.5"/>
                    <measurement group_id="O2" value="2077" lower_limit="1318.2" upper_limit="3274.2"/>
                    <measurement group_id="O3" value="995" lower_limit="468.6" upper_limit="2111.4"/>
                    <measurement group_id="O4" value="1670" lower_limit="987.2" upper_limit="2826.2"/>
                    <measurement group_id="O5" value="1600" lower_limit="884.5" upper_limit="2895.1"/>
                    <measurement group_id="O6" value="1492" lower_limit="946.5" upper_limit="2353.0"/>
                    <measurement group_id="O7" value="1393" lower_limit="600.9" upper_limit="3227.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV B: 2 Weeks after vaccination 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="12"/>
                    <count group_id="O2" value="12"/>
                    <count group_id="O3" value="12"/>
                    <count group_id="O4" value="12"/>
                    <count group_id="O5" value="11"/>
                    <count group_id="O6" value="11"/>
                    <count group_id="O7" value="12"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23974" lower_limit="17227.4" upper_limit="33364.1"/>
                    <measurement group_id="O2" value="22491" lower_limit="12970.4" upper_limit="38999.0"/>
                    <measurement group_id="O3" value="32104" lower_limit="22689.9" upper_limit="45424.2"/>
                    <measurement group_id="O4" value="42222" lower_limit="18956.4" upper_limit="94043.4"/>
                    <measurement group_id="O5" value="59752" lower_limit="32986.4" upper_limit="108235.8"/>
                    <measurement group_id="O6" value="59955" lower_limit="39010.7" upper_limit="92143.8"/>
                    <measurement group_id="O7" value="2817" lower_limit="1109.7" upper_limit="7150.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV B: 1 Month after vaccination 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="12"/>
                    <count group_id="O2" value="12"/>
                    <count group_id="O3" value="12"/>
                    <count group_id="O4" value="12"/>
                    <count group_id="O5" value="11"/>
                    <count group_id="O6" value="11"/>
                    <count group_id="O7" value="12"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18932" lower_limit="11958.2" upper_limit="29973.5"/>
                    <measurement group_id="O2" value="19197" lower_limit="9637.0" upper_limit="38241.0"/>
                    <measurement group_id="O3" value="8510" lower_limit="5282.6" upper_limit="13708.4"/>
                    <measurement group_id="O4" value="18080" lower_limit="8223.8" upper_limit="39749.5"/>
                    <measurement group_id="O5" value="26759" lower_limit="10616.0" upper_limit="67451.3"/>
                    <measurement group_id="O6" value="29668" lower_limit="17559.4" upper_limit="50125.0"/>
                    <measurement group_id="O7" value="1861" lower_limit="657.4" upper_limit="5265.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV B: 2 Months after vaccination 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="12"/>
                    <count group_id="O2" value="12"/>
                    <count group_id="O3" value="12"/>
                    <count group_id="O4" value="12"/>
                    <count group_id="O5" value="11"/>
                    <count group_id="O6" value="11"/>
                    <count group_id="O7" value="12"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13959" lower_limit="8783.3" upper_limit="22184.4"/>
                    <measurement group_id="O2" value="28374" lower_limit="15306.1" upper_limit="52600.1"/>
                    <measurement group_id="O3" value="8760" lower_limit="5253.7" upper_limit="14607.8"/>
                    <measurement group_id="O4" value="16167" lower_limit="7902.3" upper_limit="33077.1"/>
                    <measurement group_id="O5" value="19534" lower_limit="10586.7" upper_limit="36042.0"/>
                    <measurement group_id="O6" value="18280" lower_limit="10621.2" upper_limit="31462.6"/>
                    <measurement group_id="O7" value="1604" lower_limit="606.9" upper_limit="4238.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV B: 3 Months after vaccination 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="12"/>
                    <count group_id="O2" value="12"/>
                    <count group_id="O3" value="11"/>
                    <count group_id="O4" value="12"/>
                    <count group_id="O5" value="11"/>
                    <count group_id="O6" value="11"/>
                    <count group_id="O7" value="12"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9688" lower_limit="6307.1" upper_limit="14882.3"/>
                    <measurement group_id="O2" value="12697" lower_limit="7257.0" upper_limit="22214.4"/>
                    <measurement group_id="O3" value="8833" lower_limit="5170.6" upper_limit="15088.1"/>
                    <measurement group_id="O4" value="11986" lower_limit="5852.2" upper_limit="24549.6"/>
                    <measurement group_id="O5" value="16706" lower_limit="8822.8" upper_limit="31633.4"/>
                    <measurement group_id="O6" value="11588" lower_limit="6572.0" upper_limit="20434.1"/>
                    <measurement group_id="O7" value="1613" lower_limit="780.6" upper_limit="3331.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV B: 6 Months after vaccination 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="12"/>
                    <count group_id="O2" value="12"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="12"/>
                    <count group_id="O5" value="11"/>
                    <count group_id="O6" value="11"/>
                    <count group_id="O7" value="12"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15235" lower_limit="7604.2" upper_limit="30523.5"/>
                    <measurement group_id="O2" value="16492" lower_limit="10319.2" upper_limit="26357.8"/>
                    <measurement group_id="O3" value="10918" lower_limit="5615.7" upper_limit="21225.9"/>
                    <measurement group_id="O4" value="11658" lower_limit="6759.2" upper_limit="20107.4"/>
                    <measurement group_id="O5" value="11857" lower_limit="6383.5" upper_limit="22021.8"/>
                    <measurement group_id="O6" value="7435" lower_limit="4660.4" upper_limit="11862.2"/>
                    <measurement group_id="O7" value="2865" lower_limit="1655.5" upper_limit="4960.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV B: 12 Months after vaccination 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="12"/>
                    <count group_id="O2" value="12"/>
                    <count group_id="O3" value="11"/>
                    <count group_id="O4" value="12"/>
                    <count group_id="O5" value="11"/>
                    <count group_id="O6" value="11"/>
                    <count group_id="O7" value="12"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4674" lower_limit="1561.6" upper_limit="13991.5"/>
                    <measurement group_id="O2" value="9274" lower_limit="5661.4" upper_limit="15192.8"/>
                    <measurement group_id="O3" value="4127" lower_limit="2331.4" upper_limit="7303.9"/>
                    <measurement group_id="O4" value="5392" lower_limit="2058.4" upper_limit="14125.8"/>
                    <measurement group_id="O5" value="8565" lower_limit="4633.3" upper_limit="15832.7"/>
                    <measurement group_id="O6" value="7373" lower_limit="4569.2" upper_limit="11897.9"/>
                    <measurement group_id="O7" value="1970" lower_limit="839.1" upper_limit="4625.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Sentinel Cohort: GMTs of RSV A and RSV B Antigens Following Vaccination in Participants (Aged 50 to 85 Years)</title>
        <description>GMTs of RSV A and RSV B antigens were measured using neutralizing assay. The neutralizing titer LLOQ values were: A = 50 and B = 70. Assay results below the LLOQ were set to 0.5*LLOQ. Titers were expressed in terms of 1/dilution.</description>
        <time_frame>Before vaccination, and 2 weeks and 1, 2, 3, and 6 months after vaccination</time_frame>
        <population>EIP: participants who were eligible, received all RSV vaccine or placebo to which they were randomized, had blood drawn for assay testing within 27 to 42 days after Visit 1, had at least 1 valid and determinate assay result at 1-month-postvaccination visit and no major protocol violations. Here, &quot;number analyzed&quot; signifies participants evaluable at specific rows.</population>
        <group_list>
          <group group_id="O1">
            <title>Sentinel Cohort: RSV Vaccine 60 mcg Age 50-85 Years</title>
            <description>Participants aged 50-85 years received single 60-mcg dose of RSV vaccine, intramuscularly. Participants were followed up to 12 months after vaccination.</description>
          </group>
          <group group_id="O2">
            <title>Sentinel Cohort: RSV 60 mcg With Aluminum Hydroxide Age 50-85 Years</title>
            <description>Participants aged 50-85 years received single 60-mcg dose with aluminum hydroxide intramuscularly. Participants were followed up to 12 months after vaccination.</description>
          </group>
          <group group_id="O3">
            <title>Sentinel Cohort: RSV 120 mcg Age 50-85 Years</title>
            <description>Participants aged 50-85 years received single 120-mcg dose intramuscularly. Participants were followed up to 12 months after vaccination.</description>
          </group>
          <group group_id="O4">
            <title>Sentinel Cohort: RSV 120 mcg With Aluminum Hydroxide Age 50-85 Years</title>
            <description>Participants aged 50-85 years received single 120-mcg dose with aluminum hydroxide intramuscularly. Participants were followed up to 12 months after vaccination.</description>
          </group>
          <group group_id="O5">
            <title>Sentinel Cohort: RSV 240 mcg Age 50-85 Years</title>
            <description>Participants aged 50-85 years received single 240-mcg dose intramuscularly. Participants were followed up to 12 months after vaccination.</description>
          </group>
          <group group_id="O6">
            <title>Sentinel Cohort: RSV 240 mcg With Aluminum Hydroxide Age 50-85 Years</title>
            <description>Participants aged 50-85 years received single 240-mcg dose with aluminum hydroxide intramuscularly. Participants were followed up to 12 months after vaccination.</description>
          </group>
          <group group_id="O7">
            <title>Sentinel Cohort: Placebo Age 50-85 Years</title>
            <description>Participants aged 50-85 years received placebo matched to RSV vaccine intramuscularly. Participants were followed up to 12 months after vaccination.</description>
          </group>
        </group_list>
        <measure>
          <title>Sentinel Cohort: GMTs of RSV A and RSV B Antigens Following Vaccination in Participants (Aged 50 to 85 Years)</title>
          <description>GMTs of RSV A and RSV B antigens were measured using neutralizing assay. The neutralizing titer LLOQ values were: A = 50 and B = 70. Assay results below the LLOQ were set to 0.5*LLOQ. Titers were expressed in terms of 1/dilution.</description>
          <population>EIP: participants who were eligible, received all RSV vaccine or placebo to which they were randomized, had blood drawn for assay testing within 27 to 42 days after Visit 1, had at least 1 valid and determinate assay result at 1-month-postvaccination visit and no major protocol violations. Here, &quot;number analyzed&quot; signifies participants evaluable at specific rows.</population>
          <units>Titers</units>
          <param>Geometric Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="12"/>
                <count group_id="O3" value="12"/>
                <count group_id="O4" value="12"/>
                <count group_id="O5" value="12"/>
                <count group_id="O6" value="12"/>
                <count group_id="O7" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>RSV A: before vaccination 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="12"/>
                    <count group_id="O2" value="12"/>
                    <count group_id="O3" value="12"/>
                    <count group_id="O4" value="12"/>
                    <count group_id="O5" value="12"/>
                    <count group_id="O6" value="12"/>
                    <count group_id="O7" value="11"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1904" lower_limit="1278.7" upper_limit="2834.4"/>
                    <measurement group_id="O2" value="1672" lower_limit="1040.7" upper_limit="2686.7"/>
                    <measurement group_id="O3" value="2056" lower_limit="1331.2" upper_limit="3173.9"/>
                    <measurement group_id="O4" value="1923" lower_limit="1005.6" upper_limit="3678.3"/>
                    <measurement group_id="O5" value="1923" lower_limit="1336.2" upper_limit="2766.2"/>
                    <measurement group_id="O6" value="1564" lower_limit="937.6" upper_limit="2607.5"/>
                    <measurement group_id="O7" value="2359" lower_limit="1410.7" upper_limit="3943.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV A: 2 Weeks after vaccination 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="12"/>
                    <count group_id="O2" value="12"/>
                    <count group_id="O3" value="12"/>
                    <count group_id="O4" value="12"/>
                    <count group_id="O5" value="12"/>
                    <count group_id="O6" value="12"/>
                    <count group_id="O7" value="11"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17464" lower_limit="8895.2" upper_limit="34285.4"/>
                    <measurement group_id="O2" value="22594" lower_limit="11704.0" upper_limit="43617.7"/>
                    <measurement group_id="O3" value="31946" lower_limit="20617.5" upper_limit="49500.7"/>
                    <measurement group_id="O4" value="30618" lower_limit="19555.9" upper_limit="47936.7"/>
                    <measurement group_id="O5" value="29812" lower_limit="19802.0" upper_limit="44882.0"/>
                    <measurement group_id="O6" value="40272" lower_limit="21945.3" upper_limit="73902.5"/>
                    <measurement group_id="O7" value="2233" lower_limit="1688.2" upper_limit="2953.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV A: 1 Month after vaccination 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="12"/>
                    <count group_id="O2" value="12"/>
                    <count group_id="O3" value="12"/>
                    <count group_id="O4" value="12"/>
                    <count group_id="O5" value="12"/>
                    <count group_id="O6" value="12"/>
                    <count group_id="O7" value="11"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21116" lower_limit="10249.1" upper_limit="43505.0"/>
                    <measurement group_id="O2" value="21788" lower_limit="13645.3" upper_limit="34789.6"/>
                    <measurement group_id="O3" value="23161" lower_limit="13893.6" upper_limit="38609.1"/>
                    <measurement group_id="O4" value="20499" lower_limit="14652.3" upper_limit="28677.5"/>
                    <measurement group_id="O5" value="24481" lower_limit="14704.5" upper_limit="40757.9"/>
                    <measurement group_id="O6" value="36197" lower_limit="23048.4" upper_limit="56845.6"/>
                    <measurement group_id="O7" value="2675" lower_limit="1318.3" upper_limit="5428.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV A: 2 Months after vaccination 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="12"/>
                    <count group_id="O2" value="12"/>
                    <count group_id="O3" value="12"/>
                    <count group_id="O4" value="11"/>
                    <count group_id="O5" value="12"/>
                    <count group_id="O6" value="12"/>
                    <count group_id="O7" value="11"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15025" lower_limit="7591.1" upper_limit="29738.7"/>
                    <measurement group_id="O2" value="10949" lower_limit="6413.2" upper_limit="18694.3"/>
                    <measurement group_id="O3" value="16441" lower_limit="10140.5" upper_limit="26656.3"/>
                    <measurement group_id="O4" value="10493" lower_limit="6930.9" upper_limit="15884.4"/>
                    <measurement group_id="O5" value="12659" lower_limit="8728.3" upper_limit="18358.5"/>
                    <measurement group_id="O6" value="13723" lower_limit="6897.6" upper_limit="27300.9"/>
                    <measurement group_id="O7" value="1502" lower_limit="1051.7" upper_limit="2143.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV A:3 Months after vaccination 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="12"/>
                    <count group_id="O2" value="12"/>
                    <count group_id="O3" value="12"/>
                    <count group_id="O4" value="11"/>
                    <count group_id="O5" value="12"/>
                    <count group_id="O6" value="11"/>
                    <count group_id="O7" value="11"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9792" lower_limit="5705.9" upper_limit="16804.9"/>
                    <measurement group_id="O2" value="12202" lower_limit="8157.6" upper_limit="18250.8"/>
                    <measurement group_id="O3" value="11476" lower_limit="6917.1" upper_limit="19038.6"/>
                    <measurement group_id="O4" value="11561" lower_limit="6851.2" upper_limit="19508.3"/>
                    <measurement group_id="O5" value="11195" lower_limit="7550.0" upper_limit="16599.6"/>
                    <measurement group_id="O6" value="12747" lower_limit="5865.4" upper_limit="27701.7"/>
                    <measurement group_id="O7" value="1543" lower_limit="1045.0" upper_limit="2276.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV A:6 Months after vaccination 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="11"/>
                    <count group_id="O2" value="12"/>
                    <count group_id="O3" value="12"/>
                    <count group_id="O4" value="11"/>
                    <count group_id="O5" value="12"/>
                    <count group_id="O6" value="11"/>
                    <count group_id="O7" value="11"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12290" lower_limit="6656.1" upper_limit="22693.9"/>
                    <measurement group_id="O2" value="10213" lower_limit="6473.8" upper_limit="16111.2"/>
                    <measurement group_id="O3" value="12795" lower_limit="8778.0" upper_limit="18649.5"/>
                    <measurement group_id="O4" value="12172" lower_limit="6876.4" upper_limit="21545.6"/>
                    <measurement group_id="O5" value="7083" lower_limit="4674.4" upper_limit="10732.7"/>
                    <measurement group_id="O6" value="9417" lower_limit="5251.7" upper_limit="16885.6"/>
                    <measurement group_id="O7" value="1945" lower_limit="1081.1" upper_limit="3498.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV A: 12 Months after vaccination 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="11"/>
                    <count group_id="O2" value="12"/>
                    <count group_id="O3" value="11"/>
                    <count group_id="O4" value="11"/>
                    <count group_id="O5" value="12"/>
                    <count group_id="O6" value="10"/>
                    <count group_id="O7" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9446" lower_limit="5677.6" upper_limit="15715.0"/>
                    <measurement group_id="O2" value="7507" lower_limit="4093.7" upper_limit="13766.5"/>
                    <measurement group_id="O3" value="8484" lower_limit="5809.9" upper_limit="12390.3"/>
                    <measurement group_id="O4" value="10709" lower_limit="6444.0" upper_limit="17798.1"/>
                    <measurement group_id="O5" value="2705" lower_limit="644.6" upper_limit="11353.2"/>
                    <measurement group_id="O6" value="4145" lower_limit="1867.0" upper_limit="9204.4"/>
                    <measurement group_id="O7" value="2341" lower_limit="1216.8" upper_limit="4502.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV B: before vaccination 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="12"/>
                    <count group_id="O2" value="12"/>
                    <count group_id="O3" value="12"/>
                    <count group_id="O4" value="12"/>
                    <count group_id="O5" value="12"/>
                    <count group_id="O6" value="12"/>
                    <count group_id="O7" value="11"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2573" lower_limit="1589.0" upper_limit="4166.1"/>
                    <measurement group_id="O2" value="1139" lower_limit="693.5" upper_limit="1871.0"/>
                    <measurement group_id="O3" value="1190" lower_limit="670.8" upper_limit="2111.9"/>
                    <measurement group_id="O4" value="1568" lower_limit="755.8" upper_limit="3254.9"/>
                    <measurement group_id="O5" value="2144" lower_limit="1317.6" upper_limit="3490.2"/>
                    <measurement group_id="O6" value="1417" lower_limit="872.5" upper_limit="2301.3"/>
                    <measurement group_id="O7" value="2285" lower_limit="1440.4" upper_limit="3624.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV B: 2 Weeks after vaccination 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="12"/>
                    <count group_id="O2" value="12"/>
                    <count group_id="O3" value="12"/>
                    <count group_id="O4" value="12"/>
                    <count group_id="O5" value="12"/>
                    <count group_id="O6" value="12"/>
                    <count group_id="O7" value="11"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27923" lower_limit="14883.3" upper_limit="52385.8"/>
                    <measurement group_id="O2" value="19751" lower_limit="10180.1" upper_limit="38319.0"/>
                    <measurement group_id="O3" value="25820" lower_limit="11849.7" upper_limit="56262.2"/>
                    <measurement group_id="O4" value="33779" lower_limit="19683.4" upper_limit="57969.0"/>
                    <measurement group_id="O5" value="47514" lower_limit="26993.7" upper_limit="83633.1"/>
                    <measurement group_id="O6" value="41776" lower_limit="20962.6" upper_limit="83256.1"/>
                    <measurement group_id="O7" value="2441" lower_limit="1741.5" upper_limit="3421.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV B: 1 Month after vaccination 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="12"/>
                    <count group_id="O2" value="12"/>
                    <count group_id="O3" value="12"/>
                    <count group_id="O4" value="12"/>
                    <count group_id="O5" value="12"/>
                    <count group_id="O6" value="12"/>
                    <count group_id="O7" value="11"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27789" lower_limit="14463.8" upper_limit="53392.0"/>
                    <measurement group_id="O2" value="21429" lower_limit="10960.1" upper_limit="41899.2"/>
                    <measurement group_id="O3" value="16610" lower_limit="7522.2" upper_limit="36678.1"/>
                    <measurement group_id="O4" value="19632" lower_limit="13014.2" upper_limit="29615.5"/>
                    <measurement group_id="O5" value="32668" lower_limit="18110.7" upper_limit="58926.6"/>
                    <measurement group_id="O6" value="37852" lower_limit="22637.3" upper_limit="63291.6"/>
                    <measurement group_id="O7" value="3104" lower_limit="1630.2" upper_limit="5908.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV B: 2 Months after vaccination 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="12"/>
                    <count group_id="O2" value="12"/>
                    <count group_id="O3" value="12"/>
                    <count group_id="O4" value="11"/>
                    <count group_id="O5" value="12"/>
                    <count group_id="O6" value="12"/>
                    <count group_id="O7" value="11"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19061" lower_limit="9784.0" upper_limit="37133.0"/>
                    <measurement group_id="O2" value="10713" lower_limit="5704.5" upper_limit="20118.3"/>
                    <measurement group_id="O3" value="11284" lower_limit="5285.1" upper_limit="24091.8"/>
                    <measurement group_id="O4" value="9247" lower_limit="5754.6" upper_limit="14860.4"/>
                    <measurement group_id="O5" value="15567" lower_limit="9281.5" upper_limit="26110.1"/>
                    <measurement group_id="O6" value="12441" lower_limit="7391.4" upper_limit="20941.9"/>
                    <measurement group_id="O7" value="1461" lower_limit="995.6" upper_limit="2143.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV B: 3 Months after vaccination 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="12"/>
                    <count group_id="O2" value="12"/>
                    <count group_id="O3" value="12"/>
                    <count group_id="O4" value="11"/>
                    <count group_id="O5" value="12"/>
                    <count group_id="O6" value="11"/>
                    <count group_id="O7" value="11"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12225" lower_limit="5963.9" upper_limit="25058.3"/>
                    <measurement group_id="O2" value="10364" lower_limit="5186.7" upper_limit="20708.8"/>
                    <measurement group_id="O3" value="7190" lower_limit="3217.8" upper_limit="16066.1"/>
                    <measurement group_id="O4" value="11138" lower_limit="6751.8" upper_limit="18373.7"/>
                    <measurement group_id="O5" value="12998" lower_limit="7277.3" upper_limit="23215.1"/>
                    <measurement group_id="O6" value="11726" lower_limit="6130.9" upper_limit="22427.1"/>
                    <measurement group_id="O7" value="1436" lower_limit="938.4" upper_limit="2196.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV B: 6 Months after vaccination 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="11"/>
                    <count group_id="O2" value="12"/>
                    <count group_id="O3" value="12"/>
                    <count group_id="O4" value="11"/>
                    <count group_id="O5" value="12"/>
                    <count group_id="O6" value="11"/>
                    <count group_id="O7" value="11"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16998" lower_limit="7585.9" upper_limit="38087.5"/>
                    <measurement group_id="O2" value="11281" lower_limit="6198.0" upper_limit="20531.5"/>
                    <measurement group_id="O3" value="8636" lower_limit="4397.3" upper_limit="16960.1"/>
                    <measurement group_id="O4" value="12541" lower_limit="6303.2" upper_limit="24951.9"/>
                    <measurement group_id="O5" value="6949" lower_limit="4175.8" upper_limit="11565.2"/>
                    <measurement group_id="O6" value="8066" lower_limit="4681.5" upper_limit="13896.6"/>
                    <measurement group_id="O7" value="1920" lower_limit="1307.0" upper_limit="2821.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV B: 12 Months after vaccination 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="11"/>
                    <count group_id="O2" value="12"/>
                    <count group_id="O3" value="11"/>
                    <count group_id="O4" value="11"/>
                    <count group_id="O5" value="12"/>
                    <count group_id="O6" value="10"/>
                    <count group_id="O7" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9721" lower_limit="4894.4" upper_limit="19308.4"/>
                    <measurement group_id="O2" value="5801" lower_limit="3688.7" upper_limit="9122.8"/>
                    <measurement group_id="O3" value="6174" lower_limit="3406.1" upper_limit="11192.6"/>
                    <measurement group_id="O4" value="8589" lower_limit="4898.5" upper_limit="15059.1"/>
                    <measurement group_id="O5" value="3230" lower_limit="765.7" upper_limit="13626.8"/>
                    <measurement group_id="O6" value="2918" lower_limit="855.6" upper_limit="9948.1"/>
                    <measurement group_id="O7" value="2188" lower_limit="1398.7" upper_limit="3423.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Expanded Cohort: GMTs of RSV A and RSV B Antigens Following Vaccination in Participants (Aged 18 to 49 Years)</title>
        <description>GMTs of RSV A and RSV B antigens were measured using neutralizing assay. The neutralizing titer LLOQ values were: A = 50 and B = 70. Assay results below the LLOQ were set to 0.5*LLOQ. Titers were expressed in terms of 1/dilution.</description>
        <time_frame>Before vaccination,1, 2, 3, and 6 months after vaccination</time_frame>
        <population>EIP: participants who were eligible, received all RSV vaccine or placebo to which they were randomized, had blood drawn for assay testing within 27 to 42 days after Visit 1, had at least 1 valid and determinate assay result at 1-month-postvaccination visit and no major protocol violations. Here, &quot;number analyzed&quot; signifies participants evaluable at specific rows.</population>
        <group_list>
          <group group_id="O1">
            <title>Expanded Cohort: RSV 60 mcg With SIIV Age 18-49 Years</title>
            <description>Participants aged 18-49 years received 2 doses of RSV vaccine 60 mcg along with 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O2">
            <title>Expanded Cohort: RSV 60 mcg With Placebo Age 18-49 Years</title>
            <description>Participants aged 18-49 years received 2 doses of RSV vaccine 60 mcg along with placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O3">
            <title>Expanded Cohort: RSV 60 mcg With Aluminum Hydroxide and SIIV Age 18-49 Years</title>
            <description>Participants aged 18-49 years received 2 doses of RSV vaccine 60 mcg along with aluminum hydroxide and 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O4">
            <title>Expanded Cohort: RSV 60 mcg With Aluminum Hydroxide and Placebo Age 18-49 Years</title>
            <description>Participants aged 18-49 years received 2 doses of RSV vaccine 60 mcg along with aluminum hydroxide and placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O5">
            <title>Expanded Cohort: RSV 120 mcg With SIIV Age 18-49 Years</title>
            <description>Participants aged 18-49 years received 2 doses of RSV vaccine 120 mcg along with 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O6">
            <title>Expanded Cohort: RSV 120 mcg With Placebo Age 18-49 Years</title>
            <description>Participants aged 18-49 years received 2 doses of RSV vaccine 120 mcg along with placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O7">
            <title>Expanded Cohort: RSV 120 mcg With Aluminum Hydroxide and SIIV Age 18-49 Years</title>
            <description>Participants aged 18-49 years received 2 doses of RSV vaccine 120 mcg along with aluminum hydroxide and 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O8">
            <title>Expanded Cohort: RSV 120 mcg With Aluminum Hydroxide and Placebo Age 18-49 Years</title>
            <description>Participants aged 18-49 years received 2 doses of RSV vaccine 120 mcg along with aluminum hydroxide and placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O9">
            <title>Expanded Cohort: RSV 240 mcg With SIIV Age 18-49 Years</title>
            <description>Participants aged 18-49 years received 2 doses of RSV vaccine 240 mcg along with 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O10">
            <title>Expanded Cohort: RSV 240 mcg With Placebo Age 18-49 Years</title>
            <description>Participants aged 18-49 years received 2 doses of RSV vaccine 240 mcg along with placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O11">
            <title>Expanded Cohort: RSV 240 mcg With Aluminum Hydroxide and SIIV Age 18-49 Years</title>
            <description>Participants aged 18-49 years received 2 doses of RSV vaccine 240 mcg along with aluminum hydroxide and 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O12">
            <title>Expanded Cohort: RSV 240 mcg With Aluminum Hydroxide and Placebo Age 18-49 Years</title>
            <description>Participants aged 18-49 years received 2 doses of RSV vaccine 240 mcg along with aluminum hydroxide and placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O13">
            <title>Expanded Cohort: Placebo Age 18-49 Years</title>
            <description>Participants aged 18-49 years received placebo matched to RSV vaccine intramuscularly. Participants were followed up to 12 months after vaccination.</description>
          </group>
        </group_list>
        <measure>
          <title>Expanded Cohort: GMTs of RSV A and RSV B Antigens Following Vaccination in Participants (Aged 18 to 49 Years)</title>
          <description>GMTs of RSV A and RSV B antigens were measured using neutralizing assay. The neutralizing titer LLOQ values were: A = 50 and B = 70. Assay results below the LLOQ were set to 0.5*LLOQ. Titers were expressed in terms of 1/dilution.</description>
          <population>EIP: participants who were eligible, received all RSV vaccine or placebo to which they were randomized, had blood drawn for assay testing within 27 to 42 days after Visit 1, had at least 1 valid and determinate assay result at 1-month-postvaccination visit and no major protocol violations. Here, &quot;number analyzed&quot; signifies participants evaluable at specific rows.</population>
          <units>Titers</units>
          <param>Geometric Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="39"/>
                <count group_id="O2" value="39"/>
                <count group_id="O3" value="40"/>
                <count group_id="O4" value="38"/>
                <count group_id="O5" value="40"/>
                <count group_id="O6" value="40"/>
                <count group_id="O7" value="39"/>
                <count group_id="O8" value="38"/>
                <count group_id="O9" value="40"/>
                <count group_id="O10" value="39"/>
                <count group_id="O11" value="41"/>
                <count group_id="O12" value="40"/>
                <count group_id="O13" value="41"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>RSV A: before vaccination 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="39"/>
                    <count group_id="O3" value="40"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="40"/>
                    <count group_id="O6" value="40"/>
                    <count group_id="O7" value="39"/>
                    <count group_id="O8" value="38"/>
                    <count group_id="O9" value="40"/>
                    <count group_id="O10" value="39"/>
                    <count group_id="O11" value="41"/>
                    <count group_id="O12" value="40"/>
                    <count group_id="O13" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1998" lower_limit="1544.9" upper_limit="2583.6"/>
                    <measurement group_id="O2" value="1471" lower_limit="1136.8" upper_limit="1904.1"/>
                    <measurement group_id="O3" value="1518" lower_limit="1124.2" upper_limit="2049.1"/>
                    <measurement group_id="O4" value="1768" lower_limit="1355.5" upper_limit="2305.0"/>
                    <measurement group_id="O5" value="1297" lower_limit="995.4" upper_limit="1689.3"/>
                    <measurement group_id="O6" value="1713" lower_limit="1288.9" upper_limit="2276.8"/>
                    <measurement group_id="O7" value="1862" lower_limit="1443.5" upper_limit="2402.8"/>
                    <measurement group_id="O8" value="1933" lower_limit="1531.1" upper_limit="2440.5"/>
                    <measurement group_id="O9" value="1733" lower_limit="1352.7" upper_limit="2220.3"/>
                    <measurement group_id="O10" value="1640" lower_limit="1175.5" upper_limit="2289.3"/>
                    <measurement group_id="O11" value="1522" lower_limit="1162.6" upper_limit="1991.9"/>
                    <measurement group_id="O12" value="1625" lower_limit="1209.9" upper_limit="2183.4"/>
                    <measurement group_id="O13" value="1750" lower_limit="1398.4" upper_limit="2190.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV A: 1 Month after vaccination 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="39"/>
                    <count group_id="O3" value="40"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="40"/>
                    <count group_id="O6" value="40"/>
                    <count group_id="O7" value="39"/>
                    <count group_id="O8" value="38"/>
                    <count group_id="O9" value="40"/>
                    <count group_id="O10" value="39"/>
                    <count group_id="O11" value="41"/>
                    <count group_id="O12" value="40"/>
                    <count group_id="O13" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17482" lower_limit="13630.9" upper_limit="22420.4"/>
                    <measurement group_id="O2" value="21728" lower_limit="17712.2" upper_limit="26655.0"/>
                    <measurement group_id="O3" value="17460" lower_limit="12975.9" upper_limit="23494.5"/>
                    <measurement group_id="O4" value="18064" lower_limit="13868.8" upper_limit="23527.5"/>
                    <measurement group_id="O5" value="17760" lower_limit="13990.9" upper_limit="22544.3"/>
                    <measurement group_id="O6" value="22628" lower_limit="17718.2" upper_limit="28899.1"/>
                    <measurement group_id="O7" value="26465" lower_limit="20604.2" upper_limit="33993.1"/>
                    <measurement group_id="O8" value="25860" lower_limit="18817.4" upper_limit="35539.3"/>
                    <measurement group_id="O9" value="23783" lower_limit="18268.5" upper_limit="30962.6"/>
                    <measurement group_id="O10" value="29332" lower_limit="24173.0" upper_limit="35591.1"/>
                    <measurement group_id="O11" value="21196" lower_limit="15702.1" upper_limit="28611.6"/>
                    <measurement group_id="O12" value="26938" lower_limit="20516.3" upper_limit="35369.1"/>
                    <measurement group_id="O13" value="1883" lower_limit="1465.0" upper_limit="2419.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV A: 2 Months after vaccination 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="38"/>
                    <count group_id="O3" value="39"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="39"/>
                    <count group_id="O6" value="39"/>
                    <count group_id="O7" value="39"/>
                    <count group_id="O8" value="35"/>
                    <count group_id="O9" value="40"/>
                    <count group_id="O10" value="39"/>
                    <count group_id="O11" value="39"/>
                    <count group_id="O12" value="38"/>
                    <count group_id="O13" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10247" lower_limit="8239.7" upper_limit="12743.8"/>
                    <measurement group_id="O2" value="11976" lower_limit="9521.6" upper_limit="15064.2"/>
                    <measurement group_id="O3" value="10326" lower_limit="7936.9" upper_limit="13433.2"/>
                    <measurement group_id="O4" value="12522" lower_limit="9469.3" upper_limit="16557.6"/>
                    <measurement group_id="O5" value="9595" lower_limit="7224.8" upper_limit="12743.7"/>
                    <measurement group_id="O6" value="14140" lower_limit="11050.3" upper_limit="18093.4"/>
                    <measurement group_id="O7" value="15754" lower_limit="11605.8" upper_limit="21383.9"/>
                    <measurement group_id="O8" value="13518" lower_limit="10423.6" upper_limit="17530.1"/>
                    <measurement group_id="O9" value="13790" lower_limit="10401.4" upper_limit="18281.4"/>
                    <measurement group_id="O10" value="14999" lower_limit="11660.3" upper_limit="19294.4"/>
                    <measurement group_id="O11" value="11533" lower_limit="8867.3" upper_limit="14999.7"/>
                    <measurement group_id="O12" value="12812" lower_limit="9507.1" upper_limit="17265.5"/>
                    <measurement group_id="O13" value="1252" lower_limit="988.9" upper_limit="1584.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV A:3 Months after vaccination 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="37"/>
                    <count group_id="O2" value="38"/>
                    <count group_id="O3" value="39"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="38"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="39"/>
                    <count group_id="O8" value="35"/>
                    <count group_id="O9" value="40"/>
                    <count group_id="O10" value="39"/>
                    <count group_id="O11" value="40"/>
                    <count group_id="O12" value="38"/>
                    <count group_id="O13" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11164" lower_limit="8453.8" upper_limit="14743.3"/>
                    <measurement group_id="O2" value="12664" lower_limit="10280.1" upper_limit="15600.9"/>
                    <measurement group_id="O3" value="12042" lower_limit="9262.7" upper_limit="15655.6"/>
                    <measurement group_id="O4" value="12773" lower_limit="9651.2" upper_limit="16903.6"/>
                    <measurement group_id="O5" value="9205" lower_limit="7081.5" upper_limit="11965.6"/>
                    <measurement group_id="O6" value="13801" lower_limit="10058.5" upper_limit="18934.9"/>
                    <measurement group_id="O7" value="15360" lower_limit="11695.6" upper_limit="20172.0"/>
                    <measurement group_id="O8" value="13663" lower_limit="10498.8" upper_limit="17779.9"/>
                    <measurement group_id="O9" value="11805" lower_limit="9135.4" upper_limit="15255.7"/>
                    <measurement group_id="O10" value="14570" lower_limit="11447.8" upper_limit="18544.3"/>
                    <measurement group_id="O11" value="12273" lower_limit="9077.2" upper_limit="16595.1"/>
                    <measurement group_id="O12" value="10764" lower_limit="7824.2" upper_limit="14807.5"/>
                    <measurement group_id="O13" value="1718" lower_limit="1389.8" upper_limit="2123.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV A:6 Months after vaccination 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="37"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="40"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="38"/>
                    <count group_id="O6" value="39"/>
                    <count group_id="O7" value="38"/>
                    <count group_id="O8" value="35"/>
                    <count group_id="O9" value="38"/>
                    <count group_id="O10" value="38"/>
                    <count group_id="O11" value="40"/>
                    <count group_id="O12" value="36"/>
                    <count group_id="O13" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8403" lower_limit="6386.5" upper_limit="11056.6"/>
                    <measurement group_id="O2" value="8118" lower_limit="6048.2" upper_limit="10896.6"/>
                    <measurement group_id="O3" value="9568" lower_limit="7416.5" upper_limit="12343.6"/>
                    <measurement group_id="O4" value="9533" lower_limit="7128.0" upper_limit="12748.9"/>
                    <measurement group_id="O5" value="6492" lower_limit="4911.2" upper_limit="8580.7"/>
                    <measurement group_id="O6" value="10324" lower_limit="7545.2" upper_limit="14125.7"/>
                    <measurement group_id="O7" value="10005" lower_limit="7832.8" upper_limit="12780.0"/>
                    <measurement group_id="O8" value="10237" lower_limit="7792.7" upper_limit="13447.1"/>
                    <measurement group_id="O9" value="7768" lower_limit="5960.2" upper_limit="10123.8"/>
                    <measurement group_id="O10" value="10343" lower_limit="7596.7" upper_limit="14082.5"/>
                    <measurement group_id="O11" value="8823" lower_limit="6401.5" upper_limit="12160.3"/>
                    <measurement group_id="O12" value="8210" lower_limit="5890.4" upper_limit="11443.8"/>
                    <measurement group_id="O13" value="2031" lower_limit="1613.7" upper_limit="2556.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV A: 12 Months after vaccination 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="34"/>
                    <count group_id="O2" value="36"/>
                    <count group_id="O3" value="37"/>
                    <count group_id="O4" value="33"/>
                    <count group_id="O5" value="36"/>
                    <count group_id="O6" value="36"/>
                    <count group_id="O7" value="33"/>
                    <count group_id="O8" value="33"/>
                    <count group_id="O9" value="37"/>
                    <count group_id="O10" value="36"/>
                    <count group_id="O11" value="33"/>
                    <count group_id="O12" value="31"/>
                    <count group_id="O13" value="32"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7679" lower_limit="5830.0" upper_limit="10114.5"/>
                    <measurement group_id="O2" value="7050" lower_limit="4686.3" upper_limit="10605.3"/>
                    <measurement group_id="O3" value="7640" lower_limit="6033.3" upper_limit="9673.4"/>
                    <measurement group_id="O4" value="9062" lower_limit="6616.6" upper_limit="12411.7"/>
                    <measurement group_id="O5" value="4889" lower_limit="3243.0" upper_limit="7370.6"/>
                    <measurement group_id="O6" value="8435" lower_limit="5784.9" upper_limit="12300.3"/>
                    <measurement group_id="O7" value="9174" lower_limit="6766.8" upper_limit="12438.6"/>
                    <measurement group_id="O8" value="8231" lower_limit="6167.4" upper_limit="10986.4"/>
                    <measurement group_id="O9" value="6919" lower_limit="4936.1" upper_limit="9698.5"/>
                    <measurement group_id="O10" value="6983" lower_limit="5099.0" upper_limit="9562.3"/>
                    <measurement group_id="O11" value="6769" lower_limit="4811.0" upper_limit="9522.9"/>
                    <measurement group_id="O12" value="5658" lower_limit="3602.1" upper_limit="8888.6"/>
                    <measurement group_id="O13" value="1994" lower_limit="1445.8" upper_limit="2751.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV B: before vaccination 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="39"/>
                    <count group_id="O3" value="40"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="40"/>
                    <count group_id="O6" value="40"/>
                    <count group_id="O7" value="39"/>
                    <count group_id="O8" value="38"/>
                    <count group_id="O9" value="40"/>
                    <count group_id="O10" value="39"/>
                    <count group_id="O11" value="41"/>
                    <count group_id="O12" value="40"/>
                    <count group_id="O13" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1847" lower_limit="1415.4" upper_limit="2410.9"/>
                    <measurement group_id="O2" value="1475" lower_limit="1117.0" upper_limit="1949.1"/>
                    <measurement group_id="O3" value="1516" lower_limit="1120.5" upper_limit="2050.8"/>
                    <measurement group_id="O4" value="1586" lower_limit="1182.6" upper_limit="2127.6"/>
                    <measurement group_id="O5" value="1460" lower_limit="1131.3" upper_limit="1884.3"/>
                    <measurement group_id="O6" value="1502" lower_limit="1123.0" upper_limit="2010.2"/>
                    <measurement group_id="O7" value="1739" lower_limit="1396.0" upper_limit="2166.4"/>
                    <measurement group_id="O8" value="1733" lower_limit="1334.2" upper_limit="2251.6"/>
                    <measurement group_id="O9" value="1480" lower_limit="1123.8" upper_limit="1949.5"/>
                    <measurement group_id="O10" value="1520" lower_limit="1116.7" upper_limit="2067.9"/>
                    <measurement group_id="O11" value="1363" lower_limit="1029.7" upper_limit="1803.0"/>
                    <measurement group_id="O12" value="1584" lower_limit="1147.9" upper_limit="2185.8"/>
                    <measurement group_id="O13" value="1783" lower_limit="1371.8" upper_limit="2316.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV B: 1 Month after vaccination 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="39"/>
                    <count group_id="O3" value="40"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="40"/>
                    <count group_id="O6" value="40"/>
                    <count group_id="O7" value="39"/>
                    <count group_id="O8" value="38"/>
                    <count group_id="O9" value="40"/>
                    <count group_id="O10" value="39"/>
                    <count group_id="O11" value="41"/>
                    <count group_id="O12" value="40"/>
                    <count group_id="O13" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17583" lower_limit="13214.1" upper_limit="23395.6"/>
                    <measurement group_id="O2" value="19561" lower_limit="15064.1" upper_limit="25399.1"/>
                    <measurement group_id="O3" value="18762" lower_limit="13685.5" upper_limit="25721.9"/>
                    <measurement group_id="O4" value="16835" lower_limit="12239.1" upper_limit="23157.8"/>
                    <measurement group_id="O5" value="18929" lower_limit="14318.0" upper_limit="25025.3"/>
                    <measurement group_id="O6" value="24395" lower_limit="18501.1" upper_limit="32165.3"/>
                    <measurement group_id="O7" value="23560" lower_limit="18937.0" upper_limit="29311.1"/>
                    <measurement group_id="O8" value="22928" lower_limit="16479.1" upper_limit="31901.0"/>
                    <measurement group_id="O9" value="23481" lower_limit="17190.7" upper_limit="32072.3"/>
                    <measurement group_id="O10" value="31571" lower_limit="25226.8" upper_limit="39511.5"/>
                    <measurement group_id="O11" value="21150" lower_limit="15284.8" upper_limit="29265.8"/>
                    <measurement group_id="O12" value="28166" lower_limit="21107.4" upper_limit="37585.2"/>
                    <measurement group_id="O13" value="1748" lower_limit="1329.6" upper_limit="2299.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV B: 2 Months after vaccination 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="38"/>
                    <count group_id="O3" value="39"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="39"/>
                    <count group_id="O6" value="39"/>
                    <count group_id="O7" value="39"/>
                    <count group_id="O8" value="35"/>
                    <count group_id="O9" value="40"/>
                    <count group_id="O10" value="39"/>
                    <count group_id="O11" value="39"/>
                    <count group_id="O12" value="38"/>
                    <count group_id="O13" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10259" lower_limit="8034.9" upper_limit="13099.5"/>
                    <measurement group_id="O2" value="11771" lower_limit="8638.2" upper_limit="16040.4"/>
                    <measurement group_id="O3" value="11441" lower_limit="8386.4" upper_limit="15607.7"/>
                    <measurement group_id="O4" value="11253" lower_limit="8111.2" upper_limit="15611.0"/>
                    <measurement group_id="O5" value="10486" lower_limit="7919.2" upper_limit="13884.8"/>
                    <measurement group_id="O6" value="14223" lower_limit="10536.4" upper_limit="19200.6"/>
                    <measurement group_id="O7" value="15173" lower_limit="11310.1" upper_limit="20356.1"/>
                    <measurement group_id="O8" value="11716" lower_limit="8515.6" upper_limit="16119.1"/>
                    <measurement group_id="O9" value="12850" lower_limit="9187.3" upper_limit="17972.3"/>
                    <measurement group_id="O10" value="16485" lower_limit="12365.4" upper_limit="21978.4"/>
                    <measurement group_id="O11" value="11148" lower_limit="8237.5" upper_limit="15087.2"/>
                    <measurement group_id="O12" value="14024" lower_limit="10061.6" upper_limit="19547.9"/>
                    <measurement group_id="O13" value="1447" lower_limit="1079.9" upper_limit="1939.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV B: 3 Months after vaccination 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="37"/>
                    <count group_id="O2" value="38"/>
                    <count group_id="O3" value="39"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="38"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="39"/>
                    <count group_id="O8" value="35"/>
                    <count group_id="O9" value="40"/>
                    <count group_id="O10" value="39"/>
                    <count group_id="O11" value="40"/>
                    <count group_id="O12" value="38"/>
                    <count group_id="O13" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11694" lower_limit="8668.6" upper_limit="15774.1"/>
                    <measurement group_id="O2" value="12016" lower_limit="9365.0" upper_limit="15416.8"/>
                    <measurement group_id="O3" value="12852" lower_limit="9598.1" upper_limit="17209.5"/>
                    <measurement group_id="O4" value="11719" lower_limit="8535.2" upper_limit="16091.6"/>
                    <measurement group_id="O5" value="9953" lower_limit="7528.7" upper_limit="13159.2"/>
                    <measurement group_id="O6" value="13011" lower_limit="9004.5" upper_limit="18800.0"/>
                    <measurement group_id="O7" value="13364" lower_limit="10482.3" upper_limit="17038.8"/>
                    <measurement group_id="O8" value="11333" lower_limit="8551.7" upper_limit="15018.5"/>
                    <measurement group_id="O9" value="10567" lower_limit="8130.7" upper_limit="13732.8"/>
                    <measurement group_id="O10" value="14638" lower_limit="11159.9" upper_limit="19200.0"/>
                    <measurement group_id="O11" value="10322" lower_limit="7548.2" upper_limit="14113.9"/>
                    <measurement group_id="O12" value="11146" lower_limit="7975.6" upper_limit="15576.6"/>
                    <measurement group_id="O13" value="1839" lower_limit="1439.5" upper_limit="2349.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV B: 6 Months after vaccination 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="37"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="40"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="38"/>
                    <count group_id="O6" value="39"/>
                    <count group_id="O7" value="38"/>
                    <count group_id="O8" value="35"/>
                    <count group_id="O9" value="38"/>
                    <count group_id="O10" value="38"/>
                    <count group_id="O11" value="40"/>
                    <count group_id="O12" value="36"/>
                    <count group_id="O13" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8102" lower_limit="6262.1" upper_limit="10481.3"/>
                    <measurement group_id="O2" value="8411" lower_limit="6558.5" upper_limit="10786.8"/>
                    <measurement group_id="O3" value="9954" lower_limit="7389.7" upper_limit="13407.1"/>
                    <measurement group_id="O4" value="8667" lower_limit="6315.1" upper_limit="11895.8"/>
                    <measurement group_id="O5" value="6640" lower_limit="5134.2" upper_limit="8586.8"/>
                    <measurement group_id="O6" value="9482" lower_limit="6798.6" upper_limit="13225.5"/>
                    <measurement group_id="O7" value="9702" lower_limit="7732.8" upper_limit="12172.6"/>
                    <measurement group_id="O8" value="8836" lower_limit="6541.4" upper_limit="11934.4"/>
                    <measurement group_id="O9" value="7244" lower_limit="5597.4" upper_limit="9374.1"/>
                    <measurement group_id="O10" value="11073" lower_limit="7984.1" upper_limit="15356.1"/>
                    <measurement group_id="O11" value="8235" lower_limit="5889.9" upper_limit="11513.3"/>
                    <measurement group_id="O12" value="8856" lower_limit="6341.0" upper_limit="12367.3"/>
                    <measurement group_id="O13" value="2171" lower_limit="1687.8" upper_limit="2792.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV B: 12 Months after vaccination 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="34"/>
                    <count group_id="O2" value="36"/>
                    <count group_id="O3" value="37"/>
                    <count group_id="O4" value="33"/>
                    <count group_id="O5" value="36"/>
                    <count group_id="O6" value="36"/>
                    <count group_id="O7" value="33"/>
                    <count group_id="O8" value="33"/>
                    <count group_id="O9" value="37"/>
                    <count group_id="O10" value="36"/>
                    <count group_id="O11" value="33"/>
                    <count group_id="O12" value="31"/>
                    <count group_id="O13" value="32"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7539" lower_limit="5917.8" upper_limit="9603.1"/>
                    <measurement group_id="O2" value="7413" lower_limit="5610.6" upper_limit="9795.7"/>
                    <measurement group_id="O3" value="7651" lower_limit="5627.3" upper_limit="10403.5"/>
                    <measurement group_id="O4" value="7629" lower_limit="5427.0" upper_limit="10723.6"/>
                    <measurement group_id="O5" value="5778" lower_limit="4201.0" upper_limit="7947.8"/>
                    <measurement group_id="O6" value="7747" lower_limit="5099.8" upper_limit="11767.6"/>
                    <measurement group_id="O7" value="8492" lower_limit="6382.7" upper_limit="11297.8"/>
                    <measurement group_id="O8" value="7177" lower_limit="5333.3" upper_limit="9658.8"/>
                    <measurement group_id="O9" value="6078" lower_limit="4465.2" upper_limit="8274.7"/>
                    <measurement group_id="O10" value="7086" lower_limit="5112.3" upper_limit="9820.9"/>
                    <measurement group_id="O11" value="6133" lower_limit="4215.6" upper_limit="8923.1"/>
                    <measurement group_id="O12" value="5494" lower_limit="3465.4" upper_limit="8710.7"/>
                    <measurement group_id="O13" value="2017" lower_limit="1503.9" upper_limit="2705.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Expanded Cohort: GMTs of RSV A and RSV B Antigens Following Vaccination in Participants (Aged 65 to 85 Years)</title>
        <description>GMTs of RSV A and RSV B antigens were measured using neutralizing assay. The neutralizing titer LLOQ values were: A = 50 and B = 70. Assay results below the LLOQ were set to 0.5*LLOQ. Titers were expressed in terms of 1/dilution.</description>
        <time_frame>Before vaccination,1, 2, 3, and 6 months after vaccination</time_frame>
        <population>EIP: participants who were eligible, received all RSV vaccine or placebo to which they were randomized, had blood drawn for assay testing within 27 to 42 days after Visit 1, had at least 1 valid and determinate assay result at 1-month-postvaccination visit and no major protocol violations. Here, &quot;number analyzed&quot; signifies participants evaluable at specific rows.</population>
        <group_list>
          <group group_id="O1">
            <title>Expanded Cohort: RSV 60 mcg With SIIV Age 65-85 Years</title>
            <description>Participants aged 65-85 years received 2 doses of RSV vaccine 60 mcg along with 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O2">
            <title>Expanded Cohort: RSV 60 mcg With Placebo Age 65-85 Years</title>
            <description>Participants aged 65-85 years received 2 doses of RSV vaccine 60 mcg along with placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O3">
            <title>Expanded Cohort: RSV 60 mcg With Aluminum Hydroxide and SIIV Age 65-85 Years</title>
            <description>Participants aged 65-85 years received 2 doses of RSV vaccine 60 mcg along with aluminum hydroxide and 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O4">
            <title>Expanded Cohort: RSV 60 mcg With Aluminum Hydroxide and Placebo Age 65-85 Years</title>
            <description>Participants aged 65-85 years received 2 doses of RSV vaccine 60 mcg along with aluminum hydroxide and placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O5">
            <title>Expanded Cohort: RSV 120 mcg With SIIV Age 65-85 Years</title>
            <description>Participants aged 65-85 years received 2 doses of RSV vaccine 120 mcg along with 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O6">
            <title>Expanded Cohort: RSV 120 mcg With Placebo Age 65-85 Years</title>
            <description>Participants aged 65-85 years received 2 doses of RSV vaccine 120 mcg along with placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O7">
            <title>Expanded Cohort: RSV 120 mcg With Aluminum Hydroxide and SIIV Age 65-85 Years</title>
            <description>Participants aged 65-85 years received 2 doses of RSV vaccine 120 mcg along with aluminum hydroxide and 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O8">
            <title>Expanded Cohort: RSV 120 mcg With Aluminum Hydroxide and Placebo Age 65-85 Years</title>
            <description>Participants aged 65-85 years received 2 doses of RSV vaccine 120 mcg along with aluminum hydroxide and placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O9">
            <title>Expanded Cohort: RSV 240 mcg With SIIV Age 65-85 Years</title>
            <description>Participants aged 65-85 years received 2 doses of RSV vaccine 240 mcg along with 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O10">
            <title>Expanded Cohort: RSV 240 mcg With Placebo Age 65-85 Years</title>
            <description>Participants aged 65-85 years received 2 doses of RSV vaccine 240 mcg along with placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O11">
            <title>Expanded Cohort: RSV 240 mcg With Aluminum Hydroxide and SIIV Age 65-85 Years</title>
            <description>Participants aged 65-85 years received 2 doses of RSV vaccine 240 mcg along with aluminum hydroxide and 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O12">
            <title>Expanded Cohort: RSV 240 mcg With Aluminum Hydroxide and Placebo Age 65-85 Years</title>
            <description>Participants aged 65-85 years received 2 doses of RSV vaccine 240 mcg along with aluminum hydroxide and placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O13">
            <title>Expanded Cohort: Placebo Age 65-85 Years</title>
            <description>Participants aged 65-85 years received placebo matched to RSV vaccine intramuscularly. Participants were followed up to 12 months after vaccination.</description>
          </group>
        </group_list>
        <measure>
          <title>Expanded Cohort: GMTs of RSV A and RSV B Antigens Following Vaccination in Participants (Aged 65 to 85 Years)</title>
          <description>GMTs of RSV A and RSV B antigens were measured using neutralizing assay. The neutralizing titer LLOQ values were: A = 50 and B = 70. Assay results below the LLOQ were set to 0.5*LLOQ. Titers were expressed in terms of 1/dilution.</description>
          <population>EIP: participants who were eligible, received all RSV vaccine or placebo to which they were randomized, had blood drawn for assay testing within 27 to 42 days after Visit 1, had at least 1 valid and determinate assay result at 1-month-postvaccination visit and no major protocol violations. Here, &quot;number analyzed&quot; signifies participants evaluable at specific rows.</population>
          <units>Titers</units>
          <param>Geometric Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="38"/>
                <count group_id="O2" value="40"/>
                <count group_id="O3" value="40"/>
                <count group_id="O4" value="40"/>
                <count group_id="O5" value="38"/>
                <count group_id="O6" value="40"/>
                <count group_id="O7" value="40"/>
                <count group_id="O8" value="40"/>
                <count group_id="O9" value="40"/>
                <count group_id="O10" value="38"/>
                <count group_id="O11" value="41"/>
                <count group_id="O12" value="43"/>
                <count group_id="O13" value="39"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>RSV A: before vaccination 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="40"/>
                    <count group_id="O3" value="40"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="38"/>
                    <count group_id="O6" value="40"/>
                    <count group_id="O7" value="40"/>
                    <count group_id="O8" value="40"/>
                    <count group_id="O9" value="40"/>
                    <count group_id="O10" value="38"/>
                    <count group_id="O11" value="41"/>
                    <count group_id="O12" value="43"/>
                    <count group_id="O13" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2129" lower_limit="1577.8" upper_limit="2872.8"/>
                    <measurement group_id="O2" value="2096" lower_limit="1518.6" upper_limit="2892.0"/>
                    <measurement group_id="O3" value="2064" lower_limit="1638.5" upper_limit="2598.9"/>
                    <measurement group_id="O4" value="2461" lower_limit="1856.2" upper_limit="3262.5"/>
                    <measurement group_id="O5" value="2269" lower_limit="1708.5" upper_limit="3013.4"/>
                    <measurement group_id="O6" value="2269" lower_limit="1802.6" upper_limit="2855.8"/>
                    <measurement group_id="O7" value="2578" lower_limit="1945.6" upper_limit="3416.6"/>
                    <measurement group_id="O8" value="2089" lower_limit="1535.1" upper_limit="2843.5"/>
                    <measurement group_id="O9" value="2203" lower_limit="1731.5" upper_limit="2802.0"/>
                    <measurement group_id="O10" value="1965" lower_limit="1539.1" upper_limit="2508.5"/>
                    <measurement group_id="O11" value="1793" lower_limit="1351.8" upper_limit="2378.8"/>
                    <measurement group_id="O12" value="2734" lower_limit="1963.5" upper_limit="3807.4"/>
                    <measurement group_id="O13" value="1585" lower_limit="1252.3" upper_limit="2005.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV A: 1 Month after vaccination 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="40"/>
                    <count group_id="O3" value="40"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="38"/>
                    <count group_id="O6" value="40"/>
                    <count group_id="O7" value="40"/>
                    <count group_id="O8" value="40"/>
                    <count group_id="O9" value="40"/>
                    <count group_id="O10" value="38"/>
                    <count group_id="O11" value="41"/>
                    <count group_id="O12" value="43"/>
                    <count group_id="O13" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16007" lower_limit="12504.7" upper_limit="20489.7"/>
                    <measurement group_id="O2" value="20417" lower_limit="14920.6" upper_limit="27937.5"/>
                    <measurement group_id="O3" value="14905" lower_limit="11631.7" upper_limit="19098.2"/>
                    <measurement group_id="O4" value="19625" lower_limit="14184.9" upper_limit="27151.3"/>
                    <measurement group_id="O5" value="25065" lower_limit="19629.1" upper_limit="32006.7"/>
                    <measurement group_id="O6" value="22318" lower_limit="15850.6" upper_limit="31425.6"/>
                    <measurement group_id="O7" value="23566" lower_limit="17457.3" upper_limit="31812.3"/>
                    <measurement group_id="O8" value="27600" lower_limit="21382.5" upper_limit="35624.6"/>
                    <measurement group_id="O9" value="22184" lower_limit="16026.2" upper_limit="30708.8"/>
                    <measurement group_id="O10" value="21601" lower_limit="16659.4" upper_limit="28007.6"/>
                    <measurement group_id="O11" value="23510" lower_limit="17822.0" upper_limit="31013.3"/>
                    <measurement group_id="O12" value="25815" lower_limit="19944.3" upper_limit="33412.8"/>
                    <measurement group_id="O13" value="1697" lower_limit="1250.6" upper_limit="2301.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV A: 2 Months after vaccination 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="40"/>
                    <count group_id="O3" value="40"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="38"/>
                    <count group_id="O6" value="40"/>
                    <count group_id="O7" value="39"/>
                    <count group_id="O8" value="40"/>
                    <count group_id="O9" value="40"/>
                    <count group_id="O10" value="38"/>
                    <count group_id="O11" value="41"/>
                    <count group_id="O12" value="43"/>
                    <count group_id="O13" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9452" lower_limit="7428.7" upper_limit="12027.1"/>
                    <measurement group_id="O2" value="13199" lower_limit="10283.1" upper_limit="16941.3"/>
                    <measurement group_id="O3" value="9922" lower_limit="7222.7" upper_limit="13630.8"/>
                    <measurement group_id="O4" value="15484" lower_limit="11526.9" upper_limit="20800.1"/>
                    <measurement group_id="O5" value="16288" lower_limit="11911.8" upper_limit="22271.2"/>
                    <measurement group_id="O6" value="12740" lower_limit="9523.2" upper_limit="17044.6"/>
                    <measurement group_id="O7" value="11939" lower_limit="9013.1" upper_limit="15815.1"/>
                    <measurement group_id="O8" value="15840" lower_limit="11770.4" upper_limit="21316.0"/>
                    <measurement group_id="O9" value="14438" lower_limit="10978.8" upper_limit="18988.3"/>
                    <measurement group_id="O10" value="14542" lower_limit="11233.0" upper_limit="18825.2"/>
                    <measurement group_id="O11" value="16797" lower_limit="12172.8" upper_limit="23178.9"/>
                    <measurement group_id="O12" value="17410" lower_limit="13396.9" upper_limit="22624.1"/>
                    <measurement group_id="O13" value="1414" lower_limit="1074.8" upper_limit="1859.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV A:3 Months after vaccination 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="36"/>
                    <count group_id="O2" value="40"/>
                    <count group_id="O3" value="40"/>
                    <count group_id="O4" value="39"/>
                    <count group_id="O5" value="38"/>
                    <count group_id="O6" value="39"/>
                    <count group_id="O7" value="39"/>
                    <count group_id="O8" value="39"/>
                    <count group_id="O9" value="40"/>
                    <count group_id="O10" value="38"/>
                    <count group_id="O11" value="41"/>
                    <count group_id="O12" value="43"/>
                    <count group_id="O13" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12010" lower_limit="9596.8" upper_limit="15028.9"/>
                    <measurement group_id="O2" value="14230" lower_limit="10948.0" upper_limit="18497.1"/>
                    <measurement group_id="O3" value="10362" lower_limit="7851.6" upper_limit="13675.7"/>
                    <measurement group_id="O4" value="15345" lower_limit="11425.0" upper_limit="20610.2"/>
                    <measurement group_id="O5" value="16637" lower_limit="13056.4" upper_limit="21199.4"/>
                    <measurement group_id="O6" value="14957" lower_limit="11432.2" upper_limit="19567.5"/>
                    <measurement group_id="O7" value="13675" lower_limit="9813.9" upper_limit="19056.4"/>
                    <measurement group_id="O8" value="16424" lower_limit="12590.9" upper_limit="21424.4"/>
                    <measurement group_id="O9" value="16089" lower_limit="12483.9" upper_limit="20735.6"/>
                    <measurement group_id="O10" value="12200" lower_limit="9656.1" upper_limit="15413.8"/>
                    <measurement group_id="O11" value="15291" lower_limit="11066.0" upper_limit="21130.2"/>
                    <measurement group_id="O12" value="16265" lower_limit="12538.4" upper_limit="21100.0"/>
                    <measurement group_id="O13" value="1772" lower_limit="1437.1" upper_limit="2185.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV A:6 Months after vaccination 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="40"/>
                    <count group_id="O3" value="40"/>
                    <count group_id="O4" value="39"/>
                    <count group_id="O5" value="38"/>
                    <count group_id="O6" value="40"/>
                    <count group_id="O7" value="39"/>
                    <count group_id="O8" value="39"/>
                    <count group_id="O9" value="40"/>
                    <count group_id="O10" value="38"/>
                    <count group_id="O11" value="41"/>
                    <count group_id="O12" value="43"/>
                    <count group_id="O13" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8452" lower_limit="6630.3" upper_limit="10775.1"/>
                    <measurement group_id="O2" value="11903" lower_limit="9294.4" upper_limit="15242.5"/>
                    <measurement group_id="O3" value="8444" lower_limit="6262.1" upper_limit="11385.4"/>
                    <measurement group_id="O4" value="10827" lower_limit="8198.8" upper_limit="14299.0"/>
                    <measurement group_id="O5" value="11871" lower_limit="8636.7" upper_limit="16317.0"/>
                    <measurement group_id="O6" value="10202" lower_limit="7456.7" upper_limit="13958.5"/>
                    <measurement group_id="O7" value="10226" lower_limit="7555.1" upper_limit="13840.9"/>
                    <measurement group_id="O8" value="13148" lower_limit="10485.1" upper_limit="16487.1"/>
                    <measurement group_id="O9" value="10769" lower_limit="8228.7" upper_limit="14092.3"/>
                    <measurement group_id="O10" value="9495" lower_limit="7587.8" upper_limit="11881.8"/>
                    <measurement group_id="O11" value="10578" lower_limit="7678.5" upper_limit="14571.9"/>
                    <measurement group_id="O12" value="11268" lower_limit="8581.1" upper_limit="14795.8"/>
                    <measurement group_id="O13" value="2057" lower_limit="1480.4" upper_limit="2859.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV A: 12 Months after vaccination 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="39"/>
                    <count group_id="O3" value="40"/>
                    <count group_id="O4" value="37"/>
                    <count group_id="O5" value="36"/>
                    <count group_id="O6" value="40"/>
                    <count group_id="O7" value="38"/>
                    <count group_id="O8" value="36"/>
                    <count group_id="O9" value="37"/>
                    <count group_id="O10" value="36"/>
                    <count group_id="O11" value="41"/>
                    <count group_id="O12" value="43"/>
                    <count group_id="O13" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7732" lower_limit="5994.9" upper_limit="9971.5"/>
                    <measurement group_id="O2" value="7891" lower_limit="5743.4" upper_limit="10841.2"/>
                    <measurement group_id="O3" value="6518" lower_limit="4825.7" upper_limit="8804.0"/>
                    <measurement group_id="O4" value="9143" lower_limit="6587.4" upper_limit="12689.9"/>
                    <measurement group_id="O5" value="7942" lower_limit="4956.1" upper_limit="12728.1"/>
                    <measurement group_id="O6" value="8639" lower_limit="6159.4" upper_limit="12116.2"/>
                    <measurement group_id="O7" value="7731" lower_limit="5491.0" upper_limit="10885.4"/>
                    <measurement group_id="O8" value="9340" lower_limit="6921.2" upper_limit="12603.7"/>
                    <measurement group_id="O9" value="9738" lower_limit="7079.7" upper_limit="13394.9"/>
                    <measurement group_id="O10" value="5872" lower_limit="3775.9" upper_limit="9132.2"/>
                    <measurement group_id="O11" value="6946" lower_limit="4590.1" upper_limit="10510.8"/>
                    <measurement group_id="O12" value="8919" lower_limit="6166.3" upper_limit="12899.3"/>
                    <measurement group_id="O13" value="1931" lower_limit="1440.0" upper_limit="2590.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV B: before vaccination 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="40"/>
                    <count group_id="O3" value="40"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="38"/>
                    <count group_id="O6" value="40"/>
                    <count group_id="O7" value="40"/>
                    <count group_id="O8" value="39"/>
                    <count group_id="O9" value="40"/>
                    <count group_id="O10" value="38"/>
                    <count group_id="O11" value="41"/>
                    <count group_id="O12" value="43"/>
                    <count group_id="O13" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2198" lower_limit="1573.7" upper_limit="3070.9"/>
                    <measurement group_id="O2" value="1862" lower_limit="1340.9" upper_limit="2586.5"/>
                    <measurement group_id="O3" value="1999" lower_limit="1506.1" upper_limit="2653.9"/>
                    <measurement group_id="O4" value="2423" lower_limit="1840.0" upper_limit="3191.1"/>
                    <measurement group_id="O5" value="2314" lower_limit="1659.8" upper_limit="3225.1"/>
                    <measurement group_id="O6" value="2194" lower_limit="1724.9" upper_limit="2790.8"/>
                    <measurement group_id="O7" value="2685" lower_limit="1949.1" upper_limit="3698.5"/>
                    <measurement group_id="O8" value="2032" lower_limit="1414.4" upper_limit="2920.4"/>
                    <measurement group_id="O9" value="2586" lower_limit="1999.1" upper_limit="3344.0"/>
                    <measurement group_id="O10" value="2241" lower_limit="1689.0" upper_limit="2972.7"/>
                    <measurement group_id="O11" value="1635" lower_limit="1155.3" upper_limit="2313.4"/>
                    <measurement group_id="O12" value="2390" lower_limit="1744.5" upper_limit="3274.4"/>
                    <measurement group_id="O13" value="1766" lower_limit="1371.2" upper_limit="2275.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV B: 1 Month after vaccination 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="40"/>
                    <count group_id="O3" value="40"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="38"/>
                    <count group_id="O6" value="40"/>
                    <count group_id="O7" value="40"/>
                    <count group_id="O8" value="40"/>
                    <count group_id="O9" value="40"/>
                    <count group_id="O10" value="38"/>
                    <count group_id="O11" value="41"/>
                    <count group_id="O12" value="43"/>
                    <count group_id="O13" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15172" lower_limit="10995.0" upper_limit="20936.5"/>
                    <measurement group_id="O2" value="20553" lower_limit="14241.6" upper_limit="29660.2"/>
                    <measurement group_id="O3" value="15169" lower_limit="11469.2" upper_limit="20063.1"/>
                    <measurement group_id="O4" value="20421" lower_limit="13852.5" upper_limit="30105.7"/>
                    <measurement group_id="O5" value="24257" lower_limit="17639.8" upper_limit="33356.3"/>
                    <measurement group_id="O6" value="18648" lower_limit="12034.5" upper_limit="28896.9"/>
                    <measurement group_id="O7" value="24158" lower_limit="16688.4" upper_limit="34969.9"/>
                    <measurement group_id="O8" value="30071" lower_limit="21347.9" upper_limit="42359.2"/>
                    <measurement group_id="O9" value="27996" lower_limit="19063.0" upper_limit="41115.9"/>
                    <measurement group_id="O10" value="25080" lower_limit="17447.2" upper_limit="36052.5"/>
                    <measurement group_id="O11" value="24320" lower_limit="17529.7" upper_limit="33741.2"/>
                    <measurement group_id="O12" value="25719" lower_limit="18637.2" upper_limit="35491.1"/>
                    <measurement group_id="O13" value="1664" lower_limit="1229.2" upper_limit="2252.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV B: 2 Months after vaccination 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="40"/>
                    <count group_id="O3" value="40"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="38"/>
                    <count group_id="O6" value="40"/>
                    <count group_id="O7" value="39"/>
                    <count group_id="O8" value="40"/>
                    <count group_id="O9" value="40"/>
                    <count group_id="O10" value="38"/>
                    <count group_id="O11" value="41"/>
                    <count group_id="O12" value="43"/>
                    <count group_id="O13" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9162" lower_limit="6658.1" upper_limit="12608.1"/>
                    <measurement group_id="O2" value="14085" lower_limit="10386.5" upper_limit="19100.9"/>
                    <measurement group_id="O3" value="9928" lower_limit="6957.8" upper_limit="14166.3"/>
                    <measurement group_id="O4" value="16107" lower_limit="11164.1" upper_limit="23237.5"/>
                    <measurement group_id="O5" value="14496" lower_limit="9907.2" upper_limit="21210.5"/>
                    <measurement group_id="O6" value="10893" lower_limit="7861.3" upper_limit="15092.6"/>
                    <measurement group_id="O7" value="11605" lower_limit="8207.0" upper_limit="16410.6"/>
                    <measurement group_id="O8" value="17024" lower_limit="11790.9" upper_limit="24580.3"/>
                    <measurement group_id="O9" value="17255" lower_limit="12641.8" upper_limit="23552.0"/>
                    <measurement group_id="O10" value="16376" lower_limit="11778.6" upper_limit="22767.4"/>
                    <measurement group_id="O11" value="17706" lower_limit="12608.5" upper_limit="24864.7"/>
                    <measurement group_id="O12" value="17268" lower_limit="13010.8" upper_limit="22917.7"/>
                    <measurement group_id="O13" value="1413" lower_limit="1093.7" upper_limit="1824.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV B: 3 Months after vaccination 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="36"/>
                    <count group_id="O2" value="40"/>
                    <count group_id="O3" value="40"/>
                    <count group_id="O4" value="39"/>
                    <count group_id="O5" value="38"/>
                    <count group_id="O6" value="39"/>
                    <count group_id="O7" value="39"/>
                    <count group_id="O8" value="39"/>
                    <count group_id="O9" value="40"/>
                    <count group_id="O10" value="38"/>
                    <count group_id="O11" value="41"/>
                    <count group_id="O12" value="43"/>
                    <count group_id="O13" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12578" lower_limit="8794.3" upper_limit="17989.3"/>
                    <measurement group_id="O2" value="13735" lower_limit="10112.3" upper_limit="18654.7"/>
                    <measurement group_id="O3" value="9741" lower_limit="6327.5" upper_limit="14996.3"/>
                    <measurement group_id="O4" value="15856" lower_limit="11221.3" upper_limit="22404.0"/>
                    <measurement group_id="O5" value="14163" lower_limit="10608.8" upper_limit="18908.1"/>
                    <measurement group_id="O6" value="11927" lower_limit="8704.5" upper_limit="16343.6"/>
                    <measurement group_id="O7" value="13631" lower_limit="9258.0" upper_limit="20070.2"/>
                    <measurement group_id="O8" value="16675" lower_limit="11847.7" upper_limit="23468.8"/>
                    <measurement group_id="O9" value="18557" lower_limit="13406.8" upper_limit="25686.3"/>
                    <measurement group_id="O10" value="13452" lower_limit="9659.9" upper_limit="18731.6"/>
                    <measurement group_id="O11" value="15031" lower_limit="10537.4" upper_limit="21442.2"/>
                    <measurement group_id="O12" value="14645" lower_limit="10736.8" upper_limit="19976.6"/>
                    <measurement group_id="O13" value="1995" lower_limit="1627.0" upper_limit="2446.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV B: 6 Months after vaccination 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="40"/>
                    <count group_id="O3" value="40"/>
                    <count group_id="O4" value="39"/>
                    <count group_id="O5" value="38"/>
                    <count group_id="O6" value="40"/>
                    <count group_id="O7" value="39"/>
                    <count group_id="O8" value="39"/>
                    <count group_id="O9" value="40"/>
                    <count group_id="O10" value="38"/>
                    <count group_id="O11" value="41"/>
                    <count group_id="O12" value="43"/>
                    <count group_id="O13" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8429" lower_limit="6127.1" upper_limit="11596.0"/>
                    <measurement group_id="O2" value="11417" lower_limit="8472.7" upper_limit="15384.7"/>
                    <measurement group_id="O3" value="7869" lower_limit="5884.7" upper_limit="10521.8"/>
                    <measurement group_id="O4" value="11739" lower_limit="8330.6" upper_limit="16542.4"/>
                    <measurement group_id="O5" value="10606" lower_limit="7585.3" upper_limit="14830.1"/>
                    <measurement group_id="O6" value="9270" lower_limit="6321.4" upper_limit="13592.7"/>
                    <measurement group_id="O7" value="10384" lower_limit="6793.2" upper_limit="15872.9"/>
                    <measurement group_id="O8" value="13562" lower_limit="10077.8" upper_limit="18251.6"/>
                    <measurement group_id="O9" value="11710" lower_limit="8535.9" upper_limit="16064.2"/>
                    <measurement group_id="O10" value="10597" lower_limit="7911.2" upper_limit="14195.9"/>
                    <measurement group_id="O11" value="10645" lower_limit="7424.7" upper_limit="15262.1"/>
                    <measurement group_id="O12" value="10875" lower_limit="8159.0" upper_limit="14496.1"/>
                    <measurement group_id="O13" value="2374" lower_limit="1633.3" upper_limit="3452.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RSV B: 12 Months after vaccination 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="39"/>
                    <count group_id="O3" value="40"/>
                    <count group_id="O4" value="37"/>
                    <count group_id="O5" value="36"/>
                    <count group_id="O6" value="40"/>
                    <count group_id="O7" value="38"/>
                    <count group_id="O8" value="36"/>
                    <count group_id="O9" value="37"/>
                    <count group_id="O10" value="36"/>
                    <count group_id="O11" value="41"/>
                    <count group_id="O12" value="43"/>
                    <count group_id="O13" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7467" lower_limit="5426.5" upper_limit="10274.0"/>
                    <measurement group_id="O2" value="7969" lower_limit="5671.5" upper_limit="11196.5"/>
                    <measurement group_id="O3" value="6445" lower_limit="4561.6" upper_limit="9106.0"/>
                    <measurement group_id="O4" value="9200" lower_limit="6460.4" upper_limit="13101.5"/>
                    <measurement group_id="O5" value="7573" lower_limit="4659.2" upper_limit="12310.2"/>
                    <measurement group_id="O6" value="6634" lower_limit="4565.5" upper_limit="9639.4"/>
                    <measurement group_id="O7" value="7449" lower_limit="5139.4" upper_limit="10796.7"/>
                    <measurement group_id="O8" value="9256" lower_limit="6496.9" upper_limit="13186.5"/>
                    <measurement group_id="O9" value="9855" lower_limit="6874.6" upper_limit="14127.4"/>
                    <measurement group_id="O10" value="6809" lower_limit="4274.8" upper_limit="10846.9"/>
                    <measurement group_id="O11" value="7001" lower_limit="4436.2" upper_limit="11049.8"/>
                    <measurement group_id="O12" value="8500" lower_limit="5551.2" upper_limit="13016.2"/>
                    <measurement group_id="O13" value="2058" lower_limit="1525.8" upper_limit="2775.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Expanded Cohort: Hemagglutination Inhibition Assay (HAI) Titers for All Strains Following Vaccination With Seasonal Inactivated Influenza (SIIV) Vaccine in Participants (Aged 18 to 49 Years)</title>
        <description>The HAI titer LLOQ value for each strain was 10. Assay values below LLOQ were set to 0.5* LLOQ for analysis. Titers were expressed in terms of 1/dilution.</description>
        <time_frame>Before vaccination and 1 Month after SIIV vaccination</time_frame>
        <population>Evaluable influenza immunogenicity population (EIIP) : participants who were eligible, received all RSV vaccine or placebo to which they were randomized, received influenza vaccine, had blood drawn for assay testing within 27 to 42 days after Visit 1, had at least 1 valid and determinate assay result at 1-month-postvaccination visit and no major protocol violations.</population>
        <group_list>
          <group group_id="O1">
            <title>Expanded Cohort: RSV 60 mcg With SIIV Age 18-49 Years</title>
            <description>Participants aged 18-49 years received 2 doses of RSV vaccine 60 mcg along with 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O2">
            <title>Expanded Cohort: RSV 60 mcg With Placebo Age 18-49 Years</title>
            <description>Participants aged 18-49 years received 2 doses of RSV vaccine 60 mcg along with placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O3">
            <title>Expanded Cohort: RSV 60 mcg With Aluminum Hydroxide and SIIV Age 18-49 Years</title>
            <description>Participants aged 18-49 years received 2 doses of RSV vaccine 60 mcg along with aluminum hydroxide and 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O4">
            <title>Expanded Cohort: RSV 60 mcg With Aluminum Hydroxide and Placebo Age 18-49 Years</title>
            <description>Participants aged 18-49 years received 2 doses of RSV vaccine 60 mcg along with aluminum hydroxide and placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O5">
            <title>Expanded Cohort: RSV 120 mcg With SIIV Age 18-49 Years</title>
            <description>Participants aged 18-49 years received 2 doses of RSV vaccine 120 mcg along with 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O6">
            <title>Expanded Cohort: RSV 120 mcg With Placebo Age 18-49 Years</title>
            <description>Participants aged 18-49 years received 2 doses of RSV vaccine 120 mcg along with placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O7">
            <title>Expanded Cohort: RSV 120 mcg With Aluminum Hydroxide and SIIV Age 18-49 Years</title>
            <description>Participants aged 18-49 years received 2 doses of RSV vaccine 120 mcg along with aluminum hydroxide and 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O8">
            <title>Expanded Cohort: RSV 120 mcg With Aluminum Hydroxide and Placebo Age 18-49 Years</title>
            <description>Participants aged 18-49 years received 2 doses of RSV vaccine 120 mcg along with aluminum hydroxide and placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O9">
            <title>Expanded Cohort: RSV 240 mcg With SIIV Age 18-49 Years</title>
            <description>Participants aged 18-49 years received 2 doses of RSV vaccine 240 mcg along with 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O10">
            <title>Expanded Cohort: RSV 240 mcg With Placebo Age 18-49 Years</title>
            <description>Participants aged 18-49 years received 2 doses of RSV vaccine 240 mcg along with placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O11">
            <title>Expanded Cohort: RSV 240 mcg With Aluminum Hydroxide and SIIV Age 18-49 Years</title>
            <description>Participants aged 18-49 years received 2 doses of RSV vaccine 240 mcg along with aluminum hydroxide and 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O12">
            <title>Expanded Cohort: RSV 240 mcg With Aluminum Hydroxide and Placebo Age 18-49 Years</title>
            <description>Participants aged 18-49 years received 2 doses of RSV vaccine 240 mcg along with aluminum hydroxide and placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O13">
            <title>Expanded Cohort: Placebo Age 18-49 Years</title>
            <description>Participants aged 18-49 years received placebo matched to RSV vaccine intramuscularly. Participants were followed up to 12 months after vaccination.</description>
          </group>
        </group_list>
        <measure>
          <title>Expanded Cohort: Hemagglutination Inhibition Assay (HAI) Titers for All Strains Following Vaccination With Seasonal Inactivated Influenza (SIIV) Vaccine in Participants (Aged 18 to 49 Years)</title>
          <description>The HAI titer LLOQ value for each strain was 10. Assay values below LLOQ were set to 0.5* LLOQ for analysis. Titers were expressed in terms of 1/dilution.</description>
          <population>Evaluable influenza immunogenicity population (EIIP) : participants who were eligible, received all RSV vaccine or placebo to which they were randomized, received influenza vaccine, had blood drawn for assay testing within 27 to 42 days after Visit 1, had at least 1 valid and determinate assay result at 1-month-postvaccination visit and no major protocol violations.</population>
          <units>Titers</units>
          <param>Geometric Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="39"/>
                <count group_id="O2" value="33"/>
                <count group_id="O3" value="40"/>
                <count group_id="O4" value="32"/>
                <count group_id="O5" value="40"/>
                <count group_id="O6" value="33"/>
                <count group_id="O7" value="39"/>
                <count group_id="O8" value="33"/>
                <count group_id="O9" value="40"/>
                <count group_id="O10" value="36"/>
                <count group_id="O11" value="41"/>
                <count group_id="O12" value="31"/>
                <count group_id="O13" value="34"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>A-H1N1: before SIIV</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="44.5" lower_limit="30.34" upper_limit="65.26"/>
                    <measurement group_id="O2" value="25.0" lower_limit="17.15" upper_limit="36.51"/>
                    <measurement group_id="O3" value="38.0" lower_limit="25.74" upper_limit="56.03"/>
                    <measurement group_id="O4" value="33.7" lower_limit="22.47" upper_limit="50.53"/>
                    <measurement group_id="O5" value="18.9" lower_limit="13.51" upper_limit="26.47"/>
                    <measurement group_id="O6" value="27.0" lower_limit="16.99" upper_limit="42.96"/>
                    <measurement group_id="O7" value="29.6" lower_limit="19.01" upper_limit="45.99"/>
                    <measurement group_id="O8" value="26.1" lower_limit="16.68" upper_limit="40.85"/>
                    <measurement group_id="O9" value="20.5" lower_limit="14.21" upper_limit="29.48"/>
                    <measurement group_id="O10" value="28.7" lower_limit="18.16" upper_limit="45.28"/>
                    <measurement group_id="O11" value="32.1" lower_limit="22.97" upper_limit="44.88"/>
                    <measurement group_id="O12" value="22.7" lower_limit="14.61" upper_limit="35.35"/>
                    <measurement group_id="O13" value="33.5" lower_limit="21.85" upper_limit="51.43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A-H1N1: 1 month after SIIV</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="77.2" lower_limit="55.13" upper_limit="108.07"/>
                    <measurement group_id="O2" value="95.3" lower_limit="65.73" upper_limit="138.06"/>
                    <measurement group_id="O3" value="85.8" lower_limit="63.75" upper_limit="115.37"/>
                    <measurement group_id="O4" value="114.0" lower_limit="75.09" upper_limit="173.00"/>
                    <measurement group_id="O5" value="62.4" lower_limit="45.56" upper_limit="85.46"/>
                    <measurement group_id="O6" value="113.5" lower_limit="73.56" upper_limit="175.25"/>
                    <measurement group_id="O7" value="70.2" lower_limit="46.13" upper_limit="106.88"/>
                    <measurement group_id="O8" value="128.8" lower_limit="87.91" upper_limit="188.58"/>
                    <measurement group_id="O9" value="57.2" lower_limit="43.42" upper_limit="75.40"/>
                    <measurement group_id="O10" value="83.6" lower_limit="58.45" upper_limit="119.71"/>
                    <measurement group_id="O11" value="72.3" lower_limit="54.40" upper_limit="96.16"/>
                    <measurement group_id="O12" value="114.4" lower_limit="81.16" upper_limit="161.24"/>
                    <measurement group_id="O13" value="126.9" lower_limit="91.78" upper_limit="175.60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A-H3N2: before SIIV</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="35.1" lower_limit="23.42" upper_limit="52.58"/>
                    <measurement group_id="O2" value="25.4" lower_limit="16.15" upper_limit="39.89"/>
                    <measurement group_id="O3" value="32.7" lower_limit="22.27" upper_limit="47.91"/>
                    <measurement group_id="O4" value="35.7" lower_limit="22.14" upper_limit="57.44"/>
                    <measurement group_id="O5" value="23.9" lower_limit="15.90" upper_limit="36.02"/>
                    <measurement group_id="O6" value="28.8" lower_limit="18.02" upper_limit="45.95"/>
                    <measurement group_id="O7" value="30.3" lower_limit="18.90" upper_limit="48.56"/>
                    <measurement group_id="O8" value="25.7" lower_limit="15.10" upper_limit="43.83"/>
                    <measurement group_id="O9" value="20.9" lower_limit="13.37" upper_limit="32.81"/>
                    <measurement group_id="O10" value="22.4" lower_limit="14.54" upper_limit="34.63"/>
                    <measurement group_id="O11" value="32.3" lower_limit="21.51" upper_limit="48.44"/>
                    <measurement group_id="O12" value="20.3" lower_limit="13.25" upper_limit="31.06"/>
                    <measurement group_id="O13" value="34.4" lower_limit="23.03" upper_limit="51.44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A-H3N2: 1 month after SIIV</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="77.7" lower_limit="54.76" upper_limit="110.11"/>
                    <measurement group_id="O2" value="129.6" lower_limit="84.87" upper_limit="198.00"/>
                    <measurement group_id="O3" value="81.4" lower_limit="58.32" upper_limit="113.57"/>
                    <measurement group_id="O4" value="158.8" lower_limit="113.23" upper_limit="222.77"/>
                    <measurement group_id="O5" value="85.2" lower_limit="57.22" upper_limit="126.96"/>
                    <measurement group_id="O6" value="120.0" lower_limit="77.87" upper_limit="185.00"/>
                    <measurement group_id="O7" value="74.5" lower_limit="50.39" upper_limit="110.25"/>
                    <measurement group_id="O8" value="130.6" lower_limit="83.11" upper_limit="205.23"/>
                    <measurement group_id="O9" value="81.4" lower_limit="59.53" upper_limit="111.30"/>
                    <measurement group_id="O10" value="82.1" lower_limit="56.50" upper_limit="119.19"/>
                    <measurement group_id="O11" value="95.8" lower_limit="67.10" upper_limit="136.84"/>
                    <measurement group_id="O12" value="134.8" lower_limit="92.88" upper_limit="195.69"/>
                    <measurement group_id="O13" value="152.5" lower_limit="114.26" upper_limit="203.64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>B1: before SIIV</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.2" lower_limit="9.24" upper_limit="18.73"/>
                    <measurement group_id="O2" value="10.3" lower_limit="7.64" upper_limit="13.87"/>
                    <measurement group_id="O3" value="10.8" lower_limit="7.81" upper_limit="14.93"/>
                    <measurement group_id="O4" value="13.3" lower_limit="8.97" upper_limit="19.86"/>
                    <measurement group_id="O5" value="7.3" lower_limit="5.92" upper_limit="9.06"/>
                    <measurement group_id="O6" value="13.0" lower_limit="9.12" upper_limit="18.43"/>
                    <measurement group_id="O7" value="8.7" lower_limit="6.61" upper_limit="11.53"/>
                    <measurement group_id="O8" value="9.5" lower_limit="6.64" upper_limit="13.46"/>
                    <measurement group_id="O9" value="8.3" lower_limit="6.27" upper_limit="11.03"/>
                    <measurement group_id="O10" value="9.4" lower_limit="6.75" upper_limit="13.22"/>
                    <measurement group_id="O11" value="12.6" lower_limit="9.30" upper_limit="17.06"/>
                    <measurement group_id="O12" value="9.2" lower_limit="6.77" upper_limit="12.55"/>
                    <measurement group_id="O13" value="10.5" lower_limit="8.05" upper_limit="13.68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>B1: 1 month after SIIV</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23.5" lower_limit="17.09" upper_limit="32.25"/>
                    <measurement group_id="O2" value="41.7" lower_limit="27.86" upper_limit="62.52"/>
                    <measurement group_id="O3" value="29.3" lower_limit="20.47" upper_limit="41.97"/>
                    <measurement group_id="O4" value="47.2" lower_limit="29.73" upper_limit="74.99"/>
                    <measurement group_id="O5" value="18.4" lower_limit="13.75" upper_limit="24.74"/>
                    <measurement group_id="O6" value="38.4" lower_limit="25.91" upper_limit="56.86"/>
                    <measurement group_id="O7" value="19.1" lower_limit="13.83" upper_limit="26.41"/>
                    <measurement group_id="O8" value="32.7" lower_limit="20.81" upper_limit="51.27"/>
                    <measurement group_id="O9" value="15.5" lower_limit="11.28" upper_limit="21.39"/>
                    <measurement group_id="O10" value="22.3" lower_limit="15.61" upper_limit="31.85"/>
                    <measurement group_id="O11" value="23.8" lower_limit="18.32" upper_limit="30.95"/>
                    <measurement group_id="O12" value="25.6" lower_limit="16.86" upper_limit="38.82"/>
                    <measurement group_id="O13" value="31.8" lower_limit="21.21" upper_limit="47.55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>B2: before SIIV</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.3" lower_limit="11.09" upper_limit="23.85"/>
                    <measurement group_id="O2" value="11.7" lower_limit="8.93" upper_limit="15.24"/>
                    <measurement group_id="O3" value="12.5" lower_limit="9.29" upper_limit="16.71"/>
                    <measurement group_id="O4" value="18.4" lower_limit="12.60" upper_limit="26.73"/>
                    <measurement group_id="O5" value="9.3" lower_limit="7.16" upper_limit="12.20"/>
                    <measurement group_id="O6" value="12.8" lower_limit="9.20" upper_limit="17.77"/>
                    <measurement group_id="O7" value="11.5" lower_limit="8.68" upper_limit="15.30"/>
                    <measurement group_id="O8" value="10.6" lower_limit="7.32" upper_limit="15.27"/>
                    <measurement group_id="O9" value="10.4" lower_limit="7.84" upper_limit="13.83"/>
                    <measurement group_id="O10" value="12.3" lower_limit="8.75" upper_limit="17.25"/>
                    <measurement group_id="O11" value="11.6" lower_limit="8.73" upper_limit="15.53"/>
                    <measurement group_id="O12" value="11.2" lower_limit="8.19" upper_limit="15.31"/>
                    <measurement group_id="O13" value="13.1" lower_limit="9.74" upper_limit="17.69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>B2: 1 month after SIIV</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="29.0" lower_limit="21.07" upper_limit="40.04"/>
                    <measurement group_id="O2" value="39.4" lower_limit="27.06" upper_limit="57.46"/>
                    <measurement group_id="O3" value="27.8" lower_limit="20.40" upper_limit="37.97"/>
                    <measurement group_id="O4" value="46.9" lower_limit="31.34" upper_limit="70.31"/>
                    <measurement group_id="O5" value="22.6" lower_limit="17.56" upper_limit="29.11"/>
                    <measurement group_id="O6" value="28.4" lower_limit="18.66" upper_limit="43.17"/>
                    <measurement group_id="O7" value="22.3" lower_limit="16.17" upper_limit="30.65"/>
                    <measurement group_id="O8" value="39.7" lower_limit="25.21" upper_limit="62.56"/>
                    <measurement group_id="O9" value="20.1" lower_limit="14.73" upper_limit="27.51"/>
                    <measurement group_id="O10" value="28.7" lower_limit="20.16" upper_limit="40.71"/>
                    <measurement group_id="O11" value="25.9" lower_limit="19.08" upper_limit="35.19"/>
                    <measurement group_id="O12" value="37.5" lower_limit="27.37" upper_limit="51.25"/>
                    <measurement group_id="O13" value="36.2" lower_limit="26.26" upper_limit="49.80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Expanded Cohort: Hemagglutination Inhibition Assay (HAI) Titers for All Strains Following Vaccination With Seasonal Inactivated Influenza (SIIV) Vaccine in Participants (Aged 65 to 85 Years)</title>
        <description>The HAI titer LLOQ value for each strain was 10. Assay values below LLOQ were set to 0.5* LLOQ for analysis. Titers were expressed in terms of 1/dilution.</description>
        <time_frame>Before vaccination and 1 Month after SIIV vaccination</time_frame>
        <population>EIIP : participants who were eligible, received all RSV vaccine or placebo to which they were randomized, received influenza vaccine, had blood drawn for assay testing within 27 to 42 days after Visit 1, had at least 1 valid and determinate assay result at 1-month-postvaccination visit and no major protocol violations.</population>
        <group_list>
          <group group_id="O1">
            <title>Expanded Cohort: RSV 60 mcg With SIIV Age 65-85 Years</title>
            <description>Participants aged 65-85 years received 2 doses of RSV vaccine 60 mcg along with 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O2">
            <title>Expanded Cohort: RSV 60 mcg With Placebo Age 65-85 Years</title>
            <description>Participants aged 65-85 years received 2 doses of RSV vaccine 60 mcg along with placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O3">
            <title>Expanded Cohort: RSV 60 mcg With Aluminum Hydroxide and SIIV Age 65-85 Years</title>
            <description>Participants aged 65-85 years received 2 doses of RSV vaccine 60 mcg along with aluminum hydroxide and 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O4">
            <title>Expanded Cohort: RSV 60 mcg With Aluminum Hydroxide and Placebo Age 65-85 Years</title>
            <description>Participants aged 65-85 years received 2 doses of RSV vaccine 60 mcg along with aluminum hydroxide and placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O5">
            <title>Expanded Cohort: RSV 120 mcg With SIIV Age 65-85 Years</title>
            <description>Participants aged 65-85 years received 2 doses of RSV vaccine 120 mcg along with 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O6">
            <title>Expanded Cohort: RSV 120 mcg With Placebo Age 65-85 Years</title>
            <description>Participants aged 65-85 years received 2 doses of RSV vaccine 120 mcg along with placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O7">
            <title>Expanded Cohort: RSV 120 mcg With Aluminum Hydroxide and SIIV Age 65-85 Years</title>
            <description>Participants aged 65-85 years received 2 doses of RSV vaccine 120 mcg along with aluminum hydroxide and 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O8">
            <title>Expanded Cohort: RSV 120 mcg With Aluminum Hydroxide and Placebo Age 65-85 Years</title>
            <description>Participants aged 65-85 years received 2 doses of RSV vaccine 120 mcg along with aluminum hydroxide and placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O9">
            <title>Expanded Cohort: RSV 240 mcg With SIIV Age 65-85 Years</title>
            <description>Participants aged 65-85 years received 2 doses of RSV vaccine 240 mcg along with 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O10">
            <title>Expanded Cohort: RSV 240 mcg With Placebo Age 65-85 Years</title>
            <description>Participants aged 65-85 years received 2 doses of RSV vaccine 240 mcg along with placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O11">
            <title>Expanded Cohort: RSV 240 mcg With Aluminum Hydroxide and SIIV Age 65-85 Years</title>
            <description>Participants aged 65-85 years received 2 doses of RSV vaccine 240 mcg along with aluminum hydroxide and 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O12">
            <title>Expanded Cohort: RSV 240 mcg With Aluminum Hydroxide and Placebo Age 65-85 Years</title>
            <description>Participants aged 65-85 years received 2 doses of RSV vaccine 240 mcg along with aluminum hydroxide and placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
          </group>
          <group group_id="O13">
            <title>Expanded Cohort: Placebo Age 65-85 Years</title>
            <description>Participants aged 65-85 years received placebo matched to RSV vaccine intramuscularly. Participants were followed up to 12 months after vaccination.</description>
          </group>
        </group_list>
        <measure>
          <title>Expanded Cohort: Hemagglutination Inhibition Assay (HAI) Titers for All Strains Following Vaccination With Seasonal Inactivated Influenza (SIIV) Vaccine in Participants (Aged 65 to 85 Years)</title>
          <description>The HAI titer LLOQ value for each strain was 10. Assay values below LLOQ were set to 0.5* LLOQ for analysis. Titers were expressed in terms of 1/dilution.</description>
          <population>EIIP : participants who were eligible, received all RSV vaccine or placebo to which they were randomized, received influenza vaccine, had blood drawn for assay testing within 27 to 42 days after Visit 1, had at least 1 valid and determinate assay result at 1-month-postvaccination visit and no major protocol violations.</population>
          <units>Titers</units>
          <param>Geometric Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="38"/>
                <count group_id="O2" value="35"/>
                <count group_id="O3" value="40"/>
                <count group_id="O4" value="36"/>
                <count group_id="O5" value="38"/>
                <count group_id="O6" value="37"/>
                <count group_id="O7" value="40"/>
                <count group_id="O8" value="37"/>
                <count group_id="O9" value="40"/>
                <count group_id="O10" value="33"/>
                <count group_id="O11" value="41"/>
                <count group_id="O12" value="35"/>
                <count group_id="O13" value="34"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>A-H1N1: before SIIV</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.8" lower_limit="10.12" upper_limit="18.94"/>
                    <measurement group_id="O2" value="14.8" lower_limit="9.94" upper_limit="21.93"/>
                    <measurement group_id="O3" value="11.0" lower_limit="8.67" upper_limit="13.87"/>
                    <measurement group_id="O4" value="13.4" lower_limit="9.34" upper_limit="19.10"/>
                    <measurement group_id="O5" value="16.6" lower_limit="11.42" upper_limit="24.03"/>
                    <measurement group_id="O6" value="12.3" lower_limit="8.63" upper_limit="17.53"/>
                    <measurement group_id="O7" value="17.5" lower_limit="11.91" upper_limit="25.74"/>
                    <measurement group_id="O8" value="14.4" lower_limit="10.84" upper_limit="19.26"/>
                    <measurement group_id="O9" value="17.8" lower_limit="12.69" upper_limit="25.00"/>
                    <measurement group_id="O10" value="15.2" lower_limit="11.37" upper_limit="20.39"/>
                    <measurement group_id="O11" value="15.6" lower_limit="11.14" upper_limit="21.87"/>
                    <measurement group_id="O12" value="22.5" lower_limit="14.87" upper_limit="34.10"/>
                    <measurement group_id="O13" value="17.6" lower_limit="11.89" upper_limit="26.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A-H1N1: 1 month after SIIV</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="43.6" lower_limit="29.44" upper_limit="64.44"/>
                    <measurement group_id="O2" value="54.5" lower_limit="36.01" upper_limit="82.60"/>
                    <measurement group_id="O3" value="44.4" lower_limit="30.05" upper_limit="65.55"/>
                    <measurement group_id="O4" value="61.9" lower_limit="44.30" upper_limit="86.50"/>
                    <measurement group_id="O5" value="52.9" lower_limit="37.69" upper_limit="74.31"/>
                    <measurement group_id="O6" value="51.1" lower_limit="33.92" upper_limit="76.97"/>
                    <measurement group_id="O7" value="56.6" lower_limit="36.12" upper_limit="88.61"/>
                    <measurement group_id="O8" value="71.0" lower_limit="50.60" upper_limit="99.77"/>
                    <measurement group_id="O9" value="45.7" lower_limit="31.63" upper_limit="66.00"/>
                    <measurement group_id="O10" value="58.4" lower_limit="40.56" upper_limit="84.11"/>
                    <measurement group_id="O11" value="52.4" lower_limit="33.76" upper_limit="81.37"/>
                    <measurement group_id="O12" value="72.0" lower_limit="48.76" upper_limit="106.23"/>
                    <measurement group_id="O13" value="75.8" lower_limit="52.94" upper_limit="108.40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A-H3N2: before SIIV</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="29.7" lower_limit="20.41" upper_limit="43.23"/>
                    <measurement group_id="O2" value="24.7" lower_limit="16.39" upper_limit="37.24"/>
                    <measurement group_id="O3" value="26.2" lower_limit="16.56" upper_limit="41.58"/>
                    <measurement group_id="O4" value="22.9" lower_limit="14.25" upper_limit="36.72"/>
                    <measurement group_id="O5" value="34.6" lower_limit="21.08" upper_limit="56.69"/>
                    <measurement group_id="O6" value="23.5" lower_limit="16.45" upper_limit="33.66"/>
                    <measurement group_id="O7" value="30.5" lower_limit="19.70" upper_limit="47.20"/>
                    <measurement group_id="O8" value="35.7" lower_limit="20.99" upper_limit="60.84"/>
                    <measurement group_id="O9" value="22.5" lower_limit="14.37" upper_limit="35.11"/>
                    <measurement group_id="O10" value="32.6" lower_limit="21.12" upper_limit="50.40"/>
                    <measurement group_id="O11" value="34.7" lower_limit="21.82" upper_limit="55.29"/>
                    <measurement group_id="O12" value="44.5" lower_limit="28.03" upper_limit="70.66"/>
                    <measurement group_id="O13" value="28.7" lower_limit="17.54" upper_limit="46.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>A-H3N2: 1 month after SIIV</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="94.3" lower_limit="62.80" upper_limit="141.58"/>
                    <measurement group_id="O2" value="105.6" lower_limit="67.56" upper_limit="164.96"/>
                    <measurement group_id="O3" value="78.2" lower_limit="50.07" upper_limit="122.27"/>
                    <measurement group_id="O4" value="118.3" lower_limit="78.75" upper_limit="177.68"/>
                    <measurement group_id="O5" value="140.0" lower_limit="95.48" upper_limit="205.23"/>
                    <measurement group_id="O6" value="109.3" lower_limit="69.69" upper_limit="171.51"/>
                    <measurement group_id="O7" value="131.5" lower_limit="87.38" upper_limit="197.83"/>
                    <measurement group_id="O8" value="185.0" lower_limit="107.84" upper_limit="317.50"/>
                    <measurement group_id="O9" value="79.0" lower_limit="55.60" upper_limit="112.38"/>
                    <measurement group_id="O10" value="153.4" lower_limit="98.53" upper_limit="238.89"/>
                    <measurement group_id="O11" value="103.1" lower_limit="63.41" upper_limit="167.73"/>
                    <measurement group_id="O12" value="130.4" lower_limit="76.49" upper_limit="222.29"/>
                    <measurement group_id="O13" value="106.4" lower_limit="64.27" upper_limit="176.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>B1: before SIIV</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.4" lower_limit="6.86" upper_limit="12.77"/>
                    <measurement group_id="O2" value="8.6" lower_limit="6.40" upper_limit="11.56"/>
                    <measurement group_id="O3" value="12.9" lower_limit="8.78" upper_limit="18.95"/>
                    <measurement group_id="O4" value="8.5" lower_limit="6.73" upper_limit="10.79"/>
                    <measurement group_id="O5" value="11.1" lower_limit="7.96" upper_limit="15.47"/>
                    <measurement group_id="O6" value="10.4" lower_limit="7.56" upper_limit="14.26"/>
                    <measurement group_id="O7" value="11.5" lower_limit="8.26" upper_limit="15.97"/>
                    <measurement group_id="O8" value="8.7" lower_limit="6.61" upper_limit="11.37"/>
                    <measurement group_id="O9" value="8.7" lower_limit="6.69" upper_limit="11.34"/>
                    <measurement group_id="O10" value="8.5" lower_limit="6.56" upper_limit="10.91"/>
                    <measurement group_id="O11" value="9.5" lower_limit="6.97" upper_limit="12.97"/>
                    <measurement group_id="O12" value="8.6" lower_limit="6.56" upper_limit="11.39"/>
                    <measurement group_id="O13" value="9.1" lower_limit="7.08" upper_limit="11.67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>B1: 1 month after SIIV</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19.5" lower_limit="13.45" upper_limit="28.32"/>
                    <measurement group_id="O2" value="26.4" lower_limit="17.77" upper_limit="39.22"/>
                    <measurement group_id="O3" value="22.9" lower_limit="16.22" upper_limit="32.19"/>
                    <measurement group_id="O4" value="31.7" lower_limit="22.89" upper_limit="43.96"/>
                    <measurement group_id="O5" value="24.7" lower_limit="16.82" upper_limit="36.39"/>
                    <measurement group_id="O6" value="23.4" lower_limit="16.25" upper_limit="33.69"/>
                    <measurement group_id="O7" value="26.2" lower_limit="17.56" upper_limit="39.20"/>
                    <measurement group_id="O8" value="21.6" lower_limit="15.13" upper_limit="30.72"/>
                    <measurement group_id="O9" value="18.9" lower_limit="12.77" upper_limit="27.89"/>
                    <measurement group_id="O10" value="29.4" lower_limit="19.44" upper_limit="44.45"/>
                    <measurement group_id="O11" value="21.2" lower_limit="15.17" upper_limit="29.64"/>
                    <measurement group_id="O12" value="23.1" lower_limit="16.58" upper_limit="32.32"/>
                    <measurement group_id="O13" value="26.8" lower_limit="17.35" upper_limit="41.34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>B2: before SIIV</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.7" lower_limit="6.19" upper_limit="9.46"/>
                    <measurement group_id="O2" value="7.7" lower_limit="6.16" upper_limit="9.58"/>
                    <measurement group_id="O3" value="9.6" lower_limit="7.26" upper_limit="12.72"/>
                    <measurement group_id="O4" value="8.0" lower_limit="6.24" upper_limit="10.23"/>
                    <measurement group_id="O5" value="10.6" lower_limit="7.55" upper_limit="14.99"/>
                    <measurement group_id="O6" value="8.2" lower_limit="6.24" upper_limit="10.75"/>
                    <measurement group_id="O7" value="9.9" lower_limit="7.37" upper_limit="13.25"/>
                    <measurement group_id="O8" value="6.9" lower_limit="5.60" upper_limit="8.45"/>
                    <measurement group_id="O9" value="7.9" lower_limit="6.21" upper_limit="10.15"/>
                    <measurement group_id="O10" value="8.3" lower_limit="6.69" upper_limit="10.26"/>
                    <measurement group_id="O11" value="8.6" lower_limit="6.66" upper_limit="11.10"/>
                    <measurement group_id="O12" value="8.4" lower_limit="6.88" upper_limit="10.33"/>
                    <measurement group_id="O13" value="7.3" lower_limit="5.71" upper_limit="9.38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>B2: 1 month after SIIV</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.4" lower_limit="8.00" upper_limit="13.44"/>
                    <measurement group_id="O2" value="11.0" lower_limit="8.01" upper_limit="15.02"/>
                    <measurement group_id="O3" value="13.0" lower_limit="9.15" upper_limit="18.37"/>
                    <measurement group_id="O4" value="12.4" lower_limit="8.84" upper_limit="17.30"/>
                    <measurement group_id="O5" value="16.6" lower_limit="11.67" upper_limit="23.50"/>
                    <measurement group_id="O6" value="13.2" lower_limit="9.48" upper_limit="18.31"/>
                    <measurement group_id="O7" value="13.3" lower_limit="9.49" upper_limit="18.76"/>
                    <measurement group_id="O8" value="10.0" lower_limit="7.94" upper_limit="12.62"/>
                    <measurement group_id="O9" value="9.7" lower_limit="7.57" upper_limit="12.35"/>
                    <measurement group_id="O10" value="15.3" lower_limit="10.49" upper_limit="22.39"/>
                    <measurement group_id="O11" value="10.9" lower_limit="8.02" upper_limit="14.77"/>
                    <measurement group_id="O12" value="13.2" lower_limit="9.99" upper_limit="17.46"/>
                    <measurement group_id="O13" value="13.2" lower_limit="9.13" upper_limit="19.16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Local reactions and systemic events: within 14 days after vaccination 1; AEs: Baseline up to 12 months after vaccination 1 (approximately up to 378 days)</time_frame>
      <desc>Same event may appear as both an AE and SAE. However, what is presented are distinct events. An event may be categorized as serious in 1 participant and as non-serious in another, or a participant may have experienced both a serious and non-serious event.</desc>
      <group_list>
        <group group_id="E1">
          <title>Sentinel Cohort: RSV Vaccine 60 mcg Age 18-49 Years</title>
          <description>Participants aged 18-49 years received single 60-mcg dose of RSV vaccine, intramuscularly. Participants were followed up to 12 months after vaccination.</description>
        </group>
        <group group_id="E2">
          <title>Sentinel Cohort: RSV 120 mcg Age 18-49 Years</title>
          <description>Participants aged 18-49 years received single 120-mcg dose intramuscularly. Participants were followed up to 12 months after vaccination.</description>
        </group>
        <group group_id="E3">
          <title>Sentinel Cohort: RSV 240 mcg Age 18-49 Years</title>
          <description>Participants aged 18-49 years received single 240-mcg dose intramuscularly. Participants were followed up to 12 months after vaccination.</description>
        </group>
        <group group_id="E4">
          <title>Sentinel Cohort: Placebo Age 18-49 Years</title>
          <description>Participants aged 18-49 years received placebo matched to RSV vaccine intramuscularly. Participants were followed up to 12 months after vaccination.</description>
        </group>
        <group group_id="E5">
          <title>Sentinel Cohort: RSV 60 mcg With Aluminum Hydroxide Age 50-85 Years</title>
          <description>Participants aged 50-85 years received single 60-mcg dose with aluminum hydroxide intramuscularly. Participants were followed up to 12 months after vaccination.</description>
        </group>
        <group group_id="E6">
          <title>Sentinel Cohort: RSV 120 mcg With Aluminum Hydroxide Age 50-85 Years</title>
          <description>Participants aged 50-85 years received single 120-mcg dose with aluminum hydroxide intramuscularly. Participants were followed up to 12 months after vaccination.</description>
        </group>
        <group group_id="E7">
          <title>Sentinel Cohort: RSV 240 mcg With Aluminum Hydroxide Age 50-85 Years</title>
          <description>Participants aged 50-85 years received single 240-mcg dose with aluminum hydroxide intramuscularly. Participants were followed up to 12 months after vaccination.</description>
        </group>
        <group group_id="E8">
          <title>Sentinel Cohort: RSV 60 mcg With Aluminum Hydroxide Age 18-49 Years</title>
          <description>Participants aged 18-49 years received single 60-mcg dose with aluminum hydroxide intramuscularly. Participants were followed up to 12 months after vaccination.</description>
        </group>
        <group group_id="E9">
          <title>Sentinel Cohort: RSV 120 mcg With Aluminum Hydroxide Age 18-49 Years</title>
          <description>Participants aged 18-49 years received single 120-mcg dose with aluminum hydroxide intramuscularly. Participants were followed up to 12 months after vaccination.</description>
        </group>
        <group group_id="E10">
          <title>Sentinel Cohort: RSV 240 mcg With Aluminum Hydroxide Age 18-49 Years</title>
          <description>Participants aged 18-49 years received single 240-mcg dose with aluminum hydroxide intramuscularly. Participants were followed up to 12 months after vaccination.</description>
        </group>
        <group group_id="E11">
          <title>Sentinel Cohort: RSV Vaccine 60 mcg Age 50-85 Years</title>
          <description>Participants aged 50-85 years received single 60-mcg dose of RSV vaccine, intramuscularly. Participants were followed up to 12 months after vaccination.</description>
        </group>
        <group group_id="E12">
          <title>Sentinel Cohort: RSV 120 mcg Age 50-85 Years</title>
          <description>Participants aged 50-85 years received single 120-mcg dose intramuscularly. Participants were followed up to 12 months after vaccination.</description>
        </group>
        <group group_id="E13">
          <title>Sentinel Cohort: RSV 240 mcg Age 50-85 Years</title>
          <description>Participants aged 50-85 years received single 240-mcg dose intramuscularly. Participants were followed up to 12 months after vaccination.</description>
        </group>
        <group group_id="E14">
          <title>Sentinel Cohort: Placebo Age 50-85 Years</title>
          <description>Participants aged 50-85 years received placebo matched to RSV vaccine intramuscularly. Participants were followed up to 12 months after vaccination.</description>
        </group>
        <group group_id="E15">
          <title>Expanded Cohort: RSV 60 mcg With SIIV Age 18-49 Years</title>
          <description>Participants aged 18-49 years received 2 doses of RSV vaccine 60 mcg along with 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
        </group>
        <group group_id="E16">
          <title>Expanded Cohort: RSV 60 mcg With Aluminum Hydroxide and SIIV Age 18-49 Years</title>
          <description>Participants aged 18-49 years received 2 doses of RSV vaccine 60 mcg along with aluminum hydroxide and 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
        </group>
        <group group_id="E17">
          <title>Expanded Cohort: RSV 120 mcg With SIIV Age 18-49 Years</title>
          <description>Participants aged 18-49 years received 2 doses of RSV vaccine 120 mcg along with 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
        </group>
        <group group_id="E18">
          <title>Expanded Cohort: RSV 120 mcg With Aluminum Hydroxide and SIIV Age 18-49 Years</title>
          <description>Participants aged 18-49 years received 2 doses of RSV vaccine 120 mcg along with aluminum hydroxide and 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
        </group>
        <group group_id="E19">
          <title>Expanded Cohort: RSV 240 mcg With SIIV Age 18-49 Years</title>
          <description>Participants aged 18-49 years received 2 doses of RSV vaccine 240 mcg along with 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
        </group>
        <group group_id="E20">
          <title>Expanded Cohort: RSV 240 mcg With Aluminum Hydroxide and SIIV Age 18-49 Years</title>
          <description>Participants aged 18-49 years received 2 doses of RSV vaccine 240 mcg along with aluminum hydroxide and 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
        </group>
        <group group_id="E21">
          <title>Expanded Cohort: Placebo Age 18-49 Years</title>
          <description>Participants aged 18-49 years received placebo matched to RSV vaccine intramuscularly. Participants were followed up to 12 months after vaccination.</description>
        </group>
        <group group_id="E22">
          <title>Expanded Cohort: RSV 60 mcg With Placebo Age 65-85 Years</title>
          <description>Participants aged 65-85 years received 2 doses of RSV vaccine 60 mcg along with placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
        </group>
        <group group_id="E23">
          <title>Expanded Cohort: RSV 60 mcg With Aluminum Hydroxide and Placebo Age 65-85 Years</title>
          <description>Participants aged 65-85 years received 2 doses of RSV vaccine 60 mcg along with aluminum hydroxide and placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
        </group>
        <group group_id="E24">
          <title>Expanded Cohort: RSV 120 mcg With Placebo Age 65-85 Years</title>
          <description>Participants aged 65-85 years received 2 doses of RSV vaccine 120 mcg along with placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
        </group>
        <group group_id="E25">
          <title>Expanded Cohort: RSV 120 mcg With Aluminum Hydroxide and Placebo Age 65-85 Years</title>
          <description>Participants aged 65-85 years received 2 doses of RSV vaccine 120 mcg along with aluminum hydroxide and placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
        </group>
        <group group_id="E26">
          <title>Expanded Cohort: RSV 240 mcg With Placebo Age 65-85 Years</title>
          <description>Participants aged 65-85 years received 2 doses of RSV vaccine 240 mcg along with placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
        </group>
        <group group_id="E27">
          <title>Expanded Cohort: RSV 240 mcg With Aluminum Hydroxide and Placebo Age 65-85 Years</title>
          <description>Participants aged 65-85 years received 2 doses of RSV vaccine 240 mcg along with aluminum hydroxide and placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
        </group>
        <group group_id="E28">
          <title>Expanded Cohort: RSV 60 mcg With Placebo Age 18-49 Years</title>
          <description>Participants aged 18-49 years received 2 doses of RSV vaccine 60 mcg along with placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
        </group>
        <group group_id="E29">
          <title>Expanded Cohort: RSV 60 mcg With Aluminum Hydroxide and Placebo Age 18-49 Years</title>
          <description>Participants aged 18-49 years received 2 doses of RSV vaccine 60 mcg along with aluminum hydroxide and placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
        </group>
        <group group_id="E30">
          <title>Expanded Cohort: RSV 120 mcg With Placebo Age 18-49 Years</title>
          <description>Participants aged 18-49 years received 2 doses of RSV vaccine 120 mcg along with placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
        </group>
        <group group_id="E31">
          <title>Expanded Cohort: RSV 120 mcg With Aluminum Hydroxide and Placebo Age 18-49 Years</title>
          <description>Participants aged 18-49 years received 2 doses of RSV vaccine 120 mcg along with aluminum hydroxide and placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
        </group>
        <group group_id="E32">
          <title>Expanded Cohort: RSV 240 mcg With Placebo Age 18-49 Years</title>
          <description>Participants aged 18-49 years received 2 doses of RSV vaccine 240 mcg along with placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
        </group>
        <group group_id="E33">
          <title>Expanded Cohort: RSV 240 mcg With Aluminum Hydroxide and Placebo Age 18-49 Years</title>
          <description>Participants aged 18-49 years received 2 doses of RSV vaccine 240 mcg along with aluminum hydroxide and placebo at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
        </group>
        <group group_id="E34">
          <title>Expanded Cohort: RSV 60 mcg With SIIV Age 65-85 Years</title>
          <description>Participants aged 65-85 years received 2 doses of RSV vaccine 60 mcg along with 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
        </group>
        <group group_id="E35">
          <title>Expanded Cohort: RSV 60 mcg With Aluminum Hydroxide and SIIV Age 65-85 Years</title>
          <description>Participants aged 65-85 years received 2 doses of RSV vaccine 60 mcg along with aluminum hydroxide and 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
        </group>
        <group group_id="E36">
          <title>Expanded Cohort: RSV 120 mcg With SIIV Age 65-85 Years</title>
          <description>Participants aged 65-85 years received 2 doses of RSV vaccine 120 mcg along with 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
        </group>
        <group group_id="E37">
          <title>Expanded Cohort: RSV 120 mcg With Aluminum Hydroxide and SIIV Age 65-85 Years</title>
          <description>Participants aged 65-85 years received 2 doses of RSV vaccine 120 mcg along with aluminum hydroxide and 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
        </group>
        <group group_id="E38">
          <title>Expanded Cohort: RSV 240 mcg With SIIV Age 65-85 Years</title>
          <description>Participants aged 65-85 years received 2 doses of RSV vaccine 240 mcg along with 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
        </group>
        <group group_id="E39">
          <title>Expanded Cohort: RSV 240 mcg With Aluminum Hydroxide and SIIV Age 65-85 Years</title>
          <description>Participants aged 65-85 years received 2 doses of RSV vaccine 240 mcg along with aluminum hydroxide and 0.5 mL SIIV at Day 1 (Vaccination 1) and Day 35 (Vaccination 2), intramuscularly. Participants were followed up to 12 months after vaccination 1.</description>
        </group>
        <group group_id="E40">
          <title>Expanded Cohort: Placebo Age 65-85 Years</title>
          <description>Participants aged 65-85 years received placebo matched to RSV vaccine intramuscularly. Participants were followed up to 12 months after vaccination.</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA v23.0</default_vocab>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="2" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="7" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="8" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="2" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="2" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="3" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="3" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="2" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="2" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="3" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="2" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="4" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="4" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="7" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="4" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="3" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="3" subjects_at_risk="41"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="1" subjects_at_risk="41"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Atrial fibrillation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="1" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="2" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Cardiac failure congestive</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="1" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Coronary artery disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Myocardial infarction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Colitis ischaemic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Ileus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Proctitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Upper gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="1" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Cholecystitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="1" subjects_at_risk="41"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Abscess limb</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Diverticulitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Escherichia bacteraemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Influenza</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Osteomyelitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="1" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Pneumonia bacterial</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Rhinovirus infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Viral sepsis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Contusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Gun shot wound</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Maisonneuve fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Rib fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Subdural haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Toxicity to various agents</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Fluid retention</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Neck pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="1" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Osteoarthritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Rotator cuff syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Breast cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Invasive breast carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Lung carcinoma cell type unspecified stage IV</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="1" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Lung neoplasm malignant</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Oesophageal cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Prostate cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Sarcoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Tonsil cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Autonomic failure syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="1" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Brain injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Cerebrovascular accident</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="1" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Seizure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Pregnancy, puerperium and perinatal conditions</title>
            <event_list>
              <event>
                <sub_title>Abortion spontaneous</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Ectopic pregnancy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Pregnancy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Completed suicide</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Depression suicidal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Mental status changes</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Suicide attempt</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Acute kidney injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Acute respiratory failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Asthma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Chronic obstructive pulmonary disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Hypoxia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Pulmonary embolism</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Social circumstances</title>
            <event_list>
              <event>
                <sub_title>Pregnancy of partner</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Hip arthroplasty</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Deep vein thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_vocab>MedDRA v23.0</default_vocab>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="6" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="7" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="7" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="8" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="10" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="11" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="9" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="8" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="5" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="5" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="4" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="31" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="36" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="33" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="35" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="33" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="35" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="26" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="24" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="29" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="26" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="26" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="29" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="28" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="33" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="30" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="34" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="35" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="32" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="38" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="24" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="23" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="24" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="21" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="32" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="28" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="25" subjects_at_risk="41"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Leukocytosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Lymphadenitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Lymphadenopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Thrombocytopenia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Aortic valve stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="1" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Atrial fibrillation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="1" subjects_at_risk="41"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Ear pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Vertigo</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Vertigo positional</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Hypothyroidism</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Cataract</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal discomfort</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Abdominal pain lower</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Abdominal pain upper</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Dental caries</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="1" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="3" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="1" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="1" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Diarrhoea (DIARRHEA)</sub_title>
                <assessment>Systematic Assessment</assessment>
                <description>11 participants for sentinel cohort:RSV 240 mcg age 18-49 years arm, 40 participants for expanded cohort: RSV 120 mcg with aluminum hydroxide and placebo age 18-49 years arm and 40 participants at risk for expanded cohort: placebo age 65-85 years arm</description>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="11"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="3" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="2" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="2" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="4" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="6" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="10" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="10" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="8" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="6" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="5" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="5" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="7" subjects_at_risk="40"/>
                <counts group_id="E23" subjects_affected="5" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="2" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="6" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="5" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="4" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="10" subjects_at_risk="40"/>
                <counts group_id="E29" subjects_affected="7" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="10" subjects_at_risk="40"/>
                <counts group_id="E31" subjects_affected="10" subjects_at_risk="40"/>
                <counts group_id="E32" subjects_affected="9" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="10" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="3" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="9" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="4" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="4" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="10" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="6" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="3" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Faeces discoloured</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Food poisoning</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Gastric ulcer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Gastrooesophageal reflux disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Glossodynia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="1" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Paraesthesia oral</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Toothache</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="4" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Nausea (NAUSEA)</sub_title>
                <assessment>Systematic Assessment</assessment>
                <description>11 participants for sentinel cohort: RSV 240 mcg age 18-49 years arm and 40 participants for expanded cohort: RSV 120 mcg with aluminum hydroxide and placebo Age 18-49 Years were at risk.</description>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="11"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="2" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="3" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="2" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="2" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="6" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="8" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="6" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="5" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="8" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="4" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="6" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="4" subjects_at_risk="40"/>
                <counts group_id="E23" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="2" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="8" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="5" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="2" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="6" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="6" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="11" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="9" subjects_at_risk="40"/>
                <counts group_id="E32" subjects_affected="7" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="8" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="2" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="2" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="4" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="5" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="3" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="2" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Vomiting (VOMITING)</sub_title>
                <assessment>Systematic Assessment</assessment>
                <description>11 participant of sentinel cohort: RSV 240 mcg age 18-49 years arm, 40 participants of expanded cohort: RSV 60 mcg with placebo age 65-85 years and 40 participants of expanded Cohort: placebo Age 65-85 years arms were at risk.</description>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="11"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="3" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="2" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="2" subjects_at_risk="40"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="3" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="1" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E32" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="3" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="2" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Chills</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="2" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Injection site bruising</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Injection site erythema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Injection site erythema (REDNESS)</sub_title>
                <assessment>Systematic Assessment</assessment>
                <description>11 participants of sentinel cohort:RSV 240 mcg age 18-49 years,40 participants of expanded cohort (RSV 120 mcg with aluminum hydroxide and placebo age 18-49 years,RSV 60 mcg with placebo age 65-85 years and placebo age 65-85 years) arms were at risk.</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="2" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="2" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="3" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="3" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="2" subjects_at_risk="40"/>
                <counts group_id="E23" subjects_affected="4" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="3" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="5" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="3" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="3" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="2" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="3" subjects_at_risk="40"/>
                <counts group_id="E32" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="6" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="3" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="3" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="2" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Injection site haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Injection site pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Injection site pain (PAIN AT INJECTION SITE)</sub_title>
                <assessment>Systematic Assessment</assessment>
                <description>11 participants of sentinel cohort:RSV 240 mcg age 18-49 years,40 participants of expanded cohort (RSV 120 mcg with aluminum hydroxide and placebo age 18-49 years,RSV 60 mcg with placebo age 65-85 years and placebo age 65-85 years) arms were at risk.</description>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="11"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="5" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="9" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="10" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="8" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="2" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="19" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="28" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="19" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="25" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="16" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="25" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="7" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="4" subjects_at_risk="40"/>
                <counts group_id="E23" subjects_affected="10" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="5" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="8" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="8" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="8" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="16" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="21" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="21" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="27" subjects_at_risk="40"/>
                <counts group_id="E32" subjects_affected="17" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="27" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="11" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="11" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="9" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="12" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="13" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="10" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="2" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Injection site pruritus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Injection site swelling</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Injection site swelling (SWELLING)</sub_title>
                <assessment>Systematic Assessment</assessment>
                <description>11 participants of sentinel cohort:RSV 240 mcg age 18-49 years,40 participants of expanded cohort (RSV 120 mcg with aluminum hydroxide and placebo age 18-49 years,RSV 60 mcg with placebo age 65-85 years and placebo age 65-85 years) arms were at risk.</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="2" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="2" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="5" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="3" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="2" subjects_at_risk="40"/>
                <counts group_id="E23" subjects_affected="2" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="2" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="2" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="3" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="4" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="4" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="2" subjects_at_risk="40"/>
                <counts group_id="E32" subjects_affected="2" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="9" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="3" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="3" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="2" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="2" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="1" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Malaise</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Oedema peripheral</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="1" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Pyrexia (FEVER)</sub_title>
                <assessment>Systematic Assessment</assessment>
                <description>11 participants of sentinel cohort:RSV 240 mcg age 18-49 years,40 participants of expanded cohort (RSV 120 mcg with aluminum hydroxide and placebo age 18-49 years,RSV 60 mcg with placebo age 65-85 years and placebo age 65-85 years) arms were at risk</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="5" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="2" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="2" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E32" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="2" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Sensation of foreign body</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Fatigue (FATIGUE)</sub_title>
                <description>11 participants of sentinel cohort: RSV 240 mcg age 18-49 years, 40 participants of expanded cohort (RSV 120 mcg with aluminum hydroxide and placebo age 18-49 Years, RSV 60 mcg with placebo age 65-85 years and placebo age 65-85 years) were at risk.</description>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="11"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="7" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="4" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="3" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="6" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="7" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="7" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="5" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="4" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="4" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="20" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="17" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="16" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="18" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="18" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="21" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="13" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="10" subjects_at_risk="40"/>
                <counts group_id="E23" subjects_affected="16" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="8" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="13" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="11" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="11" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="19" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="16" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="15" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="20" subjects_at_risk="40"/>
                <counts group_id="E32" subjects_affected="22" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="18" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="8" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="11" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="9" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="14" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="17" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="20" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="6" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Cholelithiasis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Hyperbilirubinaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Seasonal allergy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Acute sinusitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Bronchitis viral</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Conjunctivitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Conjunctivitis bacterial</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Cystitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Cystitis bacterial</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Diverticulitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="1" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Ear infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="1" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Folliculitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Furuncle</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Gastroenteritis viral</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Herpes zoster</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Herpes zoster reactivation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Infected bite</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Infected cyst</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Influenza</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Localised infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Nasopharyngitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="2" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="1" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="2" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Nipple infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Oral herpes</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Otitis externa</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Otitis media</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Pharyngitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Pharyngitis bacterial</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Pharyngitis streptococcal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="2" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="2" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="3" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="2" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="2" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="3" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Respiratory tract infection viral</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Sinusitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="1" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="1" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Tinea cruris</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Tooth abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Tooth infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="3" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="5" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="3" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="3" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="4" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="2" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="2" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="2" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="2" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="3" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="1" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="2" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="4" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="4" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="2" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="2" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="4" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract infection bacterial</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="2" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="2" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="1" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Vaginal infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Vestibular neuronitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Viral infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="1" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="1" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Viral pharyngitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Viral upper respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="2" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="2" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Vulvovaginal mycotic infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Alcohol poisoning</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Arthropod bite</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Concussion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Contusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="2" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Epicondylitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Face injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Fall</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="2" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="1" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Hand fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Jaw fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="1" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Joint injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Limb injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Muscle strain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Post procedural haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Procedural pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Skin laceration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Alanine aminotransferase increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Aspartate aminotransferase increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Blood pressure systolic decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Transaminases increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Decreased appetite</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Diabetes mellitus inadequate control</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Gout</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="1" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Hyperglycaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Hypokalaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Type 2 diabetes mellitus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="2" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="1" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="2" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Arthralgia (JOINT PAIN)</sub_title>
                <assessment>Systematic Assessment</assessment>
                <description>11 participants of sentinel cohort: RSV 240 mcg age 18-49 years, 40 participants of expanded cohort (RSV 120 mcg with aluminum hydroxide and placebo age 18-49 Years, RSV 60 mcg with placebo age 65-85 years and placebo age 65-85 years) were at risk.</description>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="11"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="4" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="2" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="2" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="2" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="8" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="11" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="8" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="10" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="7" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="7" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="2" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="7" subjects_at_risk="40"/>
                <counts group_id="E23" subjects_affected="8" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="6" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="8" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="7" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="3" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="5" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="2" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="5" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="12" subjects_at_risk="40"/>
                <counts group_id="E32" subjects_affected="7" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="8" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="8" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="4" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="6" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="5" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="5" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="12" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="6" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Arthritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Flank pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Haemarthrosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Intervertebral disc degeneration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Intervertebral disc protrusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Limb discomfort</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Muscle spasms</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Musculoskeletal chest pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Musculoskeletal pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="2" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="1" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Musculoskeletal stiffness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Myalgia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Myalgia (MUSCLE PAIN)</sub_title>
                <assessment>Systematic Assessment</assessment>
                <description>11 participants of sentinel cohort: RSV 240 mcg age 18-49 years, 40 participants of expanded cohort (RSV 120 mcg with aluminum hydroxide and placebo age 18-49 Years, RSV 60 mcg with placebo age 65-85 years and placebo age 65-85 years) were at risk.</description>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="11"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="6" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="4" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="4" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="6" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="7" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="4" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="2" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="17" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="23" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="14" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="25" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="17" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="20" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="5" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="6" subjects_at_risk="40"/>
                <counts group_id="E23" subjects_affected="7" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="5" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="11" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="12" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="9" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="13" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="15" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="17" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="21" subjects_at_risk="40"/>
                <counts group_id="E32" subjects_affected="15" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="21" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="7" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="6" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="9" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="8" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="13" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="15" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="4" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Neck mass</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Osteoarthritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="1" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Osteopenia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Pain in extremity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Plantar fasciitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Polyarthritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Sacroiliitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Trigger finger</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Adrenal adenoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Basal cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Squamous cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="2" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Lumbar radiculopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Migraine</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Paraesthesia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Sciatica</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Sinus headache</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Tension headache</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Headache (HEADACHE)</sub_title>
                <assessment>Systematic Assessment</assessment>
                <description>11 participants of sentinel cohort: RSV 240 mcg age 18-49 years, 40 participants of expanded cohort (RSV 120 mcg with aluminum hydroxide and placebo age 18-49 Years, RSV 60 mcg with placebo age 65-85 years and placebo age 65-85 years) were at risk.</description>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="11"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="3" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="5" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="5" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="5" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="3" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="18" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="16" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="21" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="19" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="21" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="19" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="13" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="5" subjects_at_risk="40"/>
                <counts group_id="E23" subjects_affected="7" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="7" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="10" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="12" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="9" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="23" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="18" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="20" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="19" subjects_at_risk="40"/>
                <counts group_id="E32" subjects_affected="16" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="17" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="10" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="5" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="7" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="4" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="6" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="14" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="9" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Anxiety</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="1" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Bipolar II disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Insomnia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Nervousness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="1" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Nephrolithiasis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Nephropathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Dysfunctional uterine bleeding</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Galactorrhoea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Ovarian cyst</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Vulvovaginal pruritus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Asthma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Chronic obstructive pulmonary disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="4" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="2" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Nasal congestion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="2" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="2" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="1" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Nasal septum deviation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Oropharyngeal pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="1" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Productive cough</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Respiratory disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="2" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="2" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="2" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="2" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="2" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="1" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="5" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="2" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="4" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="2" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="5" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="2" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="2" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="2" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="4" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="2" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="1" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Respiratory symptom</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Rhinalgia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Rhinitis allergic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Rhinorrhoea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="2" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="2" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="2" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="2" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Upper-airway cough syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Dermal cyst</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Dermatitis contact</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Dermatitis exfoliative</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Diabetic foot</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="1" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Hyperhidrosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Pityriasis rosea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Rash</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Rash macular</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Skin exfoliation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Skin lesion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Skin ulcer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Urticaria</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="2" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Wisdom teeth removal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="1" subjects_at_risk="41"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Flushing</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E27" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E28" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E29" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E30" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E31" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E32" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E33" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E34" subjects_affected="1" subjects_at_risk="40"/>
                <counts group_id="E35" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E36" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E37" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E38" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E39" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E40" subjects_affected="0" subjects_at_risk="41"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Pfizer ClinicalTrials.gov Call Center</name_or_title>
      <organization>Pfizer Inc</organization>
      <phone>1-800-718-1021</phone>
      <email>ClinicalTrials.gov_Inquiries@pfizer.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

